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Overview of bioactive agents used in this study 
Table I 
overview of artiñcial receptor ligands used in this study 
ligand receptor action 
2-hydroxy-saclofcn 
4-aminobutylphosphonic acid 
apomorphine 
baclofen 
bicuculline 
δ-aniinovaleric acid 
isoguvacine 
phaclofen 
Picrotoxin 
sulpiride 
GAB AB 
GABAB 
D2 
G A B A B 
GABAA 
GAB AB 
GABAA 
GABAB 
GABAA 
D2 
antagonist 
antagonist 
agonist 
agonist 
antagonist 
agonist 
agonist 
antagonist 
antagonist 
antagonist 
Table II 
overview of other bioactive agents used in this study 
agent target action 
4-aminopyridine 
A23187 
BAY-K8644 
cadmium chloride 
cobalt chloride 
forskolin 
isobutylmethylxanthine 
lithium chloride 
nifedipine 
omega-conotoxin 
pertussis toxin 
tetraethylammonium chloride 
thapsigargin 
verapamil 
K+-channel 
membranes 
L-type VOCC 
voce 
VOCC 
adenylate cyclase 
phosphodiesterase 
ІП8І,4,5-Рз 5-phosphatase 
L-type VOCC 
N-type VOCC 
G, and G,, 
K+-channel 
Ca2+-ATPase 
L-type VOCC 
inactivation 
Ca2+-ionophore 
activation 
inactivation 
inactivation 
activation 
inactivation 
inactivation 
inactivation 
inactivation 
inactivation 
inactivation 
inactivation 
inactivation 
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GENERAL INTRODUCTION 

General introduction 
Scope of the thesis 
In all multicellular organisms communication between cells and organs is essential for the 
functioning of the organism as a whole. This holds for virtually all cells, but is most obvious 
for cells that constitute the organs belonging to the central nervous system and the endocrine 
system, the main systems responsible for information transfer. Both systems are involved in 
the perception, integration and export of various signals, enabling the organism to react 
adequately to the continuously changing environment. Communication does not only occur 
between neurons and endocrine cells with their respective peripheral targets (e.g. muscles, 
gonads and immune system) but also between neurons themselves as well as between neurons 
and endocrine cells. In some cases the intercellular communication process involves direct 
intercellular contacts (e.g. gap junctions, electrical synapses), but in most cases communication 
is effectuated by the release of a chemical ('first') messenger that traverses the extracellular 
space to couple to a receptor of the target cell. The receptor subsequently 'translates' the 
signal via a transduction mechanism into a cellular response (e.g. generation of electrical 
activity or secretory activity). As will be outlined below, first messengers may reach their 
targets in various ways and also signal transduction mechanisms may differ from one neuron 
or endocrine cell to another. This diversity in intercellular communication is most conspicuous 
in target cells that receive multiple input signals that are transduced simultaneously to form a 
complex cellular response. In this thesis the nature and functioning of such multiple signalling 
phenomena will be treated on the basis of research on signal transduction in the 
neuroendocrine melanotrope cells in the pituitary gland of the amphibian Xenopus laevis. 
How first messengers reach their receptors 
The classical image of the nervous system is that of a network formed by neurons and their 
processes, communicating through specialized contacts, the synapses. Neurons release a first 
messenger (neurotransmitter), such as acetylcholine or dopamine, which binds to a specific 
receptor in the plasma membrane of the target cell. The action of the neurotransmitter is 
confined to the immediate surroundings of the nerve terminal, the synaptic cleft. In contrast, 
endocrine first messengers, the hormones, always reach their target via the circulation and are 
thus capable of influencing more than one target. As a consequence, the action of hormones is 
much slower but more widespread than that of neurotransmitters. Endocrine regulation is in 
particular responsible for the control of long-term physiological processes such as growth, 
reproduction, development and adaptation. In this traditional view, the nervous and endocrine 
systems are two separate communication systems, each controlling distinct processes. 
More recently, it has become clear that the communication both within and between the 
nervous and endocrine systems is far more elaborate than previously imagined. In contrast to 
Dale's Law (1935), which states that one neuron produces only one type of transmitter, it has 
been shown that most if not all neurons produce and secrete more than one chemical 
messenger (e.g. Hökfelt et al., 1986). Probably, each messenger exerts a distinct physiological 
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action on the target cell, through a specific receptor. Since it has also been demonstrated that 
several messengers may coexist within the same nerve terminal, and even within the same 
synaptic vesicle, the question whether these messengers are released simultaneously or 
differentially is now receiving particular attention. This also holds for endocrine cells, many of 
which simultaneously produce a variety of first messengers. Examples of both co-release and 
differential release have been reported (.e.g. Lundberg and Hökfelt, 1983; Viveros et al. 1983; 
Lundberg et ai, 1988). The concept of functional cooperation between co-released messengers 
at the cellular and intracellular level is currently emerging from this field of study. Many of 
these messengers are peptides. 
Another important change in the concept of the nervous system is the finding that 
communication between neurons is not only accomplished via direct, synaptic contacts but also 
in a hormone-like way. In this 'nonsynaptic' or 'paracrine' type of communication, messengers 
(particularly peptides) are not released into a synaptic cleft but into the extracellular space of 
the nervous system; they subsequently diffuse over considerable distances through the nervous 
system to bind eventually to their distant targets (e.g. Beaudet and Descarriers, 1978; Buma 
and Roubos, 1986). 
In addition to this paracrine mode of neurotransmission, a second mode of communication 
exists in which neuronal messengers can reach distantly located targets. This is when the 
messenger, mostly a neuropeptide, is released into the circulation in a neurohaemal area, e.g. 
from the median eminence or from the neural lobe of the pituitary. In this case there is a 
convergence of the nervous and endocrine systems in that the neuronal messenger acts as a 
neurohormone. Well known examples of this type of hormone are vasopressin and oxytocin. 
The process is commonly known as 'neurosecretion'. 
Not only can the nervous system release neurohormones, it also has a profound influence 
on the endocrine system. In turn, the endocrine system influences the nervous system. 
Communication between the two systems occurs in various ways. The endocrine cells in the 
periphery can act, directly or indirectly, on the central nervous system, by sending hormones 
capable of crossing the blood-brain barrier to the brain. These actions are mostly part of 
feedback loops that start with neurons that control the secretory activity of the endocrine cells. 
Some of these neurons, primarily located in the hypothalamus, control the activity of the 
main endocrine gland, the pituitary, either via the blood (first described by Speidcl, 1919; 
Scharrer, 1929) or by a direct synaptic contact (Bargmann et al, 1967). The latter situation is 
best exemplified by the innervation of the pituitary gland in lower vertebrates. This complex 
organ consists of endocrine cells, axon terminals, and supporting cells, and is referred to as a 
neuroendocrine gland. The main supporting cell is a glial-like cell, called folliculo-slellate cell. 
This cell is present throughout the intermediate and anterior lobe of the pituitary, and its 
slender processes make intimate contacts with virtually all endocrine cells (Ferryman, 1989). 
The recent observation that the stellate cell in the anterior lobe plays a role in the regulation of 
the secretory activity of the endocrine cells (Bacs et al, 1987; Gospodarowicz and Lau, 1989) 
adds yet an other level of complexity to the scala of communication mechanisms between the 
nervous and the endocrine system. 
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How receptors transduce signals 
Changes in cellular activity are usually brought about by agents in the extracellular space, like 
neurotransmitters, neurohormones and hormones. These first messengers bind to specific 
receptors, either in the cell (as in the case of steroid hormones and thyroxin) or at the cell 
surface (e.g. neurotransmitters). In the latter case, the messenger does not enter the cell and its 
message will therefore have to be conveyed into the cell by the receptor. For that purpose, the 
receptor activates or inactivates enzymes that control key processes in the cell. This procedure, 
from receptor activation to intracellular response, is known as signal transduction. The receptor 
may control key enzymes directly, by intrinsic kinase activity (e.g. receptors for growth 
factors), or indirectly, cither by activation of transmembrane ion fluxes (e.g. GABAA receptor, 
NMDA receptor, glycine receptor) or by activation of a G-protein (e.g. GABAB receptor, 
catecholamine receptors, most neuropeptide receptors). In the latter case, it is the G-protein 
that in turn activates or inactivates an ion channel or an enzyme that generates an intracellular 
messenger ('second messenger'; for review see e.g. Gilman, 1987). 
The most important second messengers are probably adenosine S'.S'-cyclic 
monophosphate (cyclic-AMP), inositol 1,4,5-lriphosphate (IP3) and diacylglyccrol (DAG). 
Cyclic-AMP is generated by the enzyme adenylate cyclase, a process that is stimulated by the 
G-protein G, and inhibited by the G-proteins G, and G0 (Gilman, 1984, 1987). The main 
function of cyclic-AMP is to activate protein kinase A (PKA), which phosphorylates multiple 
intracellular targets (Hemmings et al., 1989). The second messengers IP, and DAG are 
generated by cleavage of the membrane phospholipid phosphatidylinositol 1,4-biphosphate. 
The cleavage is perfonned by phospholipasc С (PLC), which is activated by the G-protein Gp 
(for review see e.g. Berridge, 1988). To date, no conclusive evidence has been reported that 
PLC is under both inhibitory and stimulatory control by G-proteins. The receptor for IP3 is a 
Ca2+-selective ion channel, mediating Ca2+ release from intracellular stores (Ferris et al., 1989). 
After IP3 binds the to receptor, the ion channel is opened and calcium ions enter the 
cytoplasm, activating various calcium-binding proteins such as calmodulin and protein kinase 
С The kinase is activated by Ca2* and DAG together and plays a pivotal role in the interaction 
between the various signal transduction pathways (e.g. Houslay, 1991). Other calcium-binding 
proteins that are important in the regulation of the secretory activity of endocrine cells are e.g. 
calmodulin and calmodulm/Ca2*-dependent protein kinases (Hemmings et al., 1989; Stojilkovié 
and Ca«, 1992). 
Among the targets for second messenger-activated protein kinases are plasma membrane 
ion channels (e.g. Hemmings et al., 1989; Conn, 1990) that control intracellular calcium 
concentrations and the membrane potential of the plasma membrane. Thus, ion channel gating 
is controlled by the second messenger concentration. In addition, the gating of some channels 
may be regulated by direct coupling of G-proteins to the channel (e.g. Holz et ai, 1986; 
Stemweis and Pang, 1990). A single G-protein may bind multiple effector sites, so that 
activation of one receptor can activate and/or inactivate several intracellular signalling 
pathways. In this way, different receptors on one cell can converge their actions to one 
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common intracellular pathway to inhibit secretion, while, at the same time, each receptor can 
individually control one or more additional cellular processes, such as the biosynthesis and the 
intracellular transportation of secretory products. A simplified overview of some of the signal 
transduction pathways discussed above is provided in figure 1. In reality, the complexity of 
these pathways is often considerably higher. In order to characterize this complexity and to 
elucidate the cell physiological relevance of this complexity in terms of intercellular neuronal 
and endocrine communication, signal transduction has been studied in a neuroendocrine gland, 
the pituitary of Xenopus laevis. 
Extracellular 
cAMP 
ATP I 
L5 
Ό 
M 
R 
m 
CAMP 
t l 
•ι 
Intracellular 
Fig. I. Some possible intracellular mechanisms involved in the regulation of a-MSH 
secretion. L = ligand; R = receptor; PKA = protein kinase A; PKC = protein kinase 
C; PLC = phospholipase C; AC = adenylate cyclase; DAG = dtacylglycerol; ¡P¡ = 
inositol 1,4,5-triphosphate; cAMP = adenosine 3',5'-cyclic monophosphate. 
The melanotrope cells of Xenopus laevis as a model to study multiple signal transduction 
mechanisms 
The functioning of a neuroendocrine gland can be considered at four levels: (1) the innervation 
of the endocrine tissue, (2) the receptors present on the endocrine cells, (3) the intracellular 
events integrating the neuronal messages and (4) the resulting endocrine output. This thesis 
describes the integration of a complex neuronal input, consisting of both classical 
neurotransmitters and neuropeptides, into an endocrine output. This has been studied in the 
pars intermedia of the aquatic load Xenopus laevis. Particular attention has been given to the 
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characterization of the receptors involved and the mechanisms that couple receptor activation 
to a stimulation or inhibition of the release of the peptide hormone a-melanophore-slimulating 
hormone (a-MSH) 
The pars intermedia of Xenopus contains one endocrine cell type, the melanotrope cell 
This cell releases a-MSH, which causes dispersion of the black pigment melanin in the dermal 
melanophores In this fashion, the concentration of a-MSH in the blood regulates skin colour, 
the skin changes from white to black with increasing a-MSH concentration (Bagnara and 
Hadley, 1973, Jenks, 1977, Van Zoest et al, 1989) In adapting its skin colour to match the 
background, the animal has to regulate the a-MSH concentration in its blood This is achieved 
mainly by inhibiting the spontaneous secretion of a-MSH from melanotrope cells when the 
animal perceives a light background The inhibition is caused by agents released by neurons, 
probably of hypothalamic origin, that innervate the pars intermedia (Jenks et al, 1988, 
Roubos, 1992) To date, three agents have been identified that probably are physiological a-
MSH inhibiting factors in Xenopus Innervation with neurons containing dopamine, γ-
aminobutync acid (GABA) and Neuropeptide Y (NPY) has been identified in the pars 
intennedia (Verburg-van Kemenade et al, 1986c, 1987b, Van Slnen et al, 1991, De Rijk et 
al, 1990a, 1992) All three messengers are potent inhibitors of a-MSH from neurointermediate 
lobes m vitro (Verburg-van Kemenade et al, 1986c,d, 1987b) For GABA two distinct 
receptor types have been shown to exist on Xenopus melanotropes, the GABAA receptor and 
the GABAB receptor (Verburg-van Kemenade et aL, 1986a, 1987b) Two neuropeptides that 
are capable of stimulating a-MSH secretion have been identified thyrotropin-relcdsing 
hormone (TRH) and sauvagine, an amphibian peptide related to corlicotropin-releasing 
hormone (CRH, Verburg-van Kemenade et al, 1987a,f) Finally, adrenalin inhibits a-MSH 
release in vitro (Verburg-van Kemenade et al, 1986b), but a physiological role in the 
regulation of melanotrope cell activity remains to be established for this biogenic amine 
From the above it appears that the regulation of melanotrope cell activity is a very 
complex affair The question anses as to the physiological relevance of this complexity, and in 
particular, of at least four inhibitory receptors Two very likely possibilities are the release of 
distinct neuronal factors after specific physiological stimuli, and differential action of the 
individual inhibitors on cellular processes unrelated to a-MSH secretion This matter has 
become even more interesting now that it has been shown that all the inhibitory factors coexist 
in nerve terminals in the pars intennedia (De Rijk et al, 1992) The diversity of the neural 
input makes the neurointermediate lobe of Xenopus laevis an interesting system to study 
neuroendocrine regulation and the interactions between multiple regulatory factors at the 
cellular level 
Aim and outline of this thesis 
The aim of the studies descnbed in this thesis was to investigate how the pars intermedia 
transduces multiple neuronal mpul to a coordinated endocrine output To obtain a thorough 
understanding of this intncaie process, the following components of the process have been 
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investigated 
(1) Identification of the first messengers involved in the regulation ot melanotrope cell 
activity 
(2) Determination of the extracellular pathways (directly via synapses, or indirectly) by 
which the first messengers act on the melanotrope cell 
(3) Identification and charactenzalion of the receptors through which the various first 
messengers act upon the melanotropes 
(4) Identification and characterization of the second messengers that are responsible for 
the receptor-mediated signal transduction into a response (secretion) of the 
melanotrope cell 
(5) Assessment of interactions between different second messenger systems within the 
melanotrope cell 
The first component of the signal transduction system, the first messengers, has previously 
received much attention On the basis of in vitro supertusion experiments and of 
immunocytochcmical techniques a number of potential physiological regulators was identified 
(e g Jcnks et al, 1988, De Rijk et al, 1992) However, the action of one putative regulator of 
α-MSH release, viz α-MSH itself, was still unclear Early reports discussed this subject and 
presented evidence both pro (Kastin et al, 1971, Iturrua, 1973) and contra (Huntington and 
Hadley, 1974, Thornton and Geschwind, 1975) the possibility that α-MSH would exert a 
direct, negative feedback action on its own release from the mclanotrope cell On the basis of 
a senes experiments, desenbed in Chapter 1, it is shown such a feedback mechanism does not 
exist 
Chapter 2 deals with the second component of the signal transduction system in the 
melanotrope cell the extracellular pathways of the first messengers It has been known for 
some lime that GABA, dopamine and CRH act directly on the melanotrope cell to regulate a-
MSH secretion (Verburg-van Kemenade et al, 1986a, 1987a) but the mechanism by which 
NPY inhibits melanotrope cell activity was not known The experiments desenbed in this 
chapter reveal that NPY acts on the folhculo-steUate cell to indirectly inhibit α-MSH secretion 
Chapter 3 desenbes the pharmacological charactenzalion of the GABAB receptor of 
Xenopus melanotrope cells At the beginning of this study, no specific tools were known to 
selectively stimulate or antagonize the GABAB receptor of endoenne cells, except for the 
traditional agonist baclofen In this study, several specific GABAB receptor antagonists have 
been identified and one of these agents was used to block the GABAB receptor in vivo, 
together with the dopamine receptor antagonist sulpmde In this way it was shown that the 
inhibition of α-MSH release in animals on a white background (see above) is not exclusively 
mediated by GABAB and dopamine receptors Treatment with sulpinde caused the white 
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animal to become darker, but only slightly. It was concluded that the in vivo inhibition of a-
MSH release is accomplished by multiple neuronal messengers. 
The identification and characterization of second messengers, is treated in the last five 
chapters of this thesis. Attention has been paid to three messenger types: calcium ions, IP, and 
cyclic-AMP. In Chapter 4 the most common intracellular second messenger in secretory cells, 
the calcium ion, is considered. It is demonstrated that mobilization of intracellular calcium 
does not contribute significantly to the process of spontaneous cc-MSH release. This release 
appears to be sustained by influx of calcium ions through voltage-operated calcium channels, 
predominantly of the dihydropyridine-insensitive N-type. The second messenger IP3 plays no 
evident role in the regulation of the secretory process, because regulatory factors hardly affect 
inositol phosphate metabolism (Chapter 5). However, there is a very clear difference in the 
rate of inositol phosphate production between animals on white versus black backgrounds. It is 
suggested that the inositol signalling mechanism plays a role in long-term adaptation processes 
rather than in short-term secretory processes. The emerging picture from Chapter 6 is that in 
addition to calcium ions, cyclic-AMP, and not IP3, is involved in the regulation of the 
secretory process. Inhibitors of a-MSH release also inhibit cyclic-AMP production (dopamine, 
baclofen) and stimulators of a-MSH release also stimulate cyclic-AMP production (CRH and 
the related amphibian peptide sauvagine). 
Finally, the second messenger systems in the melanotrope cell interact with each other 
(Chapters 7 and 8). This appears from the observation that the coupling between an increase of 
cyclic-AMP production and a-MSH secretion is not absolute: stimulation of the GABAA 
receptor by its agonist isoguvacine leads to a stimulation of cyclic-AMP production that is 
concomitant with inhibition of a-MSH secretion. Similarly, the inhibition of cyclic-AMP 
production is no prerequisite for the dopaminc-induced inhibition of secretion. These data 
strongly suggest the involvement of interacting, multiple intracellular mechanisms in dopamine 
receptor-mediated signal transduction and inhibitory control of a-MSH secretion. 
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CHAPTER 1 
Analysis of autofeedback mechanisms in the secretion of 
pro-opiomelanocortin-derived peptides by 
melanotrope cells of Xenopus laevis 
With B.G. Jenks, W.J.JM Scheenen, P.H.M. Balm and E.W. Roubos 
In: General and Comparative Endocrinology (in press) 
Chapter 1 
Abstract. The secretion of most pituitary hormones is under the control of feedback 
mechanisms. The feedback control of a-melanophorc-stimulating hormone (ot-MSH) 
from melanotrope cells is controversial. The possible existence of an autofeedback 
exerted by a-MSH or other FOMC-denved peptides on melanotrope cells of the 
amphibian Xenopus laevis has been investigated. a-MSH or its potent agonist 4-
norleucineJ-D-phcnylalamnc-ot-MSH has no effect on the release of radiolabelled 
POMC-denved pcpüdes or immunoreactive ß-endorphin from superfuscd 
neurointermediate pituitary lobes. Melanin concentraüng hormone, previously reported 
to have an α-MSH-like effect on melanophores, did not affect a-MSH secretion 
Neurointermediate lobe superfusate, which contains a mixture of POMC-denved 
peptides, failed to affect the secretory activity of melanotropes. It is concluded that in 
X. laevis the secretory activity of melanotropes is not under the control of short-term 
autofeedback mechanisms involving a-MSH or other POMC-denved peptides. 
INTRODUCTION 
The secretion of many pituitary hormones is regulated by feedback mechanisms involvir 
hormones from peripheral endoenne target organs. Some pituitary hormones, such as prolacti 
and α-melanophore stimulating hormone (a-MSH), do not appear to activate peripher 
endoenne organs, so their secretion may not involve target organ feedback. For prolactin, the: 
is an autoregulatory mechanism, whereby the secreted hormone inhibits its own relea; 
(Kadowaki et al., 1984, Frawley and Clark, 1986) With regard to a-MSH, there is evidenc 
from pituitary transplant studies, for long-term effects of pars intermedia secretory products с 
the morphology of in situ melanotrope cells (Ferryman, 1974; Gianoulakis and Gupta, 198i 
Ito et ai, 1986) However, evidence for direct short-term autofeedback mechanisms 
equivocal, with positive (Kastin et ai, 1971; Iturriza, 1973) and negative (Huntington ar 
Hadley, 1974, Thornton and Geschwind, 1975) findings. In the studies cited, bioassays with 
rather low specificity were used that also may monitor inhibitory factors, such ; 
catecholamines, released from the neurointermediate lobe (Bagnara and Hadley, 1973 
Furthermore, in these studies melanotropes may also have been affected by inhibitory factor 
such as dopamine and GABA, released from the (statically) incubated lobes. Consequently, tl 
existence of an autofeedback mechanism controlling a-MSH release is still open to debate. 
The present study addresses this question, focusing on a-MSH release from melanotrof 
cells of the aquatic toad Xenopus laevis. Since these cells display high rates of biosynthes 
and secretion of POMC-derived peptides (Loh and Gainer, 1977, Martens et al., 1981a), the 
are suitable for the study of their response to inhibitory input in general and to putatn 
negative autofeedback in particular. In a tissue superfusion system, the in vitro effects of ( 
MSH treatment on the release of radiolabelled POMC-denved peptides and of immunoreacth 
ß-endorphin, a POMC-derived peptide known to be cosecreted with a-MSH (Verburg-va 
Kcmenadc et ai, 1986a, 1987a,b), were examined In addition, the responses to a hyperactn 
a-MSH analogue (4-norleucine,7-D-phenylalanine-a-MSH; NDP-MSH, Sawyer et al., 1980) ¡ 
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well as to melanin concentrating hormone (MCH), a hypothalamic peptide that has been 
suggested to bind to the a-MSH receptor in amphibians (Castrucci et al, 1987, 1989, Hadley 
et al, 1988), have been assessed Finally, to investigate whether POMC-denved peptides other 
than a-MSH exert a feedback to melanotropes, neurointermediate lobes were challenged with 
superfusatc containing POMC-denved peptides 
MATERIALS AND METHODS 
Animals. Adult X laevis from laboratory stocks were adapted to a black background for 3 weeks 
and fed trout pellets (Trouva, Trouw, Putten, The Netherlands) weekly Water temperature was 22 
°C Animals were decapitated and their neurointermediate lobes removed 
Analysis of release of radiolabelled peptides. Refore superfusion, lobes were cultured for 20 h in 
culture medium (CM) consisting of 67% (v/v) L15 medium (Gibco, Renfrewshire, UK), 10% fetal 
calf serum (FCS, Gibco), 1% (v/v) kanamycin solution (Gibco), 1% (v/v) anlibiotic/antimycotic 
solution (Gibco), 0 08 mg/ml СаСІг 2H20 and 0 2 mg/ml glucose (pH 7 4) They were then 
incubated in 100 μΐ CM for 20 h in the presence of 200 μΟ [3H]-lysine (Amersham, 
Buckinghamshire, UK, 86 Ci/mmol) To obtain maximum specific activity of labelled protein, 
labelling was performed in lysine-free culture medium, using dialyscd FCS (Gibco) and lysine-frec 
L15 medium After labelling, lobes were washed three times and superfused with incubation 
medium (IM) containing 112 mM NaCl, 2 mM KCl, 2 mM CaCl2, 15 mM HFPFS (pH 7 4, 
Calbiochem, L a Jolla, CA), 2 mg/ml glucose and 0 3 mg/ml bovine serum albumin The 
superfusion system for neurointermediate lobes has been described before (Verburg-van Kemcnadc 
et al, 1987b) Lobes were superfused simultaneously at 22 "С, in separate 10 μΐ chambers, with 
IM, for at least 75 mm before the first pulse with a potential secretagogue was applied The flow 
rate was 1 6 ml/h, an average of 3 2 ng a-MSH was released in this interval, which represents a 
concentration of 2 ng/ml (12*10-' M) Synthetic a-MSH (Sigma, St Louis, MO), NDP-MSH 
(Sigma) and dopamine (Sigma) were added in vanous concentrations (see Results) Fractions were 
collected every 15 mm, and submitted to solid phase extraction, using a Baker octodecyl-C18 
column (see Van Zoest et al, 1990), to separate free radiolabelled lysine from labelled pepudes 
Four ml of scintillation fluid (Scintillator 199, Packard, Groningen, The Netherlands) was added to 
the peptide containing column fractions and radioactivity was determined in a liquid scintillation 
counter (LKB 1216 Rackbeta) 
The effects of neurointermediate lobe-enriched medium on the release of radiolabelled peptides 
were also examined The ennched medium was obtained as follows lobes were cultured for 7 days 
in CM (see De Koning et al, 1991) to remove regulatory neuronal inputs (see Discussion) and 
were then superfused in IM, which was collected on ice, for 90 mm This medium was then placed 
in a waterbath at 22 0C for 15 mm, and applied to [3H]-lysine-labelled lobes in a parallel 
superfusion This method discnminatcs between immunoreactive a-MSH in the ennched medium 
and labelled a-MSH from the radiolabelled tissue The concentration of a-MSH in the ennched 
medium was determined by radioimmunoassay 
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HPLC analysis of radiolabelled peptides. To determine whether a-MSH had an effect on the 
profile of the secretory signal, superfusates were collected before and during administration of oc-
MSH and submitted to HPLC. Chromatography was performed as described previously (Martens et 
al, 1980), using a spherisorb 10 ODS column (Bischoff, Leonberg) with 0 5 M formic acid/0 14 M 
pyndine as the pnmary solvent and n-propanol as the secondary solvent Row rate was 2 ml/mm 
and 1 ml fractions were collected Of the superfusion fractions involved, a sample (25%) was used 
directly for HPLC analysis and the remainder was applied to a Baker column to determine the total 
amount of radioactivity released The HPLC fractions were mixed with scintillation fluid and their 
radioactivity was determined by liquid scintillation counting Peaks were identified according to 
Martens et al (1982) 
Analysis of the release of immunoreactive a-MSH. Freshly dissected neurointermediate lobes 
were superfused as above. Fractions were collected every 7.5 mm and submitted to radioimmuno-
assay for a-MSH (Van Zoest et ai, 1989), bound and free antibodies were separated by the 
polyethylene glycol/albumin method Cross-reactivity was 100% with desacctyl a-MSH but was 
<0.5% with ACTH (1-24) and ACTH (1-39). The limit of detection was 2 pg a-MSH per sample. 
MCH (synthesized by T. Matsunaga in the laboratory of Dr. V J. Hruby, Tucson) was applied at 
concentrations of 10"' to 105 M. The possible cross-reactivity of MCH with the anti-a-MSH 
antiserum was determined in both the absence and presence of unlabelled a-MSH (see Results) 
Analysis of release of immunoreactive ^-endorphin. Superfusions were conducted as above and 
7.5 mm fractions were submitted to radioimmunoassay for ß-endorphin, using a porcine ß-
endorphin antiserum kindly provided by Dr. H Vaudry (Rouen, France) The characteristics of the 
anosenim have been described (Jegou et al, 1983) and it has been successfully used to determine 
Xenopus ß-endorphin (Verburg-van Kemenadc et al, 1986a, 1987a,b). Since Xenopus intermediate 
lobe extracts do not dilute in parallel with porcine ß-endorphin (Verburg-van Kemenadc et al., 
1986a) all superfiision fractions were assayed at the same dilution. The data obtained thus refer to 
relative amounts of ß-endorphin released Dopamine ( ία 5 M) and a-MSH (3*10 " M - 9*10' M) 
were added in 15 mm pulses 
Statistics. Data of cross-reactivity were tested for significance using the two-sided, unpaired 
Student's T-test A P-value <0 05 was considered to indicate significance 
RESULTS 
Effect of a-MSH and NDP-MSH on release of radiolabelled peptides. a-MSH did not affect 
the release of [3H]-lysine labelled peptides from superfused neurointermediate lobes (Fig 1) 
Short (15 mm) pulses of a-MSH (3*10' - 9*10"' M) and NDP-MSH (2.4*10-' M) had no 
effect on the release of these peptides. To assess the effect of longer-term exposure to a-MSH, 
pulses of 2 h (6*10' M a-MSH) were given, but no effect on peptide release was seen (Fig 
1) At the end of each superfiision, 105 M dopamine was shown to rapidly inhibit secretion 
(Fig 1). HPLC analysis of peptides released pnor to and dunng a-MSH administration 
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showed that a-MSH treatment had no effect on the HPLC profile of the peptides in the 
secretory signal (Fig. 2). 
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Fig. 1. Effect of a-MSH and NDP-MSH on the release of [3H]-lysine-labelled peptides 
from superfused neurointermediate lobes. Data are the means of several independent 
experiments, indicated by the encircled numbers. Basal release (100 %) is defined as 
the average release in the three fractions preceding the pulse. Vertical bars represent 
-SEM. Fractions were collected every 15 min; DA is dopamine. 
Effects of MCH on release of immunoreactive a-MSH. MCH, in the range 10"' to IO'6 M, 
had no effect on a-MSH release (Fig. 3); at 10"5 M a slight stimulation was seen. However, 
this may reflect the slight cross-reactivity of MCH of about 0.0015% with the anti-a-MSH 
serum used in the radioimmunoassay, which becomes evident at IO'5 M. The displacement of 
[123]I-labelled a-MSH by MCH in a dilution curve is not parallel to a-MSH (Fig. 4). 
Fig. 2. Reversed-phase HPLC-profde of 
radiolabelled peptides in superfusion fractions 
5-6 (upper panel), 7-8 (middle panel) and 15-
16 (lower panel) of the fourth superfusion 
shown in Fig. 1. Des is desacetyl a-MSH, 
a/CUPl ύ coeluting peptides a-MSH and 
corticotropin-like intermediate lobe peptide-1, 
CLIP2 is corticotropin-like intermediate lobe 
pepiide-2 and ERP represents a mixture of 
endorphin-related peptides. 
HPLC Elution Time (min) 
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Effect of a-MSH on release of iinmunoreactive ^-endorphin. The release of immunorcactive 
ß-endorphin-related peptides (RRP) from superfused neurointermediate lobes was unaffected 
by a-MSH (Fig. 5). In each experiment dopamine gave the normal inhibitory response. 
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Fig. 3. Dose-response relation between MCH and the release of immunoreactive ot-
MSH from superfused neurointermediate lobes. Basal secretion is the average release 
in the four fractions preceding the pulse. Data are the means of several independent 
experiments, indicated by the encircled numbers. Vertical bars represent -SEM. 
Effect of enriched medium on the release of radiolabelled peptides. The neurointermediate 
lobe-enriched medium had no effect on the release of radioactive peptides from superfused 
radiolabclled lobes (Fig. 5). The concentration of a-MSH in the medium was 1.18*10'10 M, 
which is within the physiological range of plasma a-MSH concentrations of black-adapted 
Xenopus (Van Zoest et aL, 1989; De Rijk et ai, 1990). A pulse of dopamine at IO5 M gave a 
clear inhibitory response. 
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fig. 4. Cross-reactivity of MCH with 
the a-MSH antiserum. Concentrations 
of 10*. 107, W-6 and W' M MCH in 
incubation medium (IM) were tested in 
the a-MSH radioimmunoassay. a-MSH-
like immunoreactivity, compared to the 
IM control, was raised significantly by 
m
7
, LO6 and W5 M MCH (P<0.05, 
P<0.0J and P<0.001, respectively). 
Data are the means of four determina­
tions and vertical bars reprisent SEM. 
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DISCUSSION 
Previous studies have demonstrated that POMC-derivcd peptides are released from 
melanotrope cells of Xenopus laevis in a coordinate way (Martens et aL, 1981b; Verburg-van 
Kemenade et ai, 1986a, 1987b; Van Zoest et ai, 1990, De Koning et ai, 1991). Therefore, in 
the present study, analysis of release of radiolabelled POMC-dcrived peptides provided an 
appropriate marker for secretory events in the intermediate lobe tissue. Newly synthesized 
peptides are known to be released from Xenopus melanotrope cells in a biphasic pattern, the 
first involving release from a fast, rapidly depicted compartment and the second phase 
exhibiting a slower secretory rate (Van Zoest et ai, 1990). This complex release profile makes 
it very difficult to quantify actions of secretagogues. To overcome this problem, lobes were 
labelled to steady-state rendering relatively stable (and only slowly decreasing) release rates of 
radiolabelled POMC-derived peptides. The release of these peptides was clearly inhibited by 
dopamine, an established a-MSH inhibitory factor (Verburg-van Kemenade et ai, 1986b), but 
was unaffected by α-MSH. HPLC analysis revealed that a-MSH also had no qualitative effect 
on peptide composition of the secretory signal, thus providing evidence against a selective 
effect of α-MSH on release of individual POMC-derived peptides. NDP-MSH also had no 
effect on the secretion of POMC-derived peptides from melanotropcs. NDP-MSH is a potent 
α-MSH receptor agonist with prolonged biological activity (Sawyer et ai, 1980); in the load 
skin bioassay it is about 10 times more potent than α-MSH (Ferroni and Castrucci, 1987). 
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Fig. S. Effect of a-MSH on the release of ^-endorphin from superfused 
neurointermediate lobes. Basal release (WO %) is the average release in the three 
fractions preceding the pulse. Data are the means and SEM of four independently 
superfused lobes. Fractions were collected every 7.5 min; DA is dopamine. 
Another peptide that may bind α-MSH receptors is MCH (Castrucci et ai, 1987, 1989; 
Hadley et ai, 1988) and therefore analysis of the action of this peptide on melanotrope cells 
was also included in the present study. This peptide is reported to exert, at high 
concentrations, an a-MSH-like effect on melanophores of amphibians (Wilkes et ai, 1984; Ide 
et ai, 1985; Ferroni and Castrucci, 1987) and teleosts (Hadley et ai, 1988, Castrucci et ai, 
1989). While MCH appears to inhibit α-MSH secretion in fish (Barber et ai, 1987), the effect 
of this peptide on secretion of α-MSH from melanotropcs of amphibians has not been 
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previously studied. Such an effect would seem to be feasible because MCH-immunoreactivity 
has been demonstrated in the neural lobe of the frog. Rana ridibunda (Andersen et al, 1986). 
The effect of MCH on the release of immunoreactive α-MSH from Xenopus neuromtermediate 
lobes, was analyzed using concentrations that have a-MSH-like effects on amphibian 
melanophores (Castnicci et al, 1987, 1989; Hadley et al, 1988). While no effect of MCH on 
α-MSH release was observed at IO"7 and 10"6 M MCH, 10"5 M MCH seemed to stimulate a-
MSH secretion. However, analysis of the anti-a-MSH antiserum revealed a slight cross-
reactivity with MCH, which was sufficient to account for the apparent stimulation. The 
occurrence of this cross-reactivity may reflect the notion that the tertiary structures of a-MSH 
and MCH are related (Castrucci et al, 1989). It is concluded overall that MCH has no effect 
on α-MSH secretion from melanotrope cells of Xenopus. 
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Fig. 6. Effect of neuromtermediate lobe-enriched medium on the release of [3H]-lysine-
labelled peptides from superfused neuromtermediate lobes. Basal release (100 %) is 
the average release in the three fractions preceding the pulse. Data are the means and 
SEM of four independently superfused lobes. Fractions y/ere collected every 7.5 min. 
The concentration of dopamine was IO'5 M. 
The present data suggest a lack of autofeedback by α-MSH in Xenopus, a contention 
supported by the analysis of immunoreactive ß-endorphin release. It has been established that 
ß-endorphin is cosecreted and coregulated with α-MSH (Verburg-van Kemenade et al, 1986a, 
1987a,b). In analyzing the effect of α-MSH on release of immunoreactive endorphin, various 
concentrations of α-MSH were administered, starting well within the physiological range of 
plasma α-MSH (1.5*1012 - 2.5*1010 M, Van Zoest et al, 1989; De Rijk et al, 1990) but, 
because the local concentrations of α-MSH in the pituitary may be much higher than in the 
circulation, lobes were also challenged with higher doses, up to 6*109 M of α-MSH. That a-
MSH had no effect on the release of ß-endorphin supports the conclusion that α-MSH has no 
autofeedback effect on the secretory process of the Xenopus melanotrope. 
In earlier reports it was presumed that melanotrope cell feedback involves α-MSH (Kastin 
et al, 1971; Iturriza, 1973; Репу man, 1974; Ito et al, 1986), but other released POMC-
^^^^^^^^^^^^^^, 
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derived peptides may be concerned. The effect of superfusate of cultured neurointermediate 
lobes on the release of radiolabelled peptides from neurointermediate lobes was therefore 
examined. The superfusate of cultured lobes contains the entire peptide secretory signal of 
melanotrope cells and the superfusates do not contain potentially interfering neurotransmitters 
and neuropeptides, because in such lobes all neuronal elements have fully degenerated (De 
Koning et al., 1991). The fact that this medium had no effect on the secretory process 
indicates an absence of autofeedback mechanisms within the amphibian pars intermedia. The 
possibility that melanotrope cells control their own secretion in a more complex fashion, e.g. 
indirectly via control mechanisms in the hypothalamus (cf. Kastin and Schally, 1967; 
Lichtensteiger and Monnet, 1979), deserves further attention. 
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Indirect action of elevated potassium and Neuropeptide Y on 
a-MSH secretion from the pars intermedia οι Xenopus laevis: 
A biochemical and morphological study 
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Chapter 2 
Abstract. A number of neurochemical messengers have been shown to act directly on 
the melanotrope cells of the pare intermedia of Xenopus laevis to regulate a-MSH 
secretion. In the present study the possibility that the melanotropes are also indirectly 
controlled has been examined. For this purpose, the characteristics of a-MSH release 
from superfuscd intact lobes, cultured lobes and isolated melanotropes were compared 
after treatment with elevated potassium. Isolated melanotropes responded with an 
increased secretion of a-MSH, whereas intact lobes showed a profound inhibitory 
response, probably caused by potassium-induced release of inhibitory factors from 
nerve terminals. Cultured lobes displayed a biphasic response characterized by an 
imual acUvation followed by a strong inhibition; the stimulatory phase likely reflects a 
direct action of potassium on the melanotropes, before being overridden by an 
inhibitory mechanism. The inhibitory phase must originate from the action of non-
neuroendoenne cells because the cultured lobes lack functionally active nerve 
terminals, as verified by immunocytochemistry and electron microscopy. The most 
likely candidates for this action are folhculo-stellate cells which are in intimate contact 
with the melanotropes and are innervated by neuropeptide Y-contaimng nerve 
terminals. Like elevated potassium, neuropeptide Y inhibited a-MSH secretion from 
fresh and cultured lobes but not from isolated melanotropes. This indicates that NPY 
acts indirectly, in a nonpresynaptic way, to inhibit a-MSH secretion. 
INTRODUCTION 
The melanotropes of the neurointermediate lobe of the amphibian Xenopus laevis produce a-
melanocyte stimulating hormone (α-MSH), a peptide that causes darkening of the skin 
(Bagnara and Hadley, 1973). The release of α-MSH from melanotropes is under the control of 
various neurochemical messengers. On the basis of in vitro superfusion studies of 
neurointermediate lobes, dopamine, γ-aminobutyric acid (GABA), corticotropin-rcleasing 
hormone (CRH), thyrotropin-releasing hormone (TRH) and neuropeptide Y (NPY) have been 
identified as potential regulators (Verbürg-van Kemenade et al, 1986c,d, 1987a,b,d,f); 
dopamine, GABA and NPY inhibit, whereas CRH and TRH stimulate α-MSH release. Axons 
and synaptic structures containing GABA, NPY, CRH and TRH are present in the Xenopus 
neurointermediate lobe, as shown by light and electron microscope immunocytochemistry 
(Verburg-van Kemenade et al, 1987a,b,f; De Rijk et al, 1990a). For some of these messen­
gers the primary sites of action have been established: supcrfusion experiments with isolated 
melanotropes have shown that dopamine, GABA and CRH act directly on the melanotropes in 
regulating α-MSH secretion (Verburg-van Kemenade et al, 1986a, 1987a). The action 
mechanism of NPY on Xenopus melanotropes has not been studied. In the frog, Rana 
ndibunda, NPY was reported to act directly on melanotropes (Danger et al, 1986, 1990). 
In addition to a direct action on the melanotropes, there are two possible mechanisms 
through which secretagogues might affect α-MSH secretion indirectly: (1) in a presynaptic 
way, e.g. by stimulating release of dopamine or GABA from nerve terminals within the 
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neurointermediate lobe or (2) through action on nonendocrine cells, such as the folliculo-
stellate cells in the pars intermedia. These cells, together with the melanotropes, form the main 
constituent of the Xenopus pars intermedia. Possible involvement of the folliculo-stellate cells 
in the control of melanotropes has recently gained considerable attention (for a review, see 
Penyman, 1989) and the suggestion has been made that, in the rat anterior lobe, folliculo-
stellate cells release a factor that inhibits the stimulated secretion of prolactin, growth hormone 
and luteinizing hormone (Baes et ai, 1987). 
The present study deals with the possible existence of an indirect mechanism regulating a-
MSH secretion from Xenopus melanotropes. For this purpose characteristics of potassium-
induced a-MSH release from (1) intact, fresh neurointermediate lobes, (2) isolated 
melanotropes in primary culture and (3) tissue-cultured neurointermediate lobes were 
compared. The cultured lobes were used to exclude a possible involvement of presynaptic 
mechanisms; the absence of functionally active axon terminals as a result of degeneration in 
these cultured lobes was verified using immunocytochemistry and electron microscopy. The 
secretory dynamics of cultured lobes were compared to those of intact tissue, using pulse 
chase, high performance liquid chromatography (HPLC) and superfusion techniques. The 
effects of NPY on fresh and cultured neurointermediate lobes, as well as on isolated 
melanotropes, were analyzed to investigate whether this neuropeptide inhibits a-MSH release 
via an indirect mechanism. 
MATERIALS AND MF.THODS 
Animals. Adult X. laevis were taken from laboratory stock. They were adapted to a black 
background for three weeks. The animals were fed trout pellets (Trouvit) once a week. The water 
temperature was 22 "C. 
Preparation of cultured neurointermediate lobes. Neurointermediate lobes were dissected and 
washed with culture medium containing 67% (v/v) L15 medium (Gibco), 1% (v/v) kanamycin 
solution (Gibco), 1% (v/v) anubiotic/anumycotic solution (Gibco), 10% fetal calf serum (FCS, 
Gibco), 0.08 mg/ml CaCl2.2H20 and 0.2 mg/ml glucose (pH 7.4). Before use, the culture medium 
was sterilized by ultrafiltration using a Millex-GV 0.22 μιη filter (Millipore). After washing 4 
times with 1 ml of this medium, each lobe was cultured in 1 ml of culture medium in a muludish 
(Nunc) at 22 0C in an incubator for 1-7 days. Medium was refreshed daily. 
Biosynthetic analysis of pro-opiomelanocortin peptides. Freshly dissected or cultured 
neurointermediate lobes were washed three times with 0.S ml incubation medium (IM; 112 mM 
NaCl, 2 mM KCl, 15 mM HEPES, pH 7.4; Calbiochem, Uitrol Grade, 2 mM CaCl2, 2 mg/ml 
glucose, 0.3 mg/ml bovine serum albumin) and incubated at 22 "C for 1 or 3 h with 30 μΟι [3H]-
tryptophan (Amersham, 55 Ci/mM) in 30 μΐ IM/lobc. Lobes were then washed with 1 ml IM 
containing 1 mM tryptophan and chase-incubated for 4 h in this medium. Incubation was 
terminated by adding HCl to the medium to a final concentration of 0.1 N, after which the lobes 
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were homogenized in 1 ml 0.1 N ice-cold HCl Half of a homogcnale and the chase-medium were 
submitted to reverscd-phase HPLC using a Sphensorb 10 ODS column (Bischoff, Lconberg) with 
0.5 M formic acid/0.14 M pyridine as the primary solvent and n-propanol as the secondary solvent; 
flow rate was 2 ml/min. One-millilitrc fracuons were collected and radioactivity measured in a 
scintillation detector (LKB 1216 Rack Beta) Peaks were identified according to Martens et al. 
(1980, 1982). The other half of the homogenate was lyoplulized and resuspended in application 
buffer for sodium dodecyl sulphate (SDS) gel electrophoresis, according to Lacmmli (1970), using 
13% acrylamide gels Proteins were detected by fluorography (Bonner and Laskey, 1974). [14C]-
methylated molecular weight marker proteins were from Amcrsham (CFA626). 
Superfusion of neurointermediate lobes. Superfusion of neurointermcdiate lobes was performed as 
described previously (Verburg-van Kemcnade et al., 1987b) The superfusion system allowed four 
lobes to be superfused simultaneously Volume of a superfusion chamber was 10 μ]. Fractions were 
collected every 7.5 mm At least 10 fracuons were collected before 15 mm pulses (2 fractions) of 
NPY (0.33-1.0 μΜ) or elevated potassium (10-60 mM KCl) were introduced In experiments where 
the concentration of KCl was vaned, the concentration of NaCl was adjusted to maintain the 
osmolality of medium. 
Superfusion of cultured dispersed melanotropes. Lobes were washed with culture medium lacking 
PCS and incubated for 45 mm in 2 ml of this medium containing 10 mg collagenasc type V 
(Sigma) and 20 mg protease type IX (Sigma) at 22 °C. Then cells were dispersed by passing the 
tissue several times through a siliconized pasteur's pipette and filtered through a nylon gauze (pore 
size 150 μιη) mounted on a synnge to remove undissociated üssue (including the complete neural 
lobe) The dispersed cells were washed, collected by centnfugation and transferred to a lymphocyte 
tube (Nunc), in the presence of 2 mg/ml Cytodex-3 beads (Pharmacia) The number of living cells 
isolated per lobe was 20,000-25,000, as determined by counting cells in a sample of the 
suspension, using a Bürkcr-Turk chamber, in the presence of trypan blue (Sigma). This represents a 
yield of 30-35% It was estimated by immunocytochemical analysis that over 90% of the cells 
were melanotropes; the remaining cell types included folliculo-stellate cells, endothelial cells and 
fibroblasts 
The isolated cells were cultured for 2 days at 22 "С in 1 ml of complete culture medium to 
allow their attachment to the beads. It was found that inclusion of excess beads prevented cells 
from aggregating, thus precluding any rceslabhshment of contacts between melanotropes and 
stellate cells. The beads were washed in IM before transfer to supcrfiision chambers, which had a 
volume of 75 μΐ. The chambers were equipped with Milliporc filters (HAWP02500, pore size 0 45 
μιη) to support the beads Kach chamber contained cells derived from 4 lobes. The flow rate and 
the method of administration of high potassium were the same as desenbed above 
Radioimmunoassay, a-MS Η concentrations were measured as desenbed previously, using an anti-
a-MSH serum produced in our laboratory (Van Zoest et al., 1989). Bound and free anubodies 
were separated by the polyethylene glycol/albumin method Cross-reactivity with desacetyl a-MSH 
was 100%, but cross-reactivity with ACTH (1-24) or ACTH (1-39) was almost absent (<0 5%). 
Detection limit was 10 pg a-MSH per sample (Van Zoest et al, 1989). 
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Immunocytochemistry. Immunocytochemistry for NPY and (JABA was performed as described 
previously (De Rijk et al, 1990a). In short, for analysis with antiserum to NPY, lobes were fixed 
in Bourn's fluid, dehydrated, embedded in paraffin and cut into sections of 5 цт. For analysis with 
antiserum to G AB A, lobes were fixed in 5% glutaraldehyde and 1% paraformaldehyde m 0.05 M 
phosphate buffer (pH 7.4) for 2 h at 20 GC, and postfixed in 1% osmium tetroxide in buffer, for 1 
h at 4 0C. They were then embedded in Epon and 1 цт sections were cut. 
The sections were preincubated with 20% normal goat scram in Tns/sodium chloride buffer 
(TBS; pH 7.6) and incubated sequentially with anti-NPY (1:4000) or anti-GABA (1.1000) for 16 h 
at 4 "C, goat-antirabbit IgG (Nordic Immunology, Tilburg; 1.40) and rabbit peroxidase/ 
antiperoxidase (Nordic Immunology, Tilburg; 1:200). Finally, sections were treated with a solution 
of 0.02% 3,3' diaimnobenzidme, 0.06% nickel ammonium sulphate and 0.005% H202 in TBS, for 
10 mm. 
Analysis with antiserum to dopamine was performed according lo Buijs et al (1984). In short, 
lobes were fixed in 5% glutaraldehyde and 1% Na^jOs in 0.05 M phosphate buffer (pH 7.4) and 
kept in 20% sucrose and 1% Na^SjO, in the same buffer for 16 h at 4 "C. Cryosections (20 μπι) 
were treated with normal goat serum in the presence of 1% N a ^ O ; (10 mm) and with 
antidopamme (dilution ]·4000) for 16 h at 4 "C. Control staimngs were carried out after 
preabsorbing the antisera with the respective antigens. In the case of dopamine, absorbtion was 
performed in the presence of 1% NajS^Oj. The specificity of the antisera has been described 
previously (Buijs et ai, 1984; Scguela el ai, 1984; Danger et al, 1985). 
Electron microscopy. Ncurointermediate lobes were fixed in 3% glutaraldehyde in 0.1 M sodium 
cacodylate butfer (pH 7.4) for 15 mm at 20 °C and postfixed in a mixture of 3% glutaraldehyde in 
0.1 M sodium cacodylate buffer, 2% osmium tetroxide and 5% potassium dichromate (11:1) for 1-
1.5 h at 4 "С, as described previously (De Rijk et ai, 1990b). The lobes were then blockstained 
with 2% uranyl acetate, dehydrated and embedded in Spurr's resin. Ultrathin sections were stained 
with lead citrate and examined in a Jeol JEM lOOCX II electron microscope. 
Statistics. Percentages of stimulation and of inhibition of a-MSH secretion in response to 
secretagogue administration during superfusion were calculated on the basis of integration of the 
respective peak areas in the graphs, using defined fractions just before and during pulses with 
secretagogues (for fractions involved, see Results). The integrated areas were tested for sigmficance 
using the paired Student's t test (oc=5%). 
RESULTS 
Biosynthetic dynamics of neurointermediate lobes. The HPLC profiles of [3HJ-tryptophan-
labelled newly synthesized peptides from freshly dissected and cultured neurointermediate 
lobes (1, 2, 5 and 7 days in culture) were very similar and highly reproducible. Profiles of 
freshly dissected lobes and lobes cultured for 5 days are shown in figure 1. Most prominent 
among the HPLC-resolved peptides were desacetyl a-MSH and a-MSH. In all cases, desacetyl 
a-MSH was the major tissue form of MSH (Fig. la), whereas a-MSH was the major form of 
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Fig. 1. HPLC profiles of radioactive peptides in tissue extracts (a) and chase medium 
(b) of freshly dissected neurointermediate lobes (upper panels) and lobes cultured for 5 
days (lower panels) Lobes were pulsed for 3 h in medium containing [3Ή¡-tryptophan, 
followed by 4 h of chase incubation. Peaks represent: trp =[3H]-tryptophan; A = 
coeluting peptides $-MSH and y-MSH; В = desacetyl a-MSH: С = a-MSH. 
the peptide released into the medium (Fig. lb), an observation in keeping with the secretion-
associated acetylation of this peptide (Martens et al., 1981c; Vaudry et al., 1983; Jenks et al., 
1985; Verburg-van Kemenadc et al., 1987e). The HPLC profiles do not show endorphins or 
corticotropin-like intermediate peptides because these peptides do not contain tryptophan. The 
products eluting after 20 min from the HPLC column have not yet been identified. In the 
tissue extracts there were three such products, which eluted between 40 and 50 min. In the 
medium these products were minor or absent, but there were some products eluting between 
25 and 40 min, which were not represented in the tissue profiles. 
Electrophoretic analysis showed that both the degree of radioactive labelling and the pattern 
of labelled proteins were very similar in freshly dissected and cultured lobes (Fig. 2). 
Dominant among the newly synthesized products were pro-opiomelanocortin (POMC) and pro-
γ-MSH. 
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Fig. 2. SDS gel electrophoresis of tissue extracts 
of freshly dissected (lane F) and cultured (lane 
C) neurointermediate lobes after 3 h pulse with 
[3H]-lrp and 4 h of chase incubation. The 
electrophoretic mobilities of the radioactive 
markers are indicated (lane M). Lane F contains 
half of the tissue extract of the same freshly 
dissected neurointermediate lobe as used for 
HPLC analysis in figure la, upper panel. Lane С 
contains half of the tissue extract used for HPLC 
analysis in figure la, lower panel. POMC (36 
kDa): 18k = pro-y-MSH (18 kDa). 
Structural integrity of cultured lobes. At the light 
microscope level both fresh and cultured 
neurointermediate lobes reveal normally shaped 
melanotropes and folliculo-stellate cells, in a 
proportion of about 10:1. 
Immunocytochemistry showed that fresh 
neurointermediate lobes are innervated by dense 
networks of dopamine-, GABA- and NPY-
immunopositive fibres. The immunostaining had a 
dotted appearance indicative of nerve varicosities and was largely confined to the intermediate 
lobe (Fig. 3a-c). In cultured lobes, the density of the networks and the number of varicosities 
decreased with increasing culture duration. After 7 days of culture dopamine, GABA and NPY 
immunoreactivities were absent. As an example, this is shown for GABA in figure 3d. In no 
case staining was found with any of the preabsorbed antisera. 
At the ultrastructural level the general morphology of the cells of cultured lobes was not 
obviously different from that of fresh lobes. The melanotropes had a healthy appearance, 
showing large amounts of rough endoplasmic reticulum, numerous large mitochondria and a 
well-developed Golgi apparatus that formed many secretory granules (Fig. 4a,b). The folliculo-
stellate cells also appeared normal, extending their long, slender processes between the 
melanotropes (figs. 4a,c) with which they were firmly connected by desmosome-like structures 
(Fig. 4d). The cultured lobes clearly differed from fresh ones, however, with respect to 
synapse-like contacts on melanotropes and folliculo-stellate cells. In fresh lobes synapse-like 
structures were filled with small electron-lucent and larger electron-dense vesicles (Fig, 4e), 
while nerve terminals in cultured lobes were characterized by empty vesicles of various shape 
and diameter, as well as by various types of lysosome-like structures (Fig. 4f). In the pars 
nervosa of cultured lobes, pituicytes appeared very active, having engulfed parts of granule-
filled axon terminals. Although some axon terminals appeared normal, others showed clear 
signs of degeneration (Fig. 4g). 
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Fig. 3. ¡mmunocytochemistry of the neurointermediate lobe. Arrows indicate immunoreactive 
varicosities. I = pars intermedia; N = pars nervosa, (a) Fresh intermediate lobe, stained with 
antidopamine. χ 2,200. (b) Fresh neurointermediate lobe, anli-NPY. χ 1,000. (с) Fresh 
neurointermediate lobe, anti-GABA. χ 900. (d) Neurointermediate lobe cultured for 7 days, anti-
GABA. Note absence of immunoreactivity. χ 1,000. 
Fig. 4. Electron microscopy of 7 days cultured neurointermediate lobes (a-dj,g) and a fresh lobe 
(e). (a) Folliculo-stellate cell (F) with slender processes (arrows) extending between melanotrope 
cells (Μ). N = nuclei of melanotropes; R = rough endoplasmic reticulum, χ 8,000. (b) Highly 
active Golgi apparatus (G) forming secretory vesicles (arrows) in melanotrope cell, χ 25,000. (с) 
Part of folliculo-stellate cell (F) flanked by melanotropes (Μ), χ 30,000. (d) Desmosome-like 
connection between melanotrope (M) and folliculo-stellate cell (F). χ 150,000. (e) Normal synaptic 
contact on folliculo-stellate cell (F) with small electron-lucent (arrows) and large electron-dense 
(arrowheads) synaptic vesicles, χ 35,000. (f) Degenerative synaptic contact (S) associated with 
folliculo-stellate cell (F) and melanotrope (M), with lysosome-like structures (arrows) and empty 
vesicles of various shape and size, χ 30,000. (g) Neural lobe showing axon terminals (A) and 
pituicyte (P) which has engulfed a degenerated terminal (D). L = Lysosomes. χ 12,500. 
3H 
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Fig. 5. Response to 60 mM KCl (15 mm) during m vitro superfusion of isolated 
melanotropes (a), freshly dissected neuromtermediate lobes (b) and neuroiniermediate 
lobes cultured for 7 days (c) Fractions were collected every 7 5 mm The basal level 
of a-MSH release was calculated for each experiment as the average secretion m the 
four fractions preceding the pulse The results are the average of several independent 
experiments Bars represent -SEM AT* stimulated a-MSH release from isolated 
melanotropes by 47 8 ± 744% (n=8, P<0 001, fractions 3+4 compared to fractions 
5+6) and inhibited the release from fresh lobes by 48 2 ± 2 3% (n=10, P<0 001, 
fractions 4+5 compared to fractions 6+7) The release from cultured lobes was 
stimulated initially by 32 3 ± 6 5% in the first pulse fraction (n=6, P<0 01, fraction 4 
compared to fraction 5) and subsequently inhibited by 35 2 ± 2 1% m the next two 
fractions (n=6, P<0 001, fractions 3+4 compared to fractions 6+7) 
Secretory response to elevated potassium. Responses of isolated melanotropes, freshly 
dissected neuromtermediate lobes and cultured tissue to elevated potassium clearly differed 
(Fig 5) Freshly dissected lobes showed a strong and long-lasting inhibition of a-MSH release 
In contrast, isolated melanotropes responded with a marked increase in a-MSH secretion 
Cultured lobes showed a biphasic effect Initially, there was a clear stimulation of release, then 
a sharp inhibition started, even while high potassium was still being administered This 
biphasic response was evident in lobes cultured for 1-7 days The dose dependency of the 
stimulatory and inhibitory phase of the effect of elevated potassium on cultured tissue and 
isolated melanotropes was also examined For cultured lobes, 20 mM KCl induced inhibition 
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but there was no stimulatory component, whereas at 40 and 60 mM KCl clear stimulatory 
components followed by marked inhibitions were observed (Fig. 6, upper panel). At all 
concentrations, the inhibitory component was stronger than the stimulatory component. The 
dose-response for KCl of isolated melanotropes did not show an inhibitory component; a slight 
stimulation was observed at 20 mM KCl, whereas at 40 and 60 mM stimulation of a-MSH 
release was marked (Fig. 6, lower panel). Responses of isolated cells were strongly delayed 
compared to those displayed by intact lobes, due to the larger volume of the superfusion 
chambers used for isolated cells. 
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Fig. 6. Dose-response of the effect of KG on 7 days cultured neurointermediate lobes 
(upper panel) and on isolated melanotropes (lower panel). Each graph represents the 
average result from four lobes or cell suspensions. Basal level was calculated from the 
average release of the three fractions preceding the first pulse (fractions 9-11 for the 
cultured lobes and fractions ¡6-18 for the melanotropes). Bars indicate -SEM. 
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Effect of NPY. NPY induced a marked, long-lasting inhibition of a-MSH secretion when 
applied to freshly dissected neurointermediate lobes but had no effect on a-MSH secretion 
from isolated melanotropes (Fig. 7a,b). On cultured lobes, NPY exhibited a very strong 
inhibitory effect (Fig. 7c), very similar to the effect on freshly dissected lobes; in both cases 
maximum inhibition was achieved 1-3 fractions after NPY treatment was terminated and 
secretion returned to basal levels only very slowly. 
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Fig. 7. Effect of NPY on super/used fresh neurointermediate lobes (a), isolated 
melanotropes (b) and neurointermediate lobes cultured for 7 days (с). NPY was added 
during two 15 min periods. Experiments shown in frame A and В were performed 
simultaneously, each preparation receiving the same medium. Each graph represents 
the average of 4 lobes or cell suspensions. Basal level was calculated from the average 
release of the 3 fractions preceding the first pulse {fractions 9,10,11). Bars represent -
SEM. 
DISCUSSION 
The ultrastructural data indicate that the pars intermedia of cultured lobes was structurally 
intact, showing close contact between folliculo-stellate cells and melanotropes. Normal 
functioning of the melanotropes was reflected in the results of the biosymhetic analysis which 
demonstrated that synthesis, processing and release of POMC-derived peptides was unaffected 
by culturing. The nerve terminals within the cultured lobe, however, showed degenerative 
features, an observation in keeping with the fact that immunoreactivity to dopamine, GABA 
and NPY had disappeared. Altogether we conclude that the pars intermedia of cultured lobes is 
an actively secreting organ that is free from neural influences. Therefore the cultured lobe can 
be utilized to study involvement of indirect mechanisms in the regulation of a-MSH secretion. 
The secretory responses of freshly dissected neurointermediate lobes, cultured lobes and 
cultured melanotrope cells to the depolarizing effect of elevated potassium were clearly 
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different. Cultured melanotropes responded with an increased release of hormone, as expected 
for isolated secretory cells. In sharp contrast, fresh lobes responded with strong inhibition of 
release, a phenomenon that can be attributed to release of endogenous inhibitory factors, such 
as dopamine, GABA or NPY, from depolarized nerve terminals within the neurointermediate 
lobe. Clearly, such inhibitory action overrides any stimulatory action Ю might exert on the 
melanotropes. The biphasic response of cultured tissue to elevated K* indicates the presence of 
two K*-sensitive mechanisms. The stimulatory phase may well be attributed to direct K+-
induced depolarization of the melanotrope plasma membrane. The inhibitory phase, however, 
cannot be due to release of endogenous neural factors, as cultured lobes apparently lack 
functionally active nerve terminals. Therefore, we conclude that the inhibitory phase must 
involve a K+-induced activation of an inhibitory mechanism emanating from another cell type 
within the (cultured) lobe. Our results indicate that while this cell type reacts more slowly than 
melanotropes to elevated Ю, it is probably more sensitive to K* since 20 mM KCl induced a 
clear inhibitory response with no apparent stimulatory phase. 
In our view the most likely cell type involved in the regulation of the secretory activity of 
the melanotropes is the folliculo-stellate cell. While the neurointermediate lobe contains 
endothelial cells lining blood vessels, the pars intermedia is poorly vascularized and thus 
endothelial cells have a very restricted distribution in the tissue. Similarly, the ependymal 
lining of the hypophyseal cleft consists of a single layer of cells, making this cell type an 
unlikely mediator of an inhibitory action on melanotropes. In contrast, folliculo-stellate cells 
are relatively abundant and distributed evenly throughout the pars intermedia, with their 
processes making intimate contact with virtually every melanotrope cell (Ferryman, 1974, 
1989; De Rijk et al., 1990a). The concept that folliculo-stellate cells play a role in the 
regulation of pituitary hormone secretion finds precedent in the literature. Semoff and Hadley 
(1978) observed staining indicative of ATPase activity between melanotropes and folliculo-
stellate cells and suggested that the stellate cells regulate the extracellular ionic environment of 
the melanotropes. This idea is supported by recent studies by Ferrara and Gospodarowicz 
(1988), who showed that bovine intermediate lobe folliculo-stellate cells are probably involved 
in ion transport. In addition, folliculo-stellate cells of the pars distalis have been reported to 
produce and secrete paracrine factors which regulate the secretory activity of endocrine cells in 
this organ (Baes et al., 1987; Gospodarowicz et ai, 1989; Gospodarowicz and Lau, 1989). In 
view of the inhibitory action observed on the melanotrope in the present study, the report of a 
folliculo-stellate cell-derived factor inhibiting stimulated prolactin release is of particular 
interest (Baes et al., 1987). 
The indirect mechanism inhibiting a-MSH secretion from Xenopus melanotropes could very 
well be evoked by NPY because this peptide did not inhibit secretion from isolated 
melanotropes but had a clear inhibitory action on cultured lobes. Moreover, the inhibitory 
profile obtained by NPY, showing a prolonged inhibition and slow recovery to basal levels, is 
very similar to the profile of KMnduced inhibition of neurointermediate lobes. In contrast, 
inhibition through dopamine and GABA, which have been shown to act directly on the 
melanotrope, are rapidly reversible (Verburg-van Kemenade et ai, 1986a). Involvement of the 
folliculo-stellate cells in NPY-induced inhibition is supported by the present observation that 
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NPY-containing nerve fibres are evenly distributed throughout the pars intennedia and from 
immunoelectron microscope studies showing that NPY containing varicosities make synaptic 
contacts with folliculo-stellate cells (De Rijk et al, 1990a). Furthermore, specific [125]I-Bolton-
Hunter-NPY binding sites have been localized on folliculo-stellate cells of the Xenopus 
neurointermediatc lobe (De Rijk et ai, 1991) and an antiidiotypic antibody against NPY, 
recognizing NPY receptors, binds to the intermediate lobe folliculo-stellate cell of this species 
(E.W. Roubos, unpubl. data). Interestingly, in contrast to the situation in Xenopus, in the frog 
Rana ridibunda, NPY has been reported to act directly on mclanotropes. Continued studies on 
the location and pharmacological characteristics of NPY receptors will further our 
understanding of the control of the amphibian pars intermedia. 
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Analysis of GABAB receptor function in the in vitro and in vivo 
regulation of a-MSH secretion from melanotrope cells 
of Xenopus laevis 
With B.G. Jenks and E.W. Roubos 
Endocrinology, in press 
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Abstract. The activity of many endocrine cells is regulated by γ-aminobutync acid 
(GABA) The effects of GABA are mediated by GABAA and/or GABAB receptors 
While GABAB receptors in the central nervous system have now been extensively 
charactenzed, little is known of the function and pharmacology of GABAB receptors of 
endoenne cells. In the amphibian Xenopus laevis, GABA inhibits the release of a-
melanophore-sümulating hormone (a-MSH) from the endocrine melanotrope cells 
through both GABAA and GABAB receptors. We have investigated the following 
aspects of the GABAB receptor of the melanotrope cells of X. laevis. (1) the 
pharmacology of this receptor, using antagonists previously established to demonstrate 
GABAB receptors in the mammalian central nervous system, (2) the relative 
contribution to the regulation of hormone secretion by the GABAA and GABAB 
receptors on melanotrope cells m vitro, and (3) the role of the GABAB receptor with 
respect to the physiological function of the melanotrope cell, i.e. regulation of pigment 
dispersion in skin mclanophorcs in relation to background colour in vivo We show 
that phaclofcn, 2-hydroxy-saclofen and 4-aimnobutylphosphomc acid dose-dependently 
blocked the inhibition of a-MSH release by GABAB receptor activation but not 
GABAA receptor activation. The GABAB receptor antagonist δ-aminovalenc acid, 
appeared to be a selective agonist on the GABAB receptor of melanotrope cells The 
inhibitory secretory response to a low dose of GABA (10 s M) was not affected by 
bicuculhne, but was significantly reduced by phaclofen; a high dose of GABA (IO4 M) 
was not antagonized by phaclofen. These results indicate that at a low GABA 
concentration the GABAB receptor mechanism would dominate in inhibiting the 
melanotrope cells, whereas at high concentrations both GABA receptor mechanisms 
would be activated. Different thresholds of activation may form the basis for 
differential action of GABA acting through both GABA receptor types. The tonic 
inhibition of a-MSH release in animals on a white background was not affected by 4-
armnobutylphosphomc acid, indicating that the GABAB receptor is not (solely) 
involved in the in vivo inhibition of a-MSH release m animals on a white background. 
INTRODUCTION 
The neurotransmitter γ-aminobutyric acid (GABA) is important in regulating hormone 
secretion from many endocrine tissues, including the antenor (Anderson and Mitchell, 1986a,b; 
Roussel et al., 1990, Virmani, et al, 1990) and intermediate (Tomiko et al, 1983; Demeneix 
et al, 1986; Verburg-van Kemenade et al, 1986c) lobe of the pituitary gland, the pineal gland 
(Rosenstein et ai, 1990), the adrenal medulla (Kataoka et al, 1986; Castro et al, 1989) and 
the endocrine pancreas (Gilon et al, 1991). The action of GABA on endocrine cells is often 
mediated by the bicuculline-sensitive GABAA receptor. In some cases, however, an additional, 
bicuculline-insensitive GABAB receptor has been shown to be present. Among the endocrine 
cells with both GABAA and GABAB receptors are chromaffin cells (Castro et al, 1989), 
gonadotropes (Anderson and Mitchell, 1986b), corticotropes (Anderson and Mitchell, 1986b), 
and melanotropes (Demeneix et al, 1984, 1986, Verburg-van Kemenade et al, 1987d) The 
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physiological significance of the coexistence of GABAA and GABAB receptore is unclear. 
GABAB receptore in the central nervous system (CNS) have been well characterized, using 
recently developed GABAB receptor antagonists such as phaclofen and 2-hydroxy-saclofen. In 
endocrine systems the GABAB receptors have only been identified on the basis of their 
sensitivity to baclofen and insensitivity to bicuculline. 
A system suitable to study endocrine GABAB receptors is the intermediate lobe of the 
pituitary gland of the amphibian clawed toad, Xenopus laevis. This lobe contains only one 
endocrine cell type, the melanotropc cell. The in vitro release of oc-melanophore stimulating 
hormone (a-MSH) from these cells is inhibited by administration of GABA (Verburg-van 
Kemenade et al., 1986a) and by agonists of the GABAA receptor (e.g. isoguvacine) and of the 
GABAB receptor (baclofen) (Verburg-van Kemenade et ai, 1987d). The pars intermedia of 
Xenopus is strongly innervated by GABAcrgic neurons (De Rijk et ai, 1990a, 1992). These 
neurons form synaptic contacts with the melanotropes (De Rijk et al., 1990a). The question 
arises as to the relative importance of the GABAA and GABAB receptors, because activation of 
either receptor type fully inhibits the secretory process (Verburg-van Kemenade et aL, 1987d). 
The receptors may be separately activated as a result of independent innervation by distinct 
GABAcrgic neurons, selectively forming GABAA or GABAg synapses. Alternatively, the two 
receptor types might have different thresholds of activation, so that a low GABA concentration 
would activate only one receptor type, as suggested for rat gonadotropes (Anderson and 
Mitchell, 1986b) and rat CNS neurons (Otis and Mody, 1992). To solve this problem selective 
antagonists to the GABAB receptor in endocrine cells are required. Therefore, we first 
examined the suitability of a number of established GABAB receptor antagonists in the CNS, 
to selectively antagonize the effects of the GABAB receptor agonist baclofen on a-MSH 
release. This was followed by an analysis of the relative effectiveness of GABAA and GABAB 
receptor antagonists to block GABA-induced inhibitory responses. 
In addition, we studied the possible involvement of GABAB receptors in the in vivo 
regulation of the secretory activity of melanotrope cells. In Xenopus, a-MSH is strongly 
secreted in animals on a black background, stimulating dispersion of pigment in dermal 
melanophores thus leading to darkening of the animal (Bagnara and Hadley, 1973). On a white 
background, secretion is under tonic inhibition, and in vitro experiments have indicated that 
GABA, dopamine and NPY are potential physiological inhibitory factors (Verburg-van 
Kemenade et al, 1986c,d, 1987b). To determine if the GABAB receptor is important in the 
regulation of the physiological process of a-MSH release in animals on a white background, 
the effect of in vivo treatment of X. laevis with a GABAB receptor antagonist (4-
aminobutylphosphonic acid; 4-ABPA) was studied. Previously, indications were obtained that 
dopamine, acting via a sulpiride-sensitive Dj-receptor, is involved in the in vivo inhibition of 
a-MSH release from Xenopus melanotropes. To study whether the GABAB receptor acts in 
synergism with the D2 receptor, the action of sulpiride on pigment dispersion in the skin has 
also been considered in the present study. 
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MATERIALS AND METHODS 
Ammals Young adult Xenopus laens (8 months old) were taken from laboratory stock Three 
weeks prior to the experiments they were placed in black or while containers under constant 
illumination Water temperature was 22 °C For superfusion experiments, only black-adapted 
ammals were used, as their stable, high level of a-MSH secretion permitted us to observe clear 
effects of inhibitory factors For the m vivo experiments, both black- and white-adapted Xenopus 
were used 
Superfusion experiments. Neurointermediate lobes of Xenopus laevti were dissected out and 
placed immediately on a filter m a superftision chamber (10 μΐ volume) Four chambers were 
superfiised simultaneously with incubation medium (IM), containing 112 mM NaCl, 2 mM KCl, 2 
mM CaCl2, 15 mM HEPES (Calbiochem, La Jolla, CA), 0 3 g/1 bovine serum albumin (Sigma, St 
Louis, MO), 2 g/1 glucose, 1 mgA ascorbic acid (pH 7 4 and carbogen-aerated), at a rate of 1 5 
ml/h at 22 0C Fractions (7 5 mm each) were collected and stored at -20 °C until assayed for a-
MSH using a radioimmunoassay Lobes were superfused for at least 75 nun with IM before 
receptor agonists and antagonists were introduced into the superfusion medium Basal release of ot-
MSH was calculated as the average secretion measured in the three fractions preceding the first 
application of ligand, and expressed as 100% Ligands tested, either alone or in combinations, were 
baclofen (Ciba-Geigy Ltd, Basel, Swiüerland), isoguvacine (Cambridge Research Biochermcals 
Ltd, Cambridge, UK), phaclofcn (Tocns Neuramin, Buckhurst Hill, UK), 4-aminobutylphosphomc 
acid (4-ABPA, Sigma), δ-aminovalenc acid (DAVA, Sigma), 2-hydroxy-saclofen (2-OH-saclofen, 
Research Biochermcals, Ine, Natick, MA) and bicucullme (Sigma) The concentrations of the 
ligands used and their administration protocols are given in the Results 
Radioimmunoassay Radioimmunoassay for a-MSH were performed as described previously, using 
an a-MSH-antiscrum raised and characterized in our laboratory (Van Zoest et al, 1989) The 
antiserum has equal affinity for the acetylated and non-acetylated forms of a-MSH and cross-
reactivity with ACTH was less than 0 01 % Bound and free antibodies were separated by 
polyethylene glycol/albumin precipitation Detection limit is 2 5 pg a-MSH per sample of 50 μΐ 
All superfusion fractions were assayed in duplicate 
In vivo experiments Black- or white-adapted animals were injected with receptor agonists and an­
tagonists in 200 μΐ of saline (0 6% NaCl) Control animals were injected with 200 μΐ saline 
Melanophore indices (MI) were scored under a dissection microscope, using the entena of Hogben 
and Slome (1931) An MI of 1 indicates complete aggregation of melanin and an MI of 5 indicates 
full dispersion 
Calculations and statistics. In the figures data are graphically shown as means (n=4, unless 
otherwise indicated) + S Ε M (vertical bars) To calculate percentages of stimulation or inhibition 
ol α-MSH release in the superfusion expenments, in the graphs peak areas (covering 2 - 4 
fractions) before and during administration of ligands were integrated and compared The 
integrated areas were tested using the paired Student's T-test (a = 5%) 
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Fig. 1. The effects of phaclofen (a) and 2-OH-saclofen (b) on GABAÁ and GABAB 
receptor-mediated actions on a-MSH release from superfused neurointermediate lobes. 
Shaded areas indicate the administration of the indicated drug. Thick lines with ar-
rowheads indicate start and end of antagonist administration. The concentrations of 
baclofen (Вас) and isoguvacine (Isog) were 3.3*10* M and 2*10'5 M respectively. 
Phaclofen reduced the baclofen-induced inhibition of release from 50.8 ± 1.9% to 21.4 
± 3.6% (P<0.001): 2-OH-saclofen attenuated the baclofen response from 52.2 ± 2.2% 
to 6.14 ± 1.7% (P<0.001). There was no effect of either antagonist on the response to 
isoguvacine. 
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RESULTS 
Pharmacological profile of the GABAB receptor of Xenopus Іаеш melanotropes. The 
inhibition of a-MSH release induced by the GABAB receptor agonist baclofen was 
significantly attenuated in the presence of 1 mM phaclofen (Fig la) The response to the 
GABAA agonist isoguvacine was not affected by phaclofen The effect of phaclofen was 
reversible, as full recovery of the baclofen-response was observed after treatment with 
antagonist had been terminated A concentration of 1 mM 2-OH-saclofen antagonized the 
response to baclofen almost completely, without influencing the isoguvacine-induced inhibition 
of a-MSH secretion (Fig lb) This effect of 2-OH-saclofen was reversible and dose-
dependent, with 0 1 mM significantly reducing the strongly inhibitory effect of baclofen (Fig 
2) Also, the action of baclofen was selectively and dose-dependently antagonized by 4-ABPA 
in the range of 0 1 - 1 mM (Fig 3) However, 4-ABPA itself caused a dosc-dependent 
inhibition of a-MSH secretion (Fig 4a) The putative GABAB receptor antagonist δ-
aminovalenc acid (DAVA) also inhibited a-MSH release, but with greater potency than 4-
ABPA (Fig 4b) At 10" M, DAVA did not significantly reduce baclofen-induced inhibition of 
a-MSH release (not shown) The inhibitory responses to 4-ABPA and DAVA were 
significantly reduced by phaclofen (Fig 5a,b), but they were nol by affected by ΙΟ"* M of the 
GABAA receptor antagonist bicucullme (Fig 5c) Bicuculline completely antagonized the 
160 
120 
80 
40 
10 20 30 40 э0 60 
Superlusion Fraction Number 
Fig 2. Dose-dependency of 2-OH saclofen antagonism of baclofen action on 
superfused neurointermedtate ІоЬеч Baclofen concentration was 3 3*10* M. 2-OH-
saclofen concentrations are indicated in the figure Baclofen-induced inhibition of a-
MSH release was 60 9 ± 5 0% This was reduced in the presence of 2-OH-saclofen, 
subsequently to 35 4 ± 5 5% (0 1 mM, P<0 02), 160 ±4 3% (0 33 mM. P<0 001) and 
77±34%(1 mM, P<0001) 
2-OH-Saclofen [mM] 
0 1 0 33 1 0 
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inhibition of secretion induced by isoguvacine. The order of potencies for the GABAB receptor 
antagonists is: 4-ABPA = 2-OH-saclofen > phaclofen. In a concentration of 1 mM the ligands 
antagonized 3.3 μΜ baclofen by 93.6 ± 5.2% (n=4), 87.8 ± 3.3% (n=8) and 57.9 ± 7.2% 
(n=4), respectively. 
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Fig. 3. Effect of 4-ABPA on GABAA and GABAg receptor-mediated actions on a-MSH 
release from superfused neurointermediate lobes. Concentrations of baclofen and 
isoguvacine were 3.3*W'* M and 2*I(rs M respectively. Baclofen induced inhibition of 
a-MSH secretion (53.4 ± 4.4%) was attenuated by 4-ABPA to 28.7 ±6.4 (O.J mM, 
P<0.05) and 3.4 ± 2.8% (I mM. P<0.01) respectively. Subsequent pulses with 
isoguvacine were not significantly affected by the presence of 4-ABPA. 
Differential effects of GABA on GABAA and GABAB receptors in vitro. The release of a-
MSH from superfused neurointcrmediate lobes was inhibited by IO"5 - IO"1 M GABA. This 
inhibition was not influenced by application of 10"* M bicucullinc (Fig. 6a,b), a treatment that 
completely blocks responses to GABAA receptor agonists (Fig. 5c). Phaclofen (1 mM) almost 
completely antagonized the inhibitory response evoked by 10"s M GABA, but not the 
inhibition evoked by IO4 M GABA (Fig. 6c,d). Also, administration of 2-OH-saclofen or Λ­
ΑΒΡΑ antagonized the inhibitory responses induced by IO5 M GABA (not shown). 
Involvement of the GABA
e
 receptor in background adaptation. Intraperitoneal injection of 
baclofen in adult Xenopus laevis adapted to and remaining on a black background, leads to 
pigment aggregation. The MI decreased from about 5 to about 3 within 1 h and stayed at this 
value for at least 18 h (Fig. 7). When baclofen was injected together with 4-ABPA (10s 
mole/g body weight), the MI remained at control value (about 5) during the same period (Fig. 
7). Injection of animals adapted to and remaining on a white background with the same dose 
5/ 
4-ΛΒΡΛ 
0.1 mil 1 mM 
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Fig. 4. Effects of 4-ABPA (a) and DAVA (b) on a-MSH release from superfused 
neurointermediate lobes. Concentrations of 4-ABPA and DAVA are indicated in the 
figure. Insert: Percent inhibition of secretion induced by the same concentrations of 4-
ABPA or DAVA, representing several experiments combined; η indicates number of 
experiments, * = P<0.0S, ** = ΡκΟ.001. 
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of 4-ΑΒΡΑ had no effect on MI, while sulpiride (IO-7 mole/g body weight) caused a 
significant, but transient darkening of the skin. Coinjection of 4-ABPA and sulpiride resulted 
in a similar response (Fig. 8). Bicuculline (IO7 - 10"6 mole/g body weight) caused pigment 
aggregation in black animals. The MI significantly fell from 4.6 ± 0.1 to 3.2 ± 0.2 within 90 
min. 
DISCUSSION 
Pharmacological profile of the GABAg receptor of melanotrope cells. To our knowledge, 
only one study to identify specific antagonists for GABAB receptors on endocrine cells has 
been published, by Shibuya et al. (1991). They also used melanotrope cells of X. laevis and 
found most antagonists tested, including phaclofen and 2-OH-saclofen, to be ineffective in 
antagonizing baclofen-induced inhibition of a-MSH release: at 3*10^ M, 2-OH-saclofen was 
modestly effective and phaclofen was ineffective. The only effective antagonist was the novel 
ligand CGP 35-348 (Shibuya et al, 1991); 4-ABPA was not studied. In contrast, we find that 
both phaclofen and 2-OH-saclofen, as well as 4-ABPA, selectively antagonize GABAB 
receptor-mediated inhibition of a-MSH secretion. While phaclofen, 2-OH-saclofcn and 4-
ABPA are probably less potent agonists than CGP 35-348, we show that these antagonists 
have similar potencies to antagonize GABAB receptor agonists as they have in the mammalian 
CNS (Kerr et al., 1988; Kerr and Ong, 1991). 
The antagonistic effects of phaclofen, 2-OH-saclofen and 4-ABPA arc reversible, as can be 
concluded from the observation that baclofen-induced inhibition of a-MSH secretion was fully 
restored after treatment with the antagonist had been stopped. 2-OH-saclofen is a more potent 
antagonist than phaclofen, as is the case in the mammalian CNS (Kerr et al, 1988; Harrison et 
al, 1990; Kerr and Ong, 1991). Phaclofen, 2-OH-saclofen and 4-ABPA are widely accepted as 
selective GABAB antagonists in the CNS (for reviews see Bowery, 1989; Kerr et al, 1990; 
Kerr and Ong, 1991). Our results suggest that these antagonists can also be used to 
characterize GABAB receptors in endocrine systems. 
While most of our results conform with GABAB receptor pharmacology in the CNS, the 
GABAB receptor of Xenopus melanotrope cells shows some remarkable characteristics. The 
most obvious difference with the CNS GABAB receptor is the fact that DAVA has an agonist 
action. This appeared from the observation that DAVA-induced inhibition of a-MSH release 
was attenuated by phaclofen but not by the GABAA receptor antagonist bicuculline. While it 
has been reported that DAVA is a weak agonist of GABAA receptor (Bowery and Brown, 
1974; Dickenson et al, 1988; Bowery, 1989), it has been widely used as a GABAB receptor 
antagonist in the CNS and various other organs in mammals (Muhyaddin et al., 1982; Ong and 
Kerr, 1983; Nakahiro et al., 1985; Schwarz et al, 1988; Hills et al, 1991). The strong 
agonistic action of high concentrations of DAVA makes it hard to determine whether this 
substance has some antagonistic activity as well, but at low concentrations (10"* M) no 
evidence for an antagonistic action was observed. 
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Fig 5. Effect of GABAA and GABAS receptor antagonists on the inhibition of a-MSH 
release induced by 4-ABPA and DAVA a, effect of phaclofen on 4-ABPA response, b, 
effect of phaclofen on DAVA response, c, effect of bicuculline on 4-ABPA and DAVA 
response Concentrations are indicated m the figure Phaclofen attenuated the response 
to 01 mM 4-ABPA from 32 9 ± 6 0% inhibition to 172 ± 3 5% (NS) and to 0 33 mM 
4-ABPA from 579 ± 62% to 379 ± 5 4% (P<0 05) The response to 0 33 mM DAVA 
was attenuated from 52 6 ± 4 4% to 36 1 ± 3 0% (P<0 05) by phaclofen In frame c, 
subsequent pulses with 4-ABPA inhibited a-MSH release by 41 1 ±5 4% and 38 3 ± 
2 2% and DAVA inhibited a-MSH secretion by 46 6 ± 5 0% and 46 S ± 5 5% 
respectively 
Another difference with mammalian GABAB receptors concerns the action of 4-ABPA The 
slight inhibition of a-MSH release by 4-ABPA, which is attenuated by phaclofen, indicates 
that this antagonist, like DAVA, displays weak agonist action The observation thai both 4-
ABPA and DAVA show GABAB agonist activities may reflect a distinct charactenstic of 
GABAB receptors on endocrine cells Possibly, the similar actions of 4-ABPA and DAVA, are 
based on their structural similarities 
Differential activation of GABA receptor types by GABA. The presence of two GABA 
receptor types on the melanotrope cells of X laevis, raises two important questions (1) can 
these receptors be differentially activated and (2) if so, what are the functional implications7 
Concerning the first question, differential activation could be achieved by separate innervation 
of the receptors types, so that one GABAergic neuronal system could activate GABAA 
receptors, while another would activate GABAB receptois However, detailed immuno-
eleclronmicroscopic studies have provided no evidence for such a separate innervation The 
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varicosities in the pars intermedia of X. laevis all have the same basic morphological 
characteristics (De Rijk et al., 1990a), showing immunorcactivities to GABA, dopamine, and 
neuropeptide Y (De Rijk et aL, 1990a, 1992). Alternatively, differential activation could occur 
if the respective receptor mechanisms have different thresholds for activation. The present 
results show that the GABAB receptor mechanism has a lower threshold for activation by 
GABA than the GABAA receptor mechanism. This was evident from the observation that the 
in vitro response to a low dose of GABA was antagonized by GABAB receptor antagonists, 
but not by the GABAA receptor antagonist bicuculline. Thus, it seems feasible that at low 
GABA concentrations only the GABAB receptor mechanism is be activated while at high 
concentrations of GABA both GABAA and GABAB receptor mechanisms are activated. 
Apparently, at W4 M GABA, activation of either receptor type has a clear effect on a-MSH 
secretion. Therefore, blocking either receptor type does not significantly reduce the effect of a 
high concentration of GABA. 
Differential activation of GABAA and GABAB receptors has previously been reported for 
rat gonadotropes and CNS neurons (Anderson and Mitchell, 1986b; Otis and Mody, 1992). In 
both cases, the GABAA receptor was more sensitive to GABA than the GABAB receptor, 
which is in contrast to the situation for melanotrope cells of X. iaevts. 
Differential activation of GABAA and GABAB receptor mechanisms could have important 
functional implications for the melanotrope cell, because the two receptors activate different 
intracellular mechanisms. In Xenopus melanotropes, GABAB receptor inhibits production of 
cyclic-AMP (Jenks et al., 1991) whereas activation of the GABAA receptor causes influx of 
chloride ions. Though both receptors are involved in the inhibition of a-MSH release, the 
possibility that they have additional (differential) effects on other aspects of cell functioning 
(e.g. gene expression and posttranslational precursor processing) can not be ruled out. 
The GABAg receptor and background adaptation. Multiple factors have been shown to 
regulate a-MSH secretion from Xenopus melanotrope cells in vitro, but it is not known which 
of these factors are controlling the secretory process in vivo. The melanotrope cell is 
spontaneously secreting and, in vivo, primarily controlled through tonic inhibition by factors of 
hypothalamic origin (Jenks et al., 1988). Thus far, GABA, dopamine and NPY have been 
identified as potential inhibitory regulators, because they could be shown in nerve terminals in 
the pars intermedia (De Rijk et al, 1990a, 1992) and are capable to inhibit a-MSH secretion 
Fig. 6. The effects of bicuculline and phaclofen on GABA-induced inhibition of a-MSH 
secretion, a. Effect of Ю1 M bicuculline on the response to 10rs M GABA; b. Effect of 
10* M bicuculline on the response to 3.3*WS M GABA; c. Effect of IQ3 M phaclofen 
on the response to 10s M GABA; d. Effect of ΙΟ'3 M phaclofen on the response to ¡О* 
M GABA. Data are the average of four. In frames a, b and d, responses to GABA were 
not significantly attenuated in the presence of antagonist. In frame b, inhibition of a-
MSH release by 10* M GABA was reduced from 26.4 ± 2.2% (average of pulse 1 and 
3) to 5.7 ± 7.4% (P<0.02). 
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Fig. 7. The effect of 4-ABPA on baclofen-mduced decrease m pigment dispersion in 
melanophores (Ml) of black adapted Xenopus m vivo Baclofen (107 mole/g body 
weight) caused a clear aggregation of pigment in web melanophores This effect was 
significant (P<0 01) after 40 mm as compared to control animals injected with saline 
and to animals injected with the same amount of baclofen in addition to 105 mole/g 
BW 4-ABPA The animals treated with baclofen and 4-ABPA displayed a lower MI 
than control animals throughout the experiment, but this difference was not statistically 
significant 
t (h) 
Fig. 8. The effects of receptor antagonists on pigment dispersion (Ml) in melanophores 
of white-adapted Xenopus in vivo Concentrations were 107 mole/g body weight for 
sulpiride and 10 s mole/g body weight for 4-ABPA The increase in MI after 
administration of sulpiride was signifiant after 20 and 40 mm (P<0 05) 
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in vitro (Verburg-van Kemenade et al, 1986c,d, 1987b). It has previously been shown that 
injection of the dopamine D, receptor antagonist sulpiride slightly increases pigment dispersion 
in white animals (Verburg-van Kemenade et al., 1986d), indicating that a catecholamine is, in 
part, responsible for the tonic inhibition. We now show that 4-ABPA, which is capable of 
blocking baclofen-induced pigment aggregation in black-adapted animals, has no effect on 
pigment dispersion in melanophores of white-adapted animals. The use of 4-ABPA in our in 
vivo experiments has advantages over the use of phaclofen and 2-OH-saclofen in that 4-ABPA 
is highly soluble in saline, allowing high doses to be injected in relatively small volumes. The 
in vivo results indicate that the tonic inhibition of a-MSH release is not mediated by the 
GABAB receptor, or at least not exclusively. The tonic inhibition is also not the result of a 
simultaneous activation of a catecholamine and GABAB receptor, because coinjection of 4-
ABPA with sulpiride was not more effective in causing pigment dispersion than sulpiride 
alone. In vivo injection experiments with the GABAA receptor antagonist bicuculline were not 
possible, because bicuculline reduced pigment dispersion by itself, probably reflecting its 
action on GABAA receptors within the CNS. From the results discussed above, it appears that 
the tonic inhibition of a-MSH release in vivo is caused by a mixture of neurochemical 
messengere. The exact composition of this mixture cannot be determined until suitable 
antagonists for each of the components are available. 
In conclusion, we have characterized a GABAB receptor of Xenopus melanotrope cells in 
vitro, and identified several specific antagonists. One of these, 4-ABPA, is also useful in in 
vivo studies. In addition, we have shown that a different threshold of activation may lead to 
selective activation of a GABAB receptor mechanism in a system containing both GABAA and 
GABAB receptor types. 
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The secretion of a-MSH from Xenopus melanotropes 
depends on calcium influx through 
N-type voltage-operated calcium channels 
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Abstract. The secretory activity of endoenne cells largely depends on the 
concentration of free cytosolic calcium. We have studied which mechanisms are 
involved in supplying the calcium necessary for the secreüon of oc-melanophore-
stimulating hormone (ot-MSH) from melanotropc cells in the intermediate pituitary 
lobe of the amphibian Xenopus laevis. Using whole-cell voltage clamp, high voltage-
activated calcium currents were observed, which were blocked by 0 1 mM CdCl2. The 
currents showed a variable inactivation rate. The non-inacüvating current was 
reminiscent of L-type voltage-dependent currents, the inactivaüng current resembled 
currents through N-type channels. No evidence was found for the presence of transient, 
low voltage-activated currents indicative of T-type channels. The secretion of a-MSH 
from superfuscd neuromtermediate lobes was dependent on extracellular calcium, as 
administration of medium with low calcium concentrations (10"4 - Iff* M) rapidly 
inhibited this process. Under these low calcium conditions, secreüon was not affected 
by depolarising concentrations of potassium chloride. The calcium lonophorc A23187 
increased secretion during low calcium conditions, but had no effect on spontaneous a-
MSH release Treatment with CoCl2, a general blocker of calcium channels, strongly 
inhibited the secretory process. These results suggest that spontaneous a-MSH release 
depends on influx of calcium through voltage-operated calcium channels Specific 
blockers of the L-type calcium channel, nifedipine and verapamil, had no effect on 
spontaneous secreüon. Moreover, BAY-K8644, a specific agonist for this channel, did 
not affect a-MSH release under normal or low calcium conditions. The blocker of N-
typc voltage-operated calcium channels, ω-conotoxin, dose dependently inhibited a-
MSH release. Thapsigargin, an agent that mobilises calcium from intracellular stores, 
had no effect on spontaneous a-MSH release under normal or low calcium conditions. 
It is concluded that the spontaneous release of a-MSH by melanotropc cells of X. 
laevis is maintained by calcium influx through voltage-operated N-type calcium 
channels and that mobilizaüon of calcium from intracellular stores plays no major role 
in the regulation of this process, even when extracellular calcium is very low and, 
therefore, free calcium is ratc-hnuting. 
INTRODUCTION 
The amphibian melanotropc cell functions as a neuroendocrine transducer cell and is involved 
in the process of background adaptation. The cell integrates neuronal mput mto endocrine 
output, namely the secretion of α-melanophore-slimulating hormone (a-MSH) for the 
regulation of pigment dispersion in dermal mclanophores (Bagnara and Hadley, 1973). The 
neuronal input includes GABA, dopamine and neuropeptide Y, which mhibit a-MSH 
secretion, and corticotropin-releasing hormone and thyrotropin-releasing hormone, which 
stimulate secretion (Jenks et al, 1988, Tonon et al, 1988) These regulators activate distinct 
intracellular signalling pathways that ultimately converge to control secretion. The ultimate 
event in stimulus-secretion coupling is the regulation of the free intracellular calcium 
concentration. It can be predicted that regulatory factors functioning through transmembrane 
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signalling mechanisms directly or indirectly influence cytosolic calcium concentrations in order 
to regulate secretion (Rasmussen and Barrett, 1984) An understanding of the mechanisms 
controlling changes in cytosolic calcium levels linked to secretion will enhance our insight in 
the process ol integration of multiple neuroendoenne inputs to secretory cells 
The cytosolic free calcium concentration may be controlled by mobilization of calcium 
from intracellular stores, a process regulated by the second messenger inositol 1,4,5-
tnphosphate (Volpe et al, 1988, Migncry et al, 1989) Intracellular Ca2* may furthermore be 
regulated by entry of extracellular calcium through calcium channels and, in excitable cells, 
especially through voltage-operated calcium channels (VOCC) (Hosey and La/dunski, 1988, 
Scott et al, 1991) Free calcium levels may also be controlled by a combination of both 
mechanisms, each employed as circumstances require 
The presence of VOCC in melanotrope cells has been investigated with electrophysiological 
techniques in several species (Douglas and Taraskevich, 1980, Cota, 1986, Taleb et al, 1986, 
Louiset et al, 1988, Taraskevich and Douglas, 1989, Keja et al, 1991) It appeared that these 
cells possess a mixed population of channels consisting of N- and L-typc VOCC and, in some 
cases, also the presence of T-type VOCC has been shown (Taleb et al, 1986, Williams et al, 
1990a, Keja et al, 1991) Relatively little attention has been paid to the possible involvement 
of such channels in the secretory process Only in mouse and frog melanotrope cells a minor 
role for L-type channels has been reported (Taraskevich and Douglas, 1986, Lamacz et al, 
1988) The present study concerns a multidisciphnary study, involving electrophysiological, 
pharmacological and superfusion techniques, on the characteristics of VOCC and their role in 
the secretion of cc-MSH from melanotrope cells of the amphibian Xenopus laevis These cells 
have been chosen because their basic secretory charaticnstics are well known and their 
secretory activity can be readily assessed under experimental conditions (see eg Ref 2) 
Furthermore, the possible involvement of intracellularly stored calcium ions in secretion has 
been examined 
MATERIALS AND METHODS 
Animals. Adult Xenopus laevis (7-10 months old) were taken from laboratory stock and kept in 
black containers for three weeks pnor to the expenments Water temperature was 22 0C They 
were fed trout pellets (Trouvit, Trouw, Putten, The Netherlands) weekly 
Cell cultures. Neurointermcdiate lobes from three animals adapted to a black background were 
incubated for 25 mm in L15 medium (Gibco, Renfrewshire, UK) diluted 2 1 with distilled water 
and supplemented with 008 mg/ml СаС1
:
2Н20 and 0 5-1% protease (type IX, Sigma, St Louis, 
MO) Cells were dispersed by passing the lobes several times through a siliconized Pasteur's 
pipette and 8 ml of culture medium (CM) consisting of 66% L15 and 10% foetal calf serum (PAA, 
Austna) were added The cells were then filtered over a nylon gauze (pore size 30 pm) to remove 
undissociated tissue, and collected by centrifugalion They were resuspended in CM and plated on 
glass cover slips coated with poly-L-lysine (MW 150,000 - 300,000, Sigma) in a density of 3,500-
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5,000 cells per cover slip Trypan blue exclusion test showed that >95% of the cells were viable 
Electrophysiological studies. To record action potentials in the whole cell configuration, non-
selective pipette and bath solutions were used Medium in the pipette contained 100 mM KCl, 2 
mM CaCl2> 10 mM EGTA, 10 mM HEPES (pH 7 4) and 2 mM MgATP Non-selective 
extracellular medium contained 112 mM NaCl, 2 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 15 mM 
HEPES (pH 7 4) and 10 mM glucose 
Currents through calcium channels were recorded in whole-cell patch clamp configuration, at 22 
"С, according to Harmll et al (1981). Recordings were made from cells with a diameter of about 
10 μπι, which had been cultured for 0-9 days in CM The pipette solution contained 100 mM CsCl, 
2 mM CaClj, 2 mM MgATP, 10 mM EGTA and 10 mM HEPES (pH 7 4, Merck, Darmstadt, 
Germany) The extracellular solution contained 96 mM tetracthyl ammonium chloride, 10 mM 
BaCl2, 2 mM MgCl2 and 15 mM HEPES (pH 7 4) Currents were recorded using a List EPC-7 
patch clamp amplifier (Darmstadt, Germany), filtered at 3 kHz using the internal 3-pole Bessel 
filter and digitized at 5 kHz with a CED 1401 A/D converter (Cambridge Electromcs, Cambridge, 
UK) Holding potential was -80 mV. The current-voltage relations (I/V) were obtained by applying 
test potentials of -70 to +60 mV, with steps of 10 mV, for 200 ms Interpulse interval was 10 s. 
Errors in the test potentials as a result of senes resistance did not exceed 5 mV Measurements 
were started between 5 and 10 nun after entering the whole cell configuration The effect of 0.1 
mM CdClj was tested by bath perfusion 
In vitro superfusion. Neurointcrmcdiate lobes of Xenopus laevis were dissected out and placed in 
10 μΐ superfusion chambers Four such chambers were superfused simultaneously with incubation 
medium (IM), consisting of 112 mM NaCl, 2 mM KCl, 2 mM CaCl2, 15 mM HEPES (pH 7.4), 2 
mg/ml glucose, 0 3 mg/ml bovine serum albumin and 1 mg/1 ascorbic acid, at a rate of 1 5 ml/h, at 
22 0C In order to establish a stable release, lobes were superfused for at least 75 nun (10 fractions 
of 7 5 min) with IM before drugs (or different calcium condiüons) were applied Basal 
(spontaneous) a-MSH release was defined as the average secretion in the three fractions preceding 
the first application Drugs tested were thapsigargin (Calbiochem, La Jolla, CA), A23187 (free 
acid, Sigma). BAY K8644 (Miles Pharmaceuticals, West Haven, USA), nifedipine (Sigma), 
verapamil (Laboratoires Biosedra, Malakoff, France) and ω-conotoxin GVIA (Peninsula 
Laboratories, Belmont CA, USA) For concentrations of drugs used and their administration 
protocols, see Results BAY K8644 and nifedipine were dissolved in ethanol. The ethanol 
concentration never exceeded 0 1% (v/v) A23187 (10-6 M) was dissolved in IM containing 0 1% 
dimethyl sulfoxide In expenments where the KCl and/or CaCl2 concentrations in the medium were 
varied, the osmolarity was kept constant by adjusting the concentration of NaCl in the medium 
Low levels of CaCl2 were buffered with EGTA 
Radioimmunoassay. Radioimmunoassay for a-MSH was performed as described previously, using 
an antiserum raised in our laboratory (Van 7oest et al, 1989), which has equal affinity for the 
acetylated and non-acetylated forms of a-MSH Cross-reactivities with ACTH (1-24) and ACTH 
(1-39) were lower than 0 01% Bound and free antiserum were separated by polyethylene-
glycol/ovalbumin precipitation Detection limit was 2 pg a-MSH per 50 μΐ sample 
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Fig. 1. Spontaneous action potentials in a 
whole-cell recording from a melanotrope cell. 
Membrane potential was approximately -35 mV. 
20 mV 
0.5 s 
Calculations and statistics. Results are shown as the average of four experiments ± SEM, 
unless staled otherwise. Percentages of stimulation and of inhibition of a-MSH-secretion in 
response to experimental treatment were calculated on the basis of integration of the respective 
peak areas in the graphs, using the fractions just before and during treatment. The integrated 
areas were tested for significance using the paired Student's T-test. A Ρ value <0.05 was 
considered to indicate significance. 
RESULTS 
Patch-clamp recordings. In non-selective medium, melanoiropes had membrane potentials 
between -50 and -30 mV. In general, they spontaneously fired action potentials, both in the 
cell-attached configuration (not shown) and in the whole cell configuration (Fig. 1). A series 
of initial whole cell voltage clamp experiments using barium-selective salines that blocked 
currents through sodium and potassium channels, provided evidence for the occurrence of high 
voltage-activated calcium channels in melanoiropes. The barium current activated at potentials 
of -20 mV and higher. It had a peak amplitude of 465 ± 75 pA (n=9) at 0 or +10 mV. It was 
blocked completely by adding 0.1 mM CdC^ to the saline (n=3). The inactivation properties 
of the current varied strongly between cells. The extreme cases are shown in figure 2. Average 
inactivation at the end of a 200 msec test pulse was 31.7 ± 7.7% at +30 mV (n=9). 
Effects of factors interfering with calcium influx. Application of medium with a low calcium 
concentration reduced the rate of a-MSH secretion from intact neurointennediate lobes. This 
effect was clear within 2 superfusion fractions (15 min) and reached its maximum after 3-4 
fractions. In the presence of IO7' M CaCl2 the reduced rate of a-MSH release was not affected 
by a high (60 mM) concentration of KCl (Fig. 3). The calcium ionophore A23187 (Iff6 M) 
had no effect on spontaneous secretion, but increased a-MSH release under low (IO"4 M) 
calcium conditions (Fig. 4a,b). 
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Fig. 2. Whole-cell voltage clamp recordings of currents through calcium channels in melanotropes 
(a) Currents evoked by test pulses of 200 msec from a holding potential of -80 mV to potentials 
of-20 mV to +60 mV, with steps of 10 mV (b) Current-voltage (I/V) relation of experiment shown 
in (a) There is little mactivation of the barium currents (6% at +30 mV), since peak current (open 
circles) and the current at the end of the test риіче (filled circles) differ little (c) As (a), different 
experiment (d) I/V relation of experiment shown m (с), showing clear mactivation of the barium 
currents (70% at +30 mV) 
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Fig. 3. Response of superfused neuroinlermediate lobes 
to 60 mM KCl during low-calcium conditions (W8 M) 
Start and end of treatment with low calcium medium is 
indicated with arrows Administration of medium 
containing 60 mM KCl is indicated by the shaded area. 
Data are the means of four lobes, superfused 
separately Basal release (100 %) is defined as the 
average release in the three fractions preceding the 
pulse Vertical bars represent -SEM 
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Effect of drugs that affect voltage-operated calcium channels. Administration of CoCl2, a 
general calcium channel blocker, produced a dose-dependent inhibition of a-MSH release (Fig 
5) Verapamil ( ΐσ 6 M), a specific phenylalkylamine antagonist for the L-type VOCC, and 
nifedipine (10 8 - 105 M), a potent 1,4-dihydropyndine blocker of L-type VOCC, did not 
change the rate of a-MSH secretion (Fig 6) The dihydropyndine agonist BAY K8644 also 
had no effect on a-MSH release under normal as well as under low calcium conditions, at 
concentrations up to Iff3 M (Fig 7a.b) The antagonist of N-type VOCC ω-conotoxm (10 7 -
5*106 M) induced a dose-dcpcndcnt inhibition of a-MSH release (Fig 8a) The effect of 
conotoxin was not rapidly reversible and subsequent pulses of increasing doses of conotoxin 
caused a cumulative effect, reachmg about 70% inhibition of secretion at 5*106 M After 15 
mm of treatment with conotoxin (3 3*106 M) a stable level of secretion was established, 
which did not change upon adding 105 M nifedipine (Fig 8b) 
The effect of thapsigargm on a-MSH secretion. Thapsigargin (3 3*107 M), an agent known 
to mobilize free Ca2* from intracellular stores by inhibiting microsomal Ca2*-ATPasc, had no 
effect on a-MSH secretion under normal and low (104 M) calcium conditions (Fig 9a) 
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Fig. 4. The effect of A23187 on a-MSH release during (a) normal conditions and (b) 
low calcium conditions Data shewn are the average of eight lobes The solvent of 
A23187, 01% DMSO. had no effect on secretion m either case A23Ì87 (10* M) had 
no significant effect on basal release (9 6 ± 4 4 and 25 ± 65% stimulation of release 
respectively), but stimulated α MSH release during low calcium conditions by 191 ± 
7 7% (P<0 05) 
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DISCUSSION 
It is generally accepted that the cytosolic concentration of free calcium ions controls the 
secretory activity of secretory cells Regulation of free intracellular calcium levels is therefore 
considered the pivotal event in stimulus-secretion coupling (Rasmussen and Barrett, 1984, 
Scott et al, 1991) In the present study, we have investigated whether the mechanisms of 
calcium influx through VOCC and of calcium mobilization are involved in the spontaneous 
secretion of a-MSH from Xenopus melanotropc cells 
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fig. 5. The effect of cobalt chloride on a MSH release The different doses of CoC/2 
were applied in separate experiments, each the average of four lobes Application of 
5*J0-4 M CoCl2 inhibited a-MSH release by 32 9 ± 51% after 30 mm (P<0 02, 
fractions 8-11 compared to fr ¡6-19), 5*10 ' M CoCl2 inhibited secretion rapidly by 
45 0 ± 4 7% (P<0 01, fr 5-6 compared to fr 8-9), the secretory rate stabilizing on 
64 7 ± 4 1% of basal level (P<0 01. fr 4-6 compared to fr 11-13) 
A possible mechanism by which cytosolic calcium levels can be controlled is through 
activation of VOCC m the plasma membrane The involvement of such channels is plausible 
because melanotrope cells of vanous species display spontaneous action potentials, causing 
sufficient depolarizations to induce VOCC opening (Taraskevich and Douglas, 1979, 1989, 
Douglas and Taraskevich, 1980, Louiset et al, 1988) We now show that melanotrope cells of 
X laevis also display such action potentials Moreover, the presence of high voltage-activated 
calcium currents that might be activated by such action potentials to provide the calcium 
necessary for the spontaneous a-MSH release has been demonstrated The recorded currents 
display the charactensucs associated with currents through VOCC, because they are earned by 
banum ions, can be blocked by Cd2+ and are voltage-dependent The observation that these 
currents display two distinct types of mactivation kinetics suggests that Xenopus melanotrope 
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Fig·. 6. Dose-response of the effect of nifedipine on a-MSH secretion. None of the 
nifedipine concentrations tested affected the secretory process significantly. Data are 
the average of four lobes. 
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Fig. 7. The effect of BAY-K8644 on a-MSH secretion from superfused 
neurointermediate lobes during (a) normal and (b) low calcium conditions. BAY-K8644 
had no significant effect on hormone release under either condition. 
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cells, like those of rat (Cota, 1986; Williams et al., 1990a; Keja et al., 1991), pig (Taleb et al., 
1986) and frog (Louiset et ai, 1988), possess a mixed population of VOCC. The voltage-
dependence and the kinetic characteristics of the non-inactivating and inactivating currents are 
similar to those of L-type and N-type currents, respectively, as have been described in neurons 
(Tsien et al., 1988; Scott et al., 1991) and in melanotropes of the rat (Williams et al., 1990a; 
Keja et al., 1991) and the frog (Louiset et al., 1988). It should be noted, however, that 
additional pharmacological data (see below) are necessary to identify these channels because 
the identification of high-voltage activated calcium channels solely on inactivation properties is 
difficult (Swandulla et ai, 1991). For example, in some cases N-type VOCC do not inactivate 
(Plummer and Hess, 1991). T-type channels, which are electrophysiologically characterized by 
activation at low voltage (-60 mV), and rapid inactivation (Tsien et al., 1988; Scott et al., 
1991), have not been found in the present study. 
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Fig. Ä. (a) Dose-response of the effect of iù-conotoxin on a-MSH release. Conotoxin 
progressively reduced a-MSH release to 70.8 ± 7.6% (JO7 M, P<0.00J), 42.1 ± 3.2% 
(10-6 M, P<0.01) and 31.1 ± 2.2% (5*10* M, P<0.001) of basal level, as calculated 
from the average secretion in the last four fractions of each conotoxin administration. 
(b) The effects of 105 M nifedipine on a-MSH release during conotoxin-induced 
inhibition of secretion. Conotoxin alone inhibited secretion to about 40% of basal 
secretion. Nifedipine had no additional effect on this process. 
The role of calcium in the spontaneous a-MSH secretion from melanotropes was 
investigated using m vifro superfusion techniques. The secretory process was found to depend 
on extracellular Ca2+, as reported for mclanotrope cells of mammals (Bower and Hadley, 1972; 
Schmitt et al, 1979; Tomiko et al, 1981; Tsuruta et al, 1982) and lower vertebrates 
(Hopkins, 1970; Thornton and Geschwind, 1975; Lamacz et al., 1988). The relatively rapid 
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inhibition of secretion as a result of lowering the external calcium concentration suggests that 
spontaneous a-MSH secretion is not primarily sustained by calcium ions mobilized from 
intracellular stores. The high spontaneous (in vitro) release rate of a-MSH found for 
melanotrope cells of many species, including X. laevis, most likely is the result of spontaneous 
membrane depolarizations in the form of action potentials mediated by inward currents of Na+ 
and Ca2* (Taraskevich and Douglas, 1979; Douglas and Taraskevich, 1980; Taleb et al., 1986; 
Louiset et al., 1988; Taraskevich and Douglas, 1989). In the absence of extracellular calcium, 
these membrane depolarizations must be ineffective in inducing a-MSH release, because 
administration of 60 mM KCl, which also depolarizes the membrane, does not appear to affect 
secretion under these circumstances. It follows that the mechanism underlying spontaneous 
secretion must be dependent on the influx of extracellular calcium ions. 
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Fig. 9. The effect of thapsigargin on a-MSH release from superfused 
neurointermediate lobes during (a) normal conditions and (b) low calcium conditions. 
Data are the average of eight in frame (a) and the average of four lobes in frame (b). 
The influx of extracellular calcium that is required to maintain a high level of a-MSH 
secretion by the Xenopus melanotrope cell is most likely mediated by VOCC. This is deduced 
from the experiments with CoC^: treatment with this agent caused a dose-dependent inhibition 
of a-MSH secretion. However, while CoCl2 acts primarily on calcium channels (Hagiwara and 
Byeriy, 1981) it may also have less specific effects on intracellular calcium-binding proteins 
(Thaw et al., 1984) and it is not selective for a specific type of VOCC. Therefore, the effects 
of specific agonists and antagonists of VOCC have been examined. 
The involvement of N-type channels in melanotrope secretory activity clearly appears from 
the studies with the blocker of N-type VOCC, ω-conotoxin, which dose-dependently inhibited 
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α-MSH release. There are some reports that conotoxin also acts on L-type VOCC (for reviews 
see Refs 7 and 8). As the following arguments will show, such action does not seem to be 
relevant in the present context, because L-type channels do not appear to be involved in the 
control of secretory activity of the melanotrope cells tested in this study. 
Since blockers of the L-type VOCC, nifedipine (a 1,4-dihydropyridine) and verapamil (a 
phenylalkylamine), had no effect on α-MSH secretion, calcium influx through L-typc channels 
does not seem to be essential in maintaining spontaneous release. Moreover, BAY-K8644 (a 
specific agonist of L-type VOCC) did not affect α-MSH release under normal and low calcium 
conditions. If L-type channels would be important for spontaneous release, activation of these 
channels with BAY-K8644 would have stimulated secretion, as reported for melanotrope cells 
of the frog Rana ridibunda (Larnaca et al., 1988), the rat (Ncmeth et αϊ, 1990) and the mouse 
(Taraskevich and Douglas, 1986, 1989). Even a minor role for this class of calcium channels 
could not be demonstrated, as nifedipine also had no effect during conotoxin treatment. Such 
an effect would have been expected if L-type channels, not blocked by conotoxin, would play 
a role in providing the Ca2* necessary for the residual secretion found during conotoxin 
treatment. We conclude that, in Xenopus melanotrope cells, L-type VOCC play no significant 
role in the secretory process. This is in contrast to the situation in other species studied sofar 
(Taraskevich and Douglas, 1986; Lamacz et al., 1988), where dihydropyridine-sensitive 
channels have been reported to play some role in α-MSH release (albeit that in these species 
dihydropyridine antagonists produce only a small reduction in basal secretion). Whether the 
Xenopus melanotrope cell also differs from other melanotropes with respect to the involvement 
of N-type channels in secretion, awaits conotoxin studies with the latter cells. 
To investigate whether mobilization of calcium from intracellular stores is involved in a-
MSH secretion, we have examined the effects of thapsigargin, an agent that is known to raise 
cytosolic free calcium (Thastrup et al., 1990; Robinson and Burgoyne, 1991) including in 
Xenopus melanotrope cells (Scheenen et al., 1992). Thapsigargin causes the release of calcium 
from intracellular stores by specifically inhibiting the Ca2*-ATPase that pumps calcium into 
those stores, without affecting calcium pumps of the plasma membrane (Lytton et al., 1991). 
Thapsigargin treatment can increase hormone secretion in cells that are, at least in part, 
dependent on intracellular calcium mobilizations, as shown by an analysis of luteinizing 
hormone secretion from chicken gonadotrope cells (Johnson and Tilly, 1991). In the present 
study, thapsigargin was ineffective in stimulating α-MSH secretion under normal or low 
calcium conditions. We conclude that mobilization of calcium from intracellular stores is not 
effective in stimulating α-MSH secretion in Xenopus, even under conditions when calcium is 
rate-limiting. In contrast, the calcium ionophore A23187 significantly stimulated secretion 
under low calcium conditions, most likely by causing an increased influx of extracellular 
calcium ions. The absence of a clear effect of A23187 on spontaneous release under normal 
calcium conditions again indicates that the intracellular calcium concentration is not rate-
limiting under normal conditions. 
In conclusion, the presence of high voltage-activated calcium currents, the strong inhibition 
of α-MSH release by low calcium conditions and by Co2+, the absence of any effect of 
thapsigargin on secretion and the stimulation of secretion by A23187 all strongly suggest that 
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spontaneous a-MSH release from Xenopus melanotrope cells is sustained by influx of calcium 
through VOCC. This influx apparently occurs predominantly through N-type VOCC, as can be 
deduced from the absence of an effect of 1,4-dihydropyridincs and the inhibition of release 
induced by ω-conotoxin. 
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Analysis of inositol metabolism in neurointermediate lobes of 
Xenopus laevis in relation to background adaptation 
With B.C. Jenks, P.M.J.M. Cruijsen, С.МЛ. Mauger, E.W. Roubos, M.C. Tonon, L 
Desrues and H. Vaudry. 
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Chapter 5 
Abstract. The pituitary intermediate lobe melanotrope cells of the amphibian Xenopus 
laevis secrete α-melanophore-stimulating hormone (ot-MSH), which causes dispersion 
of black pigment in dermal melanophores The biosynthesis and secretion of POMC-
denved peptides in these cells is high in animals adapted to a black background and 
low in white background-adapted animals The present study concerns inositol 
phosphate metabolism in neurointermediatc lobes of white and black-adapted animals 
in order to determine if the inositol phospholipid signalling system is involved in 
regulating melanotrope cell biosynthetic and/or secretory activity Lobes from black-
adapted animals had a 2-fold higher rate of incorporation of [3H]inositol into 
phospholipids than lobes from white-adapted animals and chromatographic analysis of 
the radiolabelled inositols revealed that the former lobes had up to a 4-fold higher level 
of phosphorylated forms of inositols Results of white to black background transfer 
experiments showed that the higher capacity of lobes of black-adapted animals to 
produce inositol phosphates was acquired only very slowly, the animals must be 
several days on black background before their melanotrope cells achieve the level of 
phosphorylation observed in lobes of long-term black-adapted animals After black- to 
white-background transfer the transition from the high- to the low-level of inositol 
phosphates also took several days to be established These slow transitions correlate 
well with the slow transitions known to occur with respect to the biosynthetic activity 
of the melanotrope cells as a result of background change They do not correlate with 
the fast changes that occur in melanotrope secretory activity Short-term treatment (up 
to 2h) with factors that inhibit a-MSH secretion, such as dopamine (acting on a D2 
receptor), baclofen (a GABAB receptor agonist) and isoguvacinc (a GABAA receptor 
agonist), had no inhibitory effect on inositol phosphate production Therefore, there 
appears to be no direct linkage between the dopaminergic and GABAergic receptors 
and the inositol phosphate signalling system The observation that long-term treatment 
(3 days) with apomorphinc (a dopamine Dj receptor agonist) leads to inhibition of 
inositol phosphate production indicates that the action of the D2 receptor on inositol 
phosphate production is slow and probably indirect We conclude that inositol 
phospholipid metabolism does not appear to be directly involved in the regulation of 
peptide release from melanotrope cells of X laevis, but is likely involved in the 
regulation of biosynthetic processes within these cells 
INTRODUCTION 
Melanotrope cells of the intermediate lobe of the pituitary gland synthesue proopio­
melanocortin (POMC), a precursor protein for a number of bioactive peptides including ot-
MSH (Eipper and Mains, 1980) In amphibians this hormone regulates the dispersion of the 
black pigment melanin in dermal melanophores and, for the species Xenopus laevis, it has 
been shown that both the biosynthetic and secretory activity of melanotrope cells is much 
higher in black than in white background-adapted animals (Jenks et al, 1977, Loh and Gainer, 
1977) The secretory activity of these cells is regulated by multiple factors (for review see 
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Jenks et al, 1988, Tonon et al, 1988), both classical neurotransmitters (dopamine and G AB A) 
and neuropeptides (« g. neuropeptide Y and corticotropin-releasing hormone) The melanotrope 
cells integrate the vanous neuronal inputs to determine endocrine output A cntical point of 
control in this integration is the regulation of adenylate cyclase activity Cychc-AMP 
stimulates a-MSH secretion from Xenopus melanotrope cells (Verburg-van Kcmenade et al., 
1987a) and production of the cyclic nucleotide has been shown to be under both stimulatory 
and inhibitory control (Verburg-van Kemenade et ai, 1987a; Jenks et ai, 1991). An important 
function for adenylate cyclase and cyclic-AMP in the regulation of a-MSH secretion has also 
been established for mammalian melanotrope cells (Tsuruta et al, 1982, Guild et al, 1986) 
A role for phospholipid metabolism in the generation of second messengers in melanotrope 
cells is less well documented than that of the adenylate cyclase system Only in the case of the 
frog. Rana ndibunda, is there direct evidence for an involvement of receptor-regulated 
phosphomositide turnover in the regulation of the secretory activity of melanotrope cells 
(Desrues et ai, 1990) Interestingly, in this species there have been no reports for a role of 
adenylate cyclase in the regulation of the secretory process To further our understanding of 
the physiological functioning of melanotrope cells we have now made an analysis of several 
aspects of inositol phosphate metabolism in melanotrope cells of Xenopus laevis First, we 
examined the rate of incoiporation of radiolabelled inositol by neurointermediate lobes denved 
from fully black and fully white background-adapted animals (animals adapted to background 
for several weeks), we also determined the capacity of these lobes to phosphorylate the 
incorporated inositol The production of inositol phosphates was determined for lobes derived 
from animals undergoing the process of background adaptation in order to determine the speed 
with which melanotrope cells change their level of production of inositol phosphates. Finally, 
the effects of several regulators of a-MSH release on inositol phosphate production were 
determined, following both short-term (up to 2h) and long-term treatments (3 days). 
MATERIALS AND METHODS 
Animals. Xenopus laevis were bred in the aquanum facility of the Department of Animal 
Physiology, Nijmegen. Young-adult animals, maintained in black or white plastic containers, were 
used The animals were fed trout pellets (Trouvit, Trouw, Putten, The Netherlands) once a week. 
Water temperature was 22 "C 
Analysis of inositol incorporation in lobes of white- and black-adapted animals. 
Neurointermediate lobe were taken from fully white- or black-background adapted animal 
(maintained on background for 3 weeks). The lobes were nnsed in stenle L15 medium which was 
made identical to commercially available LI5 medium, except that no inositol was present The 
medium was diluted 2:1 with distilled water to obtain the appropnate ion concentrations for 
amphibian tissue cultunng; dialysed fetal calf serum (GIBCO, Renfrewshire, UK) was added to the 
medium to a final concentration of 10%, antibiotic/antimycotic solution (GIBCO) and kanamycin 
solution (GIBCO) were added, both at a concentration of 1% (v/v), and the medium was 
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supplemented with CaCl2 2H20 (0 08 mg/ml) and glucose (0 2 mg/ml) The dissected 
neuromtermediate lobes were placed in siliconized glass vials, four lobes per vial, each vial 
containing 50 μΐ of modified L15 medium prepared as desenbed above except that the dilution was 
with an aqueous ['Hlinositol preparation (Amersham, Buckinghamshire, UK, 2 96-4 44 Bq/mmol) 
The lobes were incubated at 22 CC for up to 24 hours They were then washed 5 times in Hepes-
buffered Ringer's solution (pH 7 4) containing 1 mM inositol and then given a final wash in 
inositol-free Ringer's solution This was followed by a 10 min incubation in 500 μΐ Ringer's 
solution containing 10 mM LiCl The Li-ion blocks the conversion of inositol monophosphate to 
inositol, thus allowing for a build-up of phosphorylatcd inositols, which aids in their 
chromatographic analysis Following this incubation the individual lobes were homogenized by 
somcation (Vibra Cell, Somes and Materials, Danbury, CT) in 1 ml of a 10% trichloroacetic acid 
(TCA) solution The homogenate was centnfuged (5 nun at 12,000 g) and a 50 μΐ sample of 
supernatant was taken for scintillation counting to determine the total amount of radioactivity 
associated with inositol-labelled sugars The remainder of the supernatant was submitted to 
chromatographic analysis to determine the types of inositol phosphates present, as described below 
The lipids were extracted from the pellet with 50 μΐ chloroform-methanol (11) and the amount of 
radioactivity associated with the inositol-labelled lipids was determined by liquid scintillation 
analysis 
Chromatographic analysa of inositol phosphates The analysis of the inositol phosphates was 
conducted by an established ion-exchange method (Batty et al, 1985) Each supernatant was 
washed 4 times with 2 volumes of water-saturated ether to remove the TCA, the pH was adjusted 
to 7 5 by adding NaHCO,, and the sample was then loaded on a column containing 2 ml AGI-X8 
resin (Biorad, Richmond, CA, 200-400 mesh, formate form) The resin was conditioned by 
washing 6 times with distilled water, 6 times with 0 1 M formic acid/2 M ammonium formate 
followed by a repeat of the wash in distilled water A fresh column was used for each sample The 
column was eluted step-wise with water (10 X 1 ml) to elutc inositol, 0 1 M formic acid/0 2 M 
ammomum formate (10 X 1 ml) to clute inositol monophosphate, 0 1 M formic acid/045 M 
ammonium formate (10 X 1 ml) to elute inositol biphosphate, and finally with 01 M formic 
acid/0 8 M ammomum formate (10 X 1 ml) to elute inositol triphosphate Scintillation fluid 
(Optiphase 3, LKB, Loughborough, UK) was added to each column fraction and the radioactivity 
determined using a scintillation analyzer No radioactivity came from the columns when a final 
elution with 0 1 M formic acid/2 M ammomum formate was conducted and therefore this step was 
eUminaled in our analysis 
The amount of radioactive inositol or phosphorylatcd forms of inositol resolved by the 
chromatographic analysis were expressed as a percent of the total amount of radioactivity eluting 
from the columns 
Analysis of inositol phosphate production during background adaptations. Groups of fully black-
adapted animals (4 animals per group) were transferred to while background and, following 1, 2, 3 
or 7 days on white background, the neuromtermediate lobes were removed and incubated for 4 h in 
siliconized glass vials containing 50 μ! modified L15 medium and [3Hlinositol They were then 
washed 5 times in Ringer's solution (pH 7 4) containing 1 mM inositol and than given a final 
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wash in inositol-free Ringer's soluüon Each lobe was then placed in an individual 1 5 ml conical 
plasüc vial containing 250 μΐ Ringer's soluüon and at t=0 another 250 μΐ of Ringer's soluüon, 
containing 20 mM LiCl, was added. The lobes were incubated for 10 mm, the incubaüon being 
terminated by adding 500 μΐ ice-cold 20% TCA soluüon The üssue was homogemzed by 
somcaüon and the supernatant submitted to chromatographic analysis of inositol phosphates, as 
described above 
Experiments were also conducted starting with fully-white adapted ammals which were 
transferred to black background for 1, 2, 3 or 7 days before analyzing inositol phosphate 
producüon. 
Analysis of the effect of secretogogue on inositol phosphate production in prelabelled 
neurointermediate lobes. Neurointermediate lobes of black-background adapted animals were 
labelled for 24 h in modified L15 coniaimng [3H]inositol The lobes were then washed 5 ümes in 
Ringer's soluüon containing 1 mM inositol and once in inositol-free Ringer's soluüon. Each lobe 
was placed m a vial containing 250 μΐ of Ringer's soluüon Treatment of the lobes started by 
adding either 250 μ! of Ringer's soluüon containing 20 mM LiCl (conüol) or 250 μΐ LiCl 
containing Ringer's soluüon together with secretagogue Secretagogucs tested were dopamine 
(Sigma, St Louis, MO), baclofen (Ciba Gcigy, Basel, Switzerland), apomorplunc (Sigma) and 
isoguvacine (Cambridge Research Biocheimcals, Cambridge, UK), at concentraüons given in the 
results The lobes were incubated for 5 nun up to 2 h, at 22 CC. In some experiments the lobes 
were premcubated with secretagogue before LiCl treatment (see Results) Incubaüons were 
terminated by adding 500 μΐ of ice-cold 20% trichloroaceüc acid (TCA) followed by somlïcaüon 
The supernatant was analyzed chromatographically for content of radiolabelled inositol phosphates 
Fig. I. Incorporation of [3H¡inosttol in (a) lipids and (b) sugars in neurointermediate 
lobes derived from black- (filled boxes) and white-adapted (open boxes) animals. 
Ammals had been on black or white backgrounds for three weeks prior to the 
experiment. Dam are the average of four lobes ± SEM. 
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Analysis of effect of long-term secretogogue treatment on inositol phosphate production and 
pome biosynthesis. Ncurointcrmediate lobes from black background-adapted animals were 
cultured in modified L15 for three days in the presence or absence of apomorphine (Юв M). 
The lobes were then washed in Ringer's solution and incubated in modified LI5 containing 
[3H]inositol for 4 h. Each lobe was then placed in a vial containing 250 μΐ of Ringer's solution 
and another 250 μΐ Ringer's solution containing 20 mM LiCl was added. The lobes were 
incubated for 10 min, the incubation being terminated by adding 500 μΐ ice-cold 20% TCA 
solution. The tissue was homogenized by sonication and the supernatant submitted to 
chromatographic analysis of inositol phosphates, as described previously. 
Statistics. Results are presented as average and SEM, and tested for significance using 
Student's T-test. A value of P<0.05 was considered to indicate significance. 
RESULTS 
Incorporation of inositol and inositolphosphate production in black versus white-adapted 
animals. The amount of radioactive inositol incorporated into inosilol-labelled lipids was 
higher in lobes derived from black- than from white-adapted animals (Fig. la). After 24 h of 
labelling there was approximately a 2-fold higher degree of labelling in the lipid fraction by 
the former tissue. There was no clear difference between black- and white-adapted animals 
when the total amount of radioactivity associated with inositol-labcllcd sugars was considered 
(Fig. lb). Chromatographic analysis showed, however, that the percentage of labelled inositol 
in phosphorylated forms was much higher in lobes derived from black-adapted animals (Fig. 
2). After 16 h of labelling, the level of inositol phosphates was more than 4-fold higher in 
tissue derived from black-adapted animals than in tissue from white-adapted animals. Most of 
this difference was due to differences in the 
level of inositol monophosphate; no significant 
difference was found in the amount of labelled 
inositol biphosphate and inositol triphosphate 
between the tissue from the black- and white-
adapted animals (data not shown). 
Fig. 2. Percentage of inositol phosphates in total 
radiolabelled inositol sugars in black- (filled 
boxes) and white-adapted (open boxes) animals. 
Labelling with [3H]inositol was started at t=0. The 
relative amount of inositol phosphates in lobes of 
black-adapted animals was at all time points 
higher than in lobes of white-adapted animals. 
Data are the average of four lobes ± SEM. 
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i'ig. 3. Percentage of inositol phosphates in total radiolabelled inositol sugars after 
shift of background colour. Fully background-adapted animals were shifted from black 
to white background or vice versa and remained there for the indicated number of 
days before lobes were dissected and labelled for 4 h with IΉ¡inositol. They were then 
treated for ¡0 mm with 10 mM L/C/. В indicates three weeks black adapted; W 
indicates 3 weeks white adapted. Data are the average of four animals with SEM. 
D C o n t i c i 
В D o p a m i n e t r e a t e d I 
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l i i 5 minutes 
mm 1 
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Fig. 4. Percentage of inositol phosphates in total radiolabelled inositol sugars after 
treatment of [3H]inositol-prelabelled neurointermediate lobes with 10 mM LiCl 
(control) or LiCl plus dopamine for 5 min, 20 min, 1 h and 2 h. Concentration of 
dopamine was 10'5 M. Data are the average of four lobes and SEM. IP,, IP2 and IP¡ 
indicate inositolmono-, bi-, and triphosphate, respectively. 
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The phosphorylation of inositol during background adaptations. In fully black-adapted 
animals the relative level of radiolabelled inositol phosphates (expressed as a percentage of the 
total [3H]mosilol) was more than 4-fold higher than in white-adapted animals (Fig 3) The 
transition to the lower level of inositol phosphate seen in lobes of fully white-adapted animals 
took several days to be achieved following transfer of the animals from black to white 
background Likewise, in white to black background transfers, the transition from the level of 
white-adapted animals to the black-adapted level of inositol phosphate also took several days 
to be established (Fig 3) 
Effects of a-MSH secretogogues on inositolphosphate production. Dopamine had no clear 
inhibitory effect and, in fact, had a tendency to stimulate production of inositol phosphates, 
except after 2h treatment (Fig 4) In general the action on the different forms of inositol 
phosphate was the same The dopamine D2 receptor agonist apomorphine and the GABAB 
receptor agonist baclofen also had a tendency to stimulate inositol phosphate production (Fig 
5), although only in case of 1 h treatment with baclofen was this significant (P<0 05, Fig 5b) 
The GABAA receptor agonist isoguvacine had no effect on inositol phosphate production (Fig 
5a,b) Three-day treatment of neurointermediate lobes with apomorphine lead to a significant 
decrease in the production of inositol phosphates (P<0 05, Fig 5c) 
1 
con bac apo isog 
20 minutes 
con boc apo Isog 
1 hour 3 days 
Fig. 5. Effect of a MSH release-inhibiting agents on the percentage of inositol 
phosphates m total radiolabelled inositol sugars Neurointermediate lobes were 
prelabelled with [JHJinositol, treated with secretogogues for the indicated times and 
then incubated for ¡0 mm in 10 mM LCI in the continued presence of secretagogue 
Data are the average of four lobes and SEM Con = control group not treated with 
secretagogue bac = baclofen (JO5 M), apo = apomorphine (10* M), iwg = 
isoguvacine (IO-1 M), * P<0 05 
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DISCUSSION 
To obtain a maximum specific activity of [3H]inositol during radiolabelling we used an 
inositol-free LI 5 medium (commercially available LI 5 medium contains myo-inositol) and 
dialysed fetal calf serum (normal fetal calf serum also contains free inositol). Our methods 
were sensitive enough to measure inositol phosphate in individual neurointermediate lobes, 
which contain about 50,000 melanotrope cells (De Rijk et al., 1990). The results show that 
there are clear differences between black- and white-adapted animals in both the rate of 
incorporation of inositol into phospholipids within the neurointermediate lobes as well as in 
the level of radiolabelled inositol phosphates in the cells. The higher rate of incorporation 
displayed by lobes of black background-adapted animals was not an unexpected result because 
the melanotrope cells of these animals are considerably larger than those of white-adapted 
animals (De Rijk et aL, 1990). The differences in inositol incorporation may, at least in part, 
simply reflect differences in plasma membrane surface area in these tissue preparations. 
However, the observation that the lobes of black-adapted animals had a higher percentage of 
[•'HJinositol in phosphorylated forms suggests a role for inositol phosphate metabolism in the 
regulation of melanotrope cell functioning in X. laevis. 
Wc investigated whether the inositol phosphate metabolism of Xenopus melanotrope cells is 
involved in the regulation of biosynthesis and/or secretion of POMC-derived peptides. A 
comparison of the rate of changes in inositol metabolism with rates of changes in peptide 
secretion indicates an apparent dissociation between the inositol metabolism and the secretory 
process. The pars intermedia of the white-adapted animals is under tonic hypothalamic 
inhibition; when the lobe is removed and brought into the in vitro situation this inhibition is 
eliminated and consequently the lobe very rapidly (within minutes) displays a high rate of a-
MSH secretion (Verburg-van Kemenade et ai, 1986a). It is apparent from the present results 
that changes in inositol phosphate metabolism occur much slower than these fast changes 
occurring in the secretory process. Even after 24 h of in vitro incubation, the lobes derived 
from white-adapted animals showed a lower percentage of inositol phosphates than that 
exhibited by corresponding lobes derived from black-adapted animals. 
The analysis of inositol phosphate production during background adaptations gives further 
evidence for dissociation of inositol phosphate metabolism and the secretory process of the 
melanotrope cells. When black-adapted Xenopus are transferred to a white background the 
secretion of a-MSH is inhibited almost immediately, reflected by a rapid drop (within 
minutes) in plasma a-MSH (Van Zoest et aL, 1989) and an equally rapid aggregation of 
pigment in dermal melanophores. In sharp contrast, the present study shows that it takes 
several days on white background before the low level of inositol phosphorylation of long-
term white-adapted animals is reached. This suggests that inositol phosphate metabolism is 
associated with slowly changing events in the melanotrope cells of Xenopus, such as the 
biosynthetic activity of the melanotrope cells. Indeed, the time course for the fall in the level 
of inositol phosphorylation during adaptation to white background is very similar to the time 
course for the fall in biosynthetic activity during white background adaptation established in 
earlier studies (Jenks et al., 1977; Loh and Gainer, 1977). These same studies show that, after 
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transfer from a white to a black background, the biosynthetic activity of melanotrope cells 
increases very slowly. We now show that the capacity of these cells to produce inositol 
phosphates also increases only very slowly, which again suggests that inositol phosphate 
metabolism is associated with biosynthetic events in the melanotrope cells. 
The results of our in vitro analysis of the effects of release-inhibiting factors on inositol 
phosphate production also indicates a dissociation between inositol phosphate metabolism and 
the release process. The factors, which included dopamine D2 receptor agonists and GABA 
receptor agonists, have all been established in superfusion experiments to give rapid inhibition 
of a-MSH release from Xenopus melanotrope cells (Verburg-van Kemenade et al., 1986b, 
1987b). In treatments of up to 2h with these factors there was no evidence for any inhibition 
of inositol phosphate metabolism. Indeed, there was even a tendency for a slight increase in 
the amount of phosphorylated inositols produced, although in most cases this was not 
significant. These results contrast sharply with those obtained in similar experiments using 
melanotrope cells of another amphibian species, the frog Rana ridibunda. Dopamine treatment 
leads to a relatively rapid inhibition (within 20 min) in the production of inositol phosphates in 
Rana melanotrope cells (Desrues et ai, 1992). These differences could reflect inherent 
differences in mechanisms regulating the secretory process of melanotrope cells of the two 
amphibian species. In Xenopus adenylate cyclase is clearly involved whereas in Rana other 
mechanisms, including G-protein coupled ion channels (Valentijn et al, 1991b), appear to be 
important. 
We have previously shown that 3 day-treatment of Xenopus melanotrope cells with the D2 
receptor agonist apomorphine inhibits the biosynthesis of POMC (Ayoubi, 1991). We now 
show that this same tonic treatment leads to a decrease in inositol phosphate production. 
Together, these observation lend further support to the idea that inositol phosphate metabolism, 
while not being directly involved in the regulation of release, is important in the regulation of 
the biosynthetic activity of the melanotrope cells. The primary transmembrane signalling event 
activated by the D, receptor of Xenopus melanotrope cells involves an inhibition of adenylate 
cyclase (chapter 6, this thesis). The pathway coupling this event with the slow changes seen in 
both the inositol phosphate metabolism and the biosynthetic activity of the cells remains to be 
established. 
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Dynamics of cyclic-AMP efflux in relation to α-MSH secretion 
from melanotrope cells of Xenopus laevis 
With B.C. Jenks, B. Huchedé and E.W. Roubos 
Life Sciences, in press 
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Abstract. An important factor in regulating secretion from endocrine cells is the 
cytoplasmic concentration of cychc-AMP Many regulatory substances are known to 
either stimulate or inhibit the production of this second messenger through activation 
of their receptors. In the present study, we have monitored changes in cyclic-AMP 
efflux from melanotrope cells of Xenopus laevis in response to established 
neurochemical regulators of a-MSH secretion. In vitro superfusion of neurointer-
mediate lobes allows for a dynamic recording of cyclic-AMP production in relation to 
hormone secretion Unlike a-MSH secretion, the efflux of cychc-AMP was not 
dependent on the concentration of extracellular calcium, indicating that hormone 
release and cychc-AMP efflux are mediated by different mechanisms The phosphodi­
esterase inhibitor IBMX and the adenylate cyclase activator forskohn stimulated cychc-
AMP efflux, but had no stimulatory effect on a-MSH release Treatment with IBMX 
for several hours slowly reduced the rate of hormone secretion. Therefore, we conclude 
that an increase in cychc-AMP production in melanotrope cells does not increase the 
rate of a-MSH release but may even, in the long term, reduce secretion. Corticotropin-
releasing factor stimulated cychc-AMP efflux in a similar way as the amphibian 
peptide sauvagine, suggesting that the actions of these related peptides are mediated by 
the same receptor. Dopamine and the GABAB receptor agonist baclofen both inhibited 
cychc-AMP efflux and a-MSH release, with similar dynamics of inhibition and similar 
dose-response relationships It is proposed that an inhibition of cychc-AMP efflux is 
coupled to an inhibition of a-MSH secretion 
INTRODUCTION 
The secretion of α-melanocyte stimulating hormone (a-MSH) from melanotrope cells of the 
amphibian Xenopus laevis is regulated by various factors of hypothalamic origin. 
Corticotropm-relcasmg factor (CRb) (Verburg-van Kemenade et al, 1987a) and thyrotropin-
releasing hormone (Verburg-van Kemenade et al, 1987f) stimulate a-MSH release whereas 
dopamine (Verburg-van Kemenade et al, 1986d), γ-aminobutyric acid (GABA) (Verburg-van 
Kemenade et al, 1986c, 1987d) and neuropeptide Y (Veitourg-van Kemenade et al, 1987b) 
inhibit this process. In view of the complexity of its regulatory input, the melanotrope is an 
interesting cell type to study the intracellular mechanisms by which multiple external stimuli 
are integrated to produce a coordinated secretory response Preliminary studies have indicated 
that cychc-AMP plays an important role in mediating stimulatory and inhibitory actions on 
Xenopus melanotropcs (Jenks et al, 1991, Verburg-van Kemenade et al, 1987c). We have 
shown that these cells, like many other cell types (Barber and Butcher, 1983), release cyclic-
AMP into the extracellular space (Jenks et al, 1991). The amount of cyclic-AMP efflux from 
Xenopus melanotrope cells seem to be proportional to the intracellular cychc-AMP 
concentration (Jenks et al, 1991) This relationship between intra- and extracellular cyclic-
AMP appears to be a general phenomenon as it has been reported for a number of stimulated 
and unstimulated cell types and for brain slices (Barber and Butcher, 1981, 1983; Lazareno et 
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al, 1985, Stoof and Kebabian, 1981). It is therefore possible to use the extracellular 
concentration of cychc-AMP as a parameter for cyclic-AMP production inside the cell, and 
hence, as a parameter for the effect of receptor activation on adenylate cyclase activity (Stoof 
and Kebabian, 1981) The production of second messengers is generally determined in tissue 
homogenates or in cell-free membrane preparations Monitoring cyclic-AMP efflux from 
endocrine tissues or cells allows for an analysis of the relationship between the dynamics of 
cyclic-AMP production and hormone release from living cells over a long period of time In 
the present study we have applied this approach to investigate the involvement of cyclic-AMP 
in the control of a-MSH release by several established regulators of the melanotrope cell To 
study the nature of the cyclic-AMP-dependent control mechanism(s), the effects of omission of 
extracellular calcium, and of treatment with the phosphodiesterase inhibitor 3-isobutyl-l-
methylxanthine (IBMX) and with forskolin, an activator of adenylate cyclase, on the cyclic-
AMP-dependent control of a-MSH secretion were analyzed 
MATERIALS AND METHODS 
Animals. Adult Xenopus laevis were bred and reared in our aquanum facility. Before the 
experiments, they had been kept on a black background for three weeks, at 22 "С 
Superfusion experiments. Superfusion of neurointermediate lobes was performed as described 
previously (Verburg-van Kemenade et al, 1987b), using 10 μΐ superfusion chambers The 
incubation medium (IM) contained 112 mM NaCl, 2 mM KCl, 15 mM HEPES (pH 7 4; 
Calbiochem, La Jolla, CA), 2 mM CaClj, 2 g/1 glucose, 1 mgfl ascorbic acid and 0 3 g/1 bovine 
serum albumin (Sigma, St Louis, MO). In expenments where the concentration of СаСІ2 was 
lowered to 10"3 M, the concentration of Ca2* was buffered with EGT A. Superfusion fractions were 
collected every 15 mm, for at least 75 mm before pulses of regulatory factors were added These 
factors were dopamine (Sigma), baclofen (Ciba-Geigy, Basel, Switzerland), 3-isobutyl-l-
methylxanthine (IBMX, Sigma), forskolin (Sigma), CRP (Bachern, Bubendorf, Switzerland) and 
sauvagine (Bachern) Flow rate was 16 ml per hour. Fractions were submitted to 
radioimmunoassays for a-MSH and cychc-AMP In expenments in which IBMX was administered 
throughout the superfusion, lobes were incubated for 30 mm pnor to the superfusion with IBMX-
contaimng IM. 
Radioimmunoassays. The radioimmunoassay for a-MSH was applied as desenbed previously, 
using an anu-a-MSH serum produced and characterized in our laboratory (Van Zoest et ai, 1989). 
Bound and free antibodies were separated by the polyethylene glycol/albumin method The 
antiserum has equal affinities for a-MSH and desacetyl a-MSH, whereas cross-reactmty with 
ACTH (1-24) and with ACTH (1-39) is less than 0 1%. Detection limit is 2 pg a-MSH per sample 
Radioimmunoassay of cycbc-AMP was earned out according to the manufacturer's instructions 
(RPA 509; Amersham, Buckinghamshire, England), with solutions of radioactive cyclic-AMP and 
of first and second antibodies diluted 4-fold, without loss of sensitivity or selectivity of the assay. 
Detection limit was 1 fmole per sample of 50 μΐ. The assay was performed using an Aspee 
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automatic pipettor (Gilson, Villiers le Bel, France) 
Calculations and statistics. In the figures data are graphically shown as means (n=4, unless 
otherwise indicated) and S F M (vertical bars) To calculate percentages of sümulation or 
inhibition of a-MSH release in the superfusion experiments, peak areas in the graphs (before and 
dunng administration of ligands) were integrated and compared The integrated areas were tested 
using the paired Student's T-test A Ρ value <005 was considered to indicate statistical 
significance 
RESULTS 
Extracellular calcium is not required for cyclic-AMP efflux. Dunng superfusion with IM 
containing a very low concentration of CaCl2 (105 M) the secretion of a-MSH became 
drastically reduced to 11 6 ± 2 9% of basal secretion At the same time, the rate of cyclic-
AMP efflux was not affected (Fig 1) 
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Fig. 1. The effect of low extracellular 
calcium concentration on a-MSH secretion 
(filled boxes) and cyclic-AMP efflux (open 
boxes) The concentration of IBMX was JO'4 
M throughout the superfusion Basal release 
was the average secretion infractions 5-7 
The effect of IBMX and fonkolm on a-MSH secretion and cyclic-AMP efflux. IBMX had a 
rapid stimulatory effect on cyclic-AMP efflux, but did not influence a-MSH secretion When 
neurointermcdiate lobes, pretreated with 10^ M IBMX, were supcrfused in the presence of 
IBMX, the average cyclic-AMP content of the first 8 fractions was approximately 5 times as 
high (35 6 ± 6 4 fmole) as in the absence of IBMX (6 9 ± 3 0, Fig 2a) After the initial rapid 
stimulation of cyclic-AMP efflux dunng IBMX pretreatment, the cyclic-AMP efflux dnfted 
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upward more slowly, taking several hours to reach a plateau level. Lobes not treated with 
IBMX displayed an almost constant rate of cyclic-AMP efflux up to 6.5 hours of superfusion 
(Fig. 2a). The rate of a-MSH release was also constant during this period. However, the ct-
MSH secretion from IBMX-treated lobes slowly declined during the experiment (Fig. 2b). 
Forskolin induced a strong stimulation of cyclic-AMP efflux, with a latency of 15 min. An 
elevated level of cyclic-AMP efflux persisted after forskolin treatment had stopped. Forskolin 
did not affect a-MSH secretion (Fig. 2c). 
The effect of secretogogues on cyclic-AMP efflux. CRF and sauvagine stimulated cyclic-AMP 
efflux in a dose-dependent way but had no clear effect on a-MSH release (Fig. 3). The effect 
of CRF on cyclic-AMP efflux did not significantly differ from that of sauvagine. Also, the 
dynamics of the cyclic-AMP efflux during superfusion were similar for both peptides. The 
higher doses of these peptides induced a rapid and reversible increase in cyclic-AMP efflux. 
Near-maximum efflux was reached within the first 15 min fraction. 
Dopamine and baclofen inhibited both a-MSH release and cyclic-AMP efflux, in a dose-
dependent way (Fig. 4a,b). The dynamics of both inhibitory actions were very similar: an 
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Fig. 2. The effects of IBMX and forskolin on cyclic-AMP efflux and a-MSH release. 
(a) The effect of IBMX on the efflux of cyclic-AMP and (b) release of a-MSH from 
superfused neurointermediate lobes. Four lobes were pretreated for 30 min and 
independently superfused in the presence of W M IBMX (filled boxes), while twelve 
lobes, distributed over four chambers, received the same treatment in the absence of 
IBMX (open boxes). Data are expressed as cyclic-AMP or a-MSH released per lobe. 
(c) The effect of 10* M forskolin on cyclic-AMP efflux (open boxes) and a-MSH 
release (filled boxes) in the presence of Mr1 M IBMX. Arrowheads indicate start and 
end of IBMX treatment: shading indicates forskolin (forsk) treatment. Basal release 
was calculated as the average release in the first three fractions. 
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Fig. 3. The effect of CRF (a) and sauvagine (b) on cyclic-AMP efflia (open boxes) and 
a-MSH secretion (closed boxes). The concentration of IBMX was W4 M. Basal release 
was calculated from the three fractions preceding the first pulse. Shading indicates 
secretogogue administration. 
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fig. 4. The effect of dopamine (a) and baclofen (b) on cyclic-AMP efflux (open boxes) 
and a-MSH secretion (closed boxes). The concentration of IBMX was W1 M. Basal 
release was calculated from the three fractions preceding the first pulse. 
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almost linear decrease of release during the administration of dopamine or baclofen, returning 
to basal secretory rate within 30 min. During periods in which dopamine or baclofen were not 
present in the superfusion medium, the efflux of cyclic-AMP increased, apparently as a result 
of the presence of IBMX. The quantitative data on stimulation and inhibition of a-MSH 
release and cyclic-AMP efflux induced by the various factors are presented in Table 1. 
DISCUSSION 
The mechanism by which cyclic-AMP is released from cells is not well understood, though it 
is almost certainly an energy-dependent process (Barber and Butcher, 1983; Brunton and 
Hcaslcy, 1988). Our study with low extracellular calcium indicates that cyclic-AMP release 
from melanotropc cells of X. laevis does not depend on extracellular calcium ions. The 
production and efflux of cyclic-AMP from melanotrope cells of the rat are also calcium-
independent (Tsuruta et al, 1982). Apparently, the mechanism of cyclic-AMP efflux is 
different from common secretory mechanisms, including that of a-MSH, which depend on the 
influx of calcium ions. The conclusion that the rate of cyclic-AMP efflux is not dependent on 
the secretory activity of the melanotropc cell but on the cytosolic concentration of cyclic-AMP 
is also based on the results of experiments with IBMX. This agent is commonly used to raise 
cyclic-AMP levels by inhibiting phosphodiesterase activity. We have studied the dynamics of 
IBMX action on both cyclic-AMP efflux and a-MSH release and found that the two are 
completely opposed: cyclic-AMP efflux increased, while a-MSH secretion decreased. An 
elevation of the intracellular concentration of cyclic-AMP is usually associated with an 
increased secretion of a-MSH from melanotropes (Tsuruta et al., 1982; Verburg-van 
Kemenade et al, 1986b, 1987c; Jenks et al, 1991). It is possible that compartmcntalisation of 
the melanotrope cell is at the basis of the decrease of a-MSH release during IBMX treatment. 
Treatment with IBMX would be expected to elevate cyclic-AMP levels throughout the 
melanotrope cell. Possibly, there are compartments within the cell where elevated cyclic-AMP 
levels work to the detriment of a-MSH secretion. The same explanation may hold for the 
results with forskolin treatment where, again, a large elevation in cyclic-AMP production was 
not accompanied by an increased level of a-MSH secretion. 
In the present study we show that the physiological a-MSH releasing factors such as the 
neurohormone CRF, and the related amphibian peptide sauvagine (Verburg-van Kemenade et 
al, 1987a), also increase cyclic-AMP efflux with only the highest doses inducing any 
stimulation of a-MSH release. The absence of a clear effect of CRF and sauvagine on a-MSH 
release in our present study is probably due to the presence of ШМХ. The observation that 
CRF and sauvagine induced similar responses with respect to cyclic-AMP efflux, both in 
magnitude and dynamics, supports the notion that these peptides may act on the same receptor 
on the melanotropes (Verburg-van Kemenade et al, 1987a). 
The apparent absence of a coupling between stimulation of cyclic-AMP production and a-
MSH secretion has prompted us to investigate the effect of inhibitory inputs to the 
melanotrope cell on cyclic-AMP efflux. Activation of the GABAB receptor or the dopamine D2 
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Table I 
Effects of Secretogogues on α MSH Secretion and Cyclic AMP Efflux. 
Secretogogue 
CRF 
sauvagine 
dopamine 
baclofen 
Concentration 
3 3 
3 3 
[M] 
ю-
8 
ю-
7 
I O " 6 
i o " 8 
I O " 7 
I O " 6 
ю-
6 
« I O - 6 
ю-
5 
ю-
6 
. I O " 6 
ю-
5 
MSH-secretion 
[% st imulat ion] 
- 3 9 ± 2 6 (NS) 
0 4 ± 1 8 (NS) 
3 5 ± 1 6 (NS) 
0 9 ± 1 4 (NS) 
4 7 ± 2 7 (NS) 
10 1 ± 1 5 (..) 
- 1 5 5 ± 1 5 (...) 
- 3 7 5 ± 2 5 (—.) 
- 6 4 5 ± 2 2 (—.) 
- 8 6 ± 1 4 («) 
- 2 9 3 ± 3 1 (...) 
- 4 9 9 ± 1 0 (..«) 
сАМР efflux 
[% st imulat ion] 
2 0 ± 7 8 (NS) 
61 3 ± 22 0 (.) 
88 3 ± 1 7 9 (.) 
28 5 ± 1 8 2 (NS) 
43 0 ± 11 5 (.) 
80 0 ± 7 6 (...) 
- 1 6 3 ± 6 5 (NS) 
- 3 3 3 ± 3 8 (...) 
- 5 0 6 ± 2 9 (..·.) 
- 0 3 ± 9 3 (NS) 
- 2 2 2 ± 3 7 (..) 
- 2 9 2 ± 4 9 (.) 
Data shown are the average of four independent experiments Statistical significance of 
secretogogue effect on a-MSH secretion or on cyclic-AMP efflux is indicated (NS) not 
significant. (*) P<0 05. (**) P<0 02, (***) P<0 0J. (****) P<0 001 
receptor has been shown to inhibit cychc-AMP production in melanotropc cells of Xenopus 
laevis (Verburg-van Kemenade et al, 1987c, Jenks et al, 1991) Our analysis of a-MSH 
secretion and cychc-AMP efflux from superfiised neuromtermediate lobes shows that both 
cychc-AMP efflux and a-MSH secretion are inhibited by the specific GABAB receptor agonist 
baclofen as well as by dopamine Baclofen and dopamine inhibited both processes with similar 
potency and dynamics, suggesting a causal relationship between the events Therefore, the 
inhibition of a-MSH secretion upon receptor activation could well be caused by a reduced 
activity of adenylate cyclase, the cyclic-AMP generating enzyme On the other hand, it may be 
that the G-protein that couples the D2 and/or GABAB receptor to adenylate cyclase has 
additional intracellular targets that arc (in part) responsible for the inhibition of hormone 
secretion Both receptor types have, in some cases, been reported to be coupled to plasma 
membrane channels for calcium or potassium ions (Robertsson and Taylor, 1986, Ogata, 
1990a, Stack and Surprenant, 1991, Valentijn et al, 1991a) 
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Abstract. Activation of both dopamine D2 and GABAB receptors of melanotrope cells 
of Xenopus laevis leads to an inhibition of the release of a-mclanophore-stimulating 
hormone (a-MSH) and a reduction of the production of cyclic-AMP This suggests that 
these receptors act by identical intracellular signal transduction mechanisms To test 
this hypothesis, the signal transduction mechanisms of both receptors were 
characterized in more detail The inhibitory responses to dopamine and the GABAB 
receptor agomst baclofen appeared to be strongly attenuated by pertussis toxin, 
indicating the involvement of a G-protein Inhibition of a-MSH release induced by 
baclofen was abolished by 8-bromo-cyclic-AMP, in contrast to inhibition by dopamine, 
which was only slightly attenuated by this cychc-AMP analogue The phosphodiester-
ase inhibitor IBMX had no effect on the inhibitory secretory response to dopamine but 
markedly reduced the response to baclofen Dopaminc-induced inhibition of a-MSH 
secretion does not seem to be primarily due to a reduction in the intracellular calcium 
concentration, because the calcium lonophorc A23187 did not reverse this inhibition 
The involvement of potassium channels in the signal transduction mechanism of D^ 
and GABAB receptors was investigated using teiracthyl ammonium chloride and 4-
aminopyndinc These agents, alone or in combination, caused a transient stimulation of 
a-MSH release, but had no effect on dopamine- or baclofcn-induced inhibition of 
secretion In conclusion, activation of the GABAB receptor probably inhibits a-MSH 
release solely through inhibition of cyclic-AMP production, whereas dopanune-
mediated inhibition appears to involve not only cyclic-AMP but also one or more other 
signal transduction mechanisms 
INTRODUCTION 
The secretory activity of the melanotrope cell in the pars intermedia of the pituitary gland of 
the amphibian Xenopus laevis is regulated by multiple inhibitory and stimulatory agents, 
including GABA, dopamine, neuropeptide Y, corticotropin releasing hormone and thyrotropin 
releasing hormone (Jenks et al, 1988) We have previously shown that activation of both the 
dopamine D2 and the GABAB receptors of these cells leads to inhibition of a-MSH secretion 
(Verburg-van Kemenade et al, 1986d, 1987d) as well as of cyclic-AMP production (Verburg-
van Kemenade et al, 1987c, Jenks et al, 1991) This fmdmg suggests that these receptors 
control melanotrope cell activity by the same (adenylate cyclase mediated) signal transduction 
mechanism This notion seems to be supported by the fact that the inhibitory effects of 
dopamine and of the GABAB agonist baclofen on a-MSH release are additive and not 
synergistic (Kongsamut et al, 1991, Jenks et al, 1992) 
It would seem rather inefficient that two different neurotransmitters would exert identical 
actions on their target A possible rationale for this dual control would be that dopamme and 
GABA are differentially released to the melanotropes, mediating a-MSH inhibition under 
different states of neuronal activity Another possibility is that the dopamine and GABAB 
receptors effectuate their respective inhibitions of a-MSH release not only via a common 
adenylate cyclase system but act, moreover, via one or more additional receptor-specific signal 
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transduction systems. In this way, each transmitter would be able to control specifically, in 
addition to a-MSH release, cellular events like biosynthesis and processing of a-MSH. In the 
present study we have investigated this latter possibility, examining whether the dopamine D2 
and GABAB receptors act via different signal transduction systems. 
It has been well established that dopamine as well as GABA (via the GABAB receptor) act 
via various signal transduction mechanisms, viz. by inhibiting adenylate cyclase through a G, 
or G0 protein, activating potassium channels (Vallar and Meldolesi, 1989; Lledo et al, 1990b; 
Cass and Zahniser, 1991) and inactivating calcium (Vallar and Meldolesi, 1989; Lledo et al, 
1990a; Keja et al, 1992) and sodium channels (Valcntijn et al, 1991a). In our in vitro 
superfusion study with neurointermediate pituitary lobes, first the involvement of G-proteins in 
the action of dopamine and baclofen has been determined, using pertussis toxin Then the 
relative importance of cyclic-AMP in dopamine- and baclofen-induced inhibition of a-MSH 
was investigated, using agents that increase intracellular cyclic-AMP levels, like 8-bromo-
cyclic-AMP (8Br-cAMP) and IBMX. Finally, we analyzed the effects on the inhibition process 
of potassium channel blockers, tetraethyl ammonium chloride (TEA) and 4-aminopyridine (4-
AP), and of a calcium ionophore, A23187. 
MATEMALS AND METHODS 
Animals. Adult Xenopus laevis (age 6-8 months) were bred in our aquatic facility and adapted to 
black background for three weeks just pnor to the expenments. The toads were fed trout pellets 
(Trouvit, Trouw, Putten, The Netherlands) once a week. The water temperature was 22 "C 
Incubation with pertussis toxin. Neurointermediate lobes were dissected out and washed four 
times with culture medium containing 67% (v/v) L15 medium (Gibco, Renfrewshire, UK), 1% 
(v/v) kanamycin solution (Gibco), 1% (v/v) antibiotic/antimycotic solution (Gibco), 10% fetal calf 
serum (FCS, Gibco). 0.08 mg/ml СаС12.2Н20 and 0.2 mg/ml glucose (pH 7.4). Before use, the 
culture medium was sterilized by ultrafiltration using a disposable 0.22 μπι filter (Type FP 030/3, 
Schleicher & Schuell, Dassel, Germany). Groups of four lobes were cultured in 1 ml of culture 
medium in a muludish (Nunc, Roskildc, Denmark) at 22 0C, in the presence or absence of 1 μg/πü 
of pertussis toxin (Sigma, St Louis MO, U.S.A.) for 24 h. Before transferring the lobes to 
superfusion chambers, they were washed three times with incubation medium (IM) containing 112 
mM NaCl, 2 mM KCl, 2 mM CaCl2, 2 mg/ml glucose, 0.3 mg/ml bovine serum albumin (Sigma) 
and 15 mM HEPES (pH 7.4; Calbiochem, La Jolla, CA). 
Superfusion experiments. Neurointermediate lobes were superftised in 10 μΐ chambers with IM, as 
previously described (Verburg-van Kemenade et al, 1987b). Fractions were collected every 7.5 
mm and at least for 75 mm before pulses of potential secretagogues were introduced. Flow rate 
was 1.6 ml per hour. Potential secretagogues tested were dopamine (Sigma), baclofen (Ciba-Geigy, 
Basel, Switzerland), isoguvacine (Cambridge Research Biochemicals, Cambridge, UK), IBMX 
(Sigma), forskolin (Sigma), 8-bromo-cyclic-AMP (8Br-cAMP; Sigma), 4-aimnopyndine (4-AP; 
Sigma), tetraethyl ammonium chloride (TEA; Sigma) and A23187 (free acid; Sigma). 
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Superfusion of cultured dispersed melanotropes. Suspensions of intermediate lobe cells were 
prepared as previously desenbed (De Koning el ai, 1991), with minor modifications. Briefly, 
neurointermediate lobes were incubated with trypsin (Gibco) and subsequently dispersed 
mechanically. Dispersed cells were separated from undissociated tissue, including the complete 
neural lobe, by passing the suspension over a nylon gauze (pore size 30 μτη). Cells were collected 
by centrifugation, washed and incubated for two days in culture medium to permit attachment to 
Cytodex-3 beads (Pharmacia, Uppsala, Sweden), at 22 "C. Then cells were washed in IM before 
transfer to superfusion chambers, equipped with Millipore filters (SSWP02500, pore size 3 цт; 
Millipore, Bedford MA, U.S.A.) to support the beads. How rate and method of administration of 
secretagogues were as described above. 
Radioimmunoassay. a-MSH concentrations were measured as described previously, using an anti-
a-MSH serum produced and characterized in our laboratory (Van Zoest et al, 1989). Bound and 
free antibodies were separated by polyethylene glycol/albuimn precipitation. The antiserum has 
equal affinity for a-MSH and desacetyl a-MSH, whereas cross-reactivity with ACTH (1-24) and 
with ACTH (1-39) is less than 0.1%. Detection limit is 2 pg a-MSH per sample of 10 ml. 
Calculations and statistics. Data are expressed as percent of basal secretion and graphically shown 
as means (of four neurointermediate lobes, supcrfuscd separately) and S.E.M. (vertical bars). The 
basal level of a-MSH release was calculated as the average secretion in the three fractions 
preceding the first pulse To calculate percentages of stimulation or inhibition of a-MSH release in 
the superfusion experiments, peak areas in the graphs (before and during administration of ligands) 
were integrated and compared. Peak areas concerned are indicated in the legends of the graphs. 
The integrated areas were tested using Student's T-tesl. A Ρ value <0.()5 was considered to indicate 
statistical significance. 
Fig. 1. The effect of pertussis toxin (PTx) 
pretreatment on the response of superfused neuro­
intermediate lobes to inhibitory agents. Four lobes 
incubated for 24 h with 1 pg/ml of PTx (open boxes) 
and four control lobes (filled boxes), all superfused 
simultaneously in separate chambers, were chal­
lenged successively with ΙΟ6 M dopamine, 3.3*Iff6 
M baclofen and 2*1 (У' M isoguvacine. Fractions 
were collected every 7.5 min. The response to 
dopamine and to baclofen were significantly reduced 
in the PTx treated group, as compared to the control 
group (27.3 ± 4.2% versus 71.9 ± 4.9%, P<0.001 
and 14 5 ± 5.2% versus 65.9 ± 2.9% inhibition, 
P<0.001 respectively). The response to isoguvacine 
was not significantly different in both groups (44.9 
± 4.4% versus 55.2 ± 2.11% inhibition). 
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RESULTS 
The effect of pertussis toxin treatment on secretagogue-induced inhibition of a-MSH 
release. Dopamine, baclofen (GABAB receptor agonist) and isoguvacine (GABAA receptor 
agonist) induced rapid and strong inhibitions of a-MSH release from intact neurointermediate 
lobes. These inhibitions were rapidly reversible. The responses to dopamine and to baclofen, 
but not to isoguvacine, were greatly reduced by pretreatmenl with pertussis toxin (Fig. 1). 
The effect of 8Br-cAMP on secretagogue-induced inhibition of a-MSH release. Treatment 
with 8Br-cAMP stimulated basal a-MSH secretion from intact neurointermediate lobes (Fig. 
2a,b). A pulse of 8Br-cAMP during dopamine administration induced a small but significant 
attenuation of the inhibition induced by the dopamine treatment (Fig. 2a). Treatment with 8Br-
cAMP during baclofen administration resulted in a clear stimulatory response, with a-MSH 
secretion returning to almost basal levels (Fig. 2b). The recovery of a-MSH release caused by 
8Br-cAMP was significantly higher during baclofen than during dopamine treatment (78.5 ± 
6.7 versus 33.3 ± 3.1% recovery, respectively, P<0.01), the response to cyclic-AMP before 
treatment with dopamine or baclofen was virtually identical (13.1 ± 0.9% and 13.0 ± 3.7%, 
respectively). 
The effect of IBMX on secretagogue-induced inhibition of a-MSH release. The inhibition of 
the release of a-MSH from intact lobes by dopamine was not influenced by the introduction of 
\0Λ M IBMX into the medium (Fig. 3a). The inhibitory responses to 3.3*106 and Ι Ο 5 M 
baclofen were clearly attenuated by IBMX (Fig. 3b). 
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Fig. 2. The effect of SBr-cAMP on a-MSH secretion inhibited by dopamine (a) and 
baclofen (b). SBr-cAMP stimulated basal secretion from neurointermediate lobes by 
13.0 ± 1.9% (PKO.01, n=8). Stimulation by 8Br-cAMP was 53.8 ± 4.8% (P<0.01, 
fractions 32-33 compared to fr. 30-31) during dopamine treatment and 107 ± 7 6 % 
(P<0.01, fr. 28-29 compared to fr. 26-27). 
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Effect of A23187 on dopamine-induced inhibition of a-MSH release. Long-term treatment 
with dopamine decreased a-MSH release from intact lobes to a stable level of secretion at 
about 40 % of basal release. The calcium lonophore A23187 (IQ·6 or Ю-5 M) had no effect on 
dopamine-induced inhibition of secretion (Fig. 4). 
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Fig. 3. The effect of 1BMX on a-MSH release from neurointermediate lobes during 
administration of dopamine (a) and baclofen (b). Each graph represents the average of 
four lobes superfused in the absence (filled boxes) or presence (open boxes) of 10^ M 
IBMX. The inhibition of a-MSH release induced by dopamine was not significantly 
changed by IBMX (subsequently 47.4 ± 2.9 versus 37.3 ± 4.6%, 59.7 ± 4.9 versus 
57.4 ± 1.0% and 70.5 ± 2.0 versus 59.0 ± 5.7%). The responses to the higher 
concentrations of baclofen were significantly attenuated by IBMX (subsequently 14.9 ± 
3.3 versus 6.2 ± 1.8% (NS), 41.8 ± 7.2 versus 13.7 ± 3.2% (P<0.05) and 43.2 ± 5.8 
versus 25.0 ± 2.2% (P<0.05)). 
Effect of potassium channel blockers. Secretion of a-MSH from isolated melanotropes during 
in vitro superfusion was inhibited by 3.3*10"6 M dopamine and by 10"5 M baclofen (Fig. 
5a,b,c). The effect of baclofen on a-MSH release from isolated melanotrope cells was rapidly 
reversible, as it was on release from intact lobes. After baclofen treatment the rate of a-MSH 
secretion very rapidly but transiently increased above the level maintained prior to baclofen 
application. In contrast, dopamine-induced inhibition of a-MSH release was much prolonged 
after dopamine treatment had been stopped. The a-MSH release did not increase above the 
level before the start of the dopamine treatment (Fig. 5a,b,c). The responses evoked by 
baclofen and by dopamine were not affected by treatment with high doses of the potassium 
channel blockers 4-AP (Fig. 5a) and TEA (Fig. 5b), nor by simultaneous treatment with both 
blockers (Fig. 5c). However, application of each blockers resulted in a transient stimulation of 
a-MSH release. These stimulations attained a maximum within 7.5 min (1 fraction) and 
rapidly disappeared. 
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Fig. 4. The effect of A231S7 on dopamine-induced inhibition of a-MSH release. 
A23187 was dissolved in DMSO, final concentration m the experiment not exceeding 
0.1%. The calcium ionophore had no effect on a-MSH release (P>0.05). 
DISCUSSION 
The secretion of a-MSH from melanotrope cells of Xenopus laevis is inhibited by NPY 
(Verburg-van Kemenade et al., 1987b; De Koning et al., 1991), dopamine (Verburg-van 
Kemenade et ai, 1986d) and G AB A (Verburg-van Kemenade et ai, 1986c). The action of the 
latter neurotransmitter is mediated by two receptors, the GABAA receptor and the GABAB 
receptor (Verburg-van Kemenade et al., 1987d). In the present study we have investigated the 
possibility that the dopamine D2 and the GABAB receptor control melanotrope cell activity via 
different signal transduction pathways. We have previously reported that activation of the О
г 
and GABAB receptors inhibits cyclic-AMP production in melanotrope cells of Xenopus laevis 
(Verburg-van Kemenade et al., 1987c; Jenks et al, 1991). In addition, dopamine and baclofen 
inhibit the efflux of cyclic-AMP from these cells with very similar dynamics and potencies, 
which suggests that both messengers inhibit cyclic-AMP production via a common pathway 
(De Koning, unpublished observation). In accordance with these data, we now report that the 
responses to dopamine and baclofen, but not to the GABAA receptor agonist isoguvacine, can 
be reduced with pertussis toxin. Apparently, G proteins (viz. G, or G0) are components of the 
putative common mechanism. 
Although both dopamine and baclofen clearly inhibit cyclic-AMP production in 
melanotrope cells, they do not affect a-MSH secretion in an identical way. This firstly appears 
from the analysis of the effects of the cyclic-AMP analogue 8Br-cAMP and of IBMX (agents 
that elevate the intracellular concentration of cyclic-AMP) on dopamine- and baclofen-induced 
inhibition of a-MSH release. Both IBMX and 8Br-cAMP appeared to antagonise the inhibitory 
action of baclofen but not that of dopamine. This results suggests that activation of the 
10~ M Dopamine 
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GABAB receptor results exclusively in an inhibition of adenylate cyclase. In contrast, 
activation of the D2 receptor must activate additional intracellular pathways, because the action 
of dopamine on a-MSH secretion appears, for a large part, independent of the intracellular 
cyclic-AMP concentration. This conclusion seems in contradiction with the traditional view 
(Barnes et ai. 1978; Stoof and Kebabian, 1981; McDonald et al., 1984) that D2 receptors 
inhibit secretory activity by decreasing the concentration of cyclic-AMP. It is, however, 
supporting evidence that more recently emerged from studies on mammalian pituitary cells that 
Dj receptors also inhibit secretion in a cyclic-AMP independent fashion (Lafond et al., 1986; 
Ray et al., 1986; Boyd et al, 1988). 
Theoretically, the cyclic-AMP-independent inhibition of a-MSH release by dopamine may 
involve two mechanisms: (1) reduction of the intracellular free Ca2+ concentration or (2) an 
increase of potassium influx. These possibilities arise from electrophysiological studies on 
melanotrope cells of the rat and the frog, which have provided evidence that activation of Dj 
receptors inhibits calcium (Williams et al, 1990b; Stack and Surprenant, 1991; Valentijn et 
al, 1991a; Keja et al, 1992) conductances and increases a potassium current (Stack and 
Surprenant, 1991; Valentijn et ai, 1991a; Keja et al, 1992). As to the first mechanism, our 
results show that it is unlikely that the dopamine-induced inhibition depends on the cytosolic 
concentration of Ca2+ because the calcium ionophore A23187 had no effect on the action of 
dopamine. It should be noted that treatment with A23187 is effective in raising intracellular 
Ca2* levels in Xenopus melanotropes, because in a separate experiment, using low extracellular 
calcium conditions to inhibit secretion, A23187 was effective in stimulating secretion (De 
Koning, unpublished results). With respect to the second mechanism, the absence of any effect 
by TEA or by 4-AP on dopamine-induced inhibition indicates that activation of a potassium 
current is also not essential for the action of dopamine on a-MSH secretion. This absence of 
effect of TEA and 4-AP was not the result of ineffective drug application, because both 4-AP 
and TEA stimulated a-MSH secretion, apparently as a result of potassium channel inactivation 
and subsequent membrane depolarization. We propose that, while part of the dopamine D2 
receptor mediated inhibition of secretion is effectuated by reducing adenylate cyclase activity, 
also at least one other, cyclic-AMP independent and pertussis toxin-sensitive mechanism is 
involved in secretory inhibition. In contrast, the reduction in cyclic-AMP production is 
sufficient to fully account for the inhibition of secretion through the GABAB receptor. The 
lack of effect of 4-AP and TEA on baclofen-induccd inhibition of a-MSH secretion action 
supports this conclusion. While GABAB receptor activation has been reported to inhibit cyclic-
Fig. 5. The effect of 4-AP (a), TEA (b) and 4-AP + TEA (c) on baclofen- and 
dopamine-induced inhibition of a-MSH release from superfused melanotrope cells. 
Concentrations used were 3.3*10* M (dopamine), ΙΟ5 M (baclofen), ΙΟ'3 M (4-AP) 
and 5*Iff3 M (TEA). TEA and 4-AP had no significant effect on the inhibitory action 
of baclofen or dopamine, either alone or together. Secretion was stimulated by 51 ± 9 
% by 4-AP (P<0.02), by 166 ± 26% by TEA (P<0.01) and by 347 ± ΙΙ6Ψ0 by the 
combination of the blockers (P<0.02). 
100 
GABAB and D2 receptors of melanotropes 
Percent Basal Release -
4-AP 
3 10 15 20 25 30 35 40 45 50 
Superfuàon Fraction Number 
Percent Baiai Release -
TEA 
S 10 15 ZO 25 30 35 40 45 50 
Superfusion Fraction Number 
, - Percent Bae&l Release -
TEA + 4-AP 
10 15 20 25 30 35 40 45 50 
Superfusion Fraction Number 
Ю] 
Chapter 7 
AMP production in many cell types (Wojcik et al., 1990) it has recently become known that 
this receptor often couples to 4-AP-sensitive potassium channels in neurones (Inoue et al., 
1985; Andrade et al., 1986; Ogata, 1990a,b). In the present study this coupling has been 
investigated for the first time in an endocrine cell type and no evidence for an involvement of 
potassium channels in GABAB receptor-mediated signal transduction has been gained. 
The conclusion that the D2 receptor and the GABAB receptor control distinct intracellular 
pathways is also supported by the dynamics of their inhibition of a-MSH release from 
supcrfused isolated melanotrope cells. While the dynamics of the action of both agents on 
intact neurointcrmcdiate lobes are very similar (e.g. rapidly reversible), their actions on 
isolated cells clearly differ: in contrast to baclofen-induced inhibition, the action of dopamine 
is not rapidly reversible and strongly prolonged. 
In conclusion, it appears that the dopamine D2 receptor, unlike the GABAB receptor, 
independently activates multiple intracellular pathways, each pathway being capable to induce 
a drastic inhibition of a-MSH release. It is highly probable that the physiological relevance of 
the simultaneous presence of dopamine D2 and GABAB receptors on melanotropes lies in the 
possibility for dopamine to control, in addition to a-MSH secretion, other important aspects of 
cellular functioning via additional signal transduction pathways. 
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Abstract. The effects of GABAA receptor activation on the secretion of a-melanophore 
stimulating hormone (α-MSH) from the superfused pars intermedia of the amphibian 
Xenopus laevis were examined The GABAA receptor agonist isoguvacine inhibited 
secretion of α-MSH from the pars intermedia, an action completely antagomzed by the 
chloride channel blocker Picrotoxin Isoguvacine stimulated secretion from picrotoxin-
treated tissue This effect was blocked by the GABAA receptor antagonist bicuculhne, 
indicating that it is a specific action via the GABAA receptor We conclude that, 
besides the inhibitory chloride channel, there is a stimulatory signalling property 
associated with the GABAA receptor Isoguvacine stimulated the production of cyclic-
AMP, an action that was not blocked by Picrotoxin This suggests that the stimulatory 
mechanism of the GABAA receptor involves, directly or indirectly, the generation of 
cyclic-AMP 
INTRODUCTION 
The GABAA receptor is the mam member of the chloride channel class of receptors in the 
central nervous system Activation of the receptor leads to channel opening, an milux of CI, 
and consequent hyperpolanzation and inaclivation of neurons Molecular studies have revealed 
that the GABAA receptor structure is very complex It has a multimene structure with 5 known 
subunits, oc, β, γ, δ and ε (for review see Burt and Kamatchi, 1991, Costa, 1991) Molecular 
analysis of cloned receptors indicates that different combinations of the various subunits can 
give nse to pharmacologically different receptor subtypes (Verdoom et al, 1990) To which 
degree this fact is responsible for the occurrence of functionally different GABAA receptors in 
native effector systems remains to be established In view of the potential for multiple GABAA 
receptor types, functional studies of native GABAA receptor action take on additional 
significance Such studies may reveal unique transmembrane signalling properties reflecting 
receptor heterogeneity for this important class of ion channel receptor 
Besides its central function, the GABAA receptor has been shown to have important 
neuroendoenne actions in the regulation of the secretion of pituitary hormones (Anderson and 
Mitchell, 1986, Virmam et al, 1990) The receptor is, for instance, directly involved in the 
regulation of α-MSH secretion from melanotrope cells of the pituitary pars intermedia, both in 
mammals (Tomiko et al, 1983, Demeneix et al, 1986) and amphibians (Adjeroud et al, 1986, 
Verburg-van Kemenade et al, 1987a, Louisct et al, 1990, Kongsamut et al, 1991) The 
secretion of α-MSH from superfused intermediate lobes can be easily measured and thus, by 
monitoring hormone secretion, the dynamics of integrated responses of this neuroendocrine 
transducer cell to receptor activation can be determined Therefore, the melanotrope cell is an 
ideal effector system to carry out functional studies of GABAA receptor action 
As expected, we have found that the inhibitory action of the GABAA receptor agonist 
isoguvacine on α-MSH secretion from superfused neurointermediate lobes could be completely 
blocked by the chlonde channel blocker Picrotoxin More interesting was the observation that, 
following this treatment, isoguvacine induced stimulatory responses The results of these 
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functional studies are presented here, together with the results of studies to establish the 
receptor specificity of the stimulatory response. In addition, the effect of isoguvacine on the 
production of cychc-AMP in superfused intermediate lobe tissue was analyzed to determine if 
the cyclic nucleotide could be involved in this stimulatory response of the melanotrope cell to 
GABAA receptor activation. 
MATERIALS AND METHODS 
Animals. Adult Xenopus laevis were bred in our aquatic facility and adapted to black background 
for three weeks pnor to the experiments. The animals were fed trout pellets (Trouvit, Trouw, 
Putten, The Netherlands) once a week The watertemperature was 22 °C. 
Tissue superfusion methods. Freshly dissected neurointermediate lobes were rinsed in Ringer's 
solution, containing 112 mM NaCl, 2 mM KCl, 2 mM CaCl2, 15 mM Hepes (pH 7.4), 0.3 mg/ml 
bovine serum albumin, 2 mg/ml glucose and 1 Mg/ml ascorbic acid, and placed individually on a 
filter in a 10 μΐ superfusion chamber Ringers solution was pumped through the chambers using a 
multichannel peristaltic pump at a rate of 1 5 ml/h and 7 5 mm fractions were collected and 
submitted to radioimmunoassay for ot-MSH and, in some experiments, also to a radioimmunoassay 
for cychc-AMP. In these latter experiments IBMX (Sigma, St Louis, MO) was present in the 
superfusion medium at a concentration of 10"* M Factors tested for their effect on a-MSH 
secretion were introduced to the superfusion medium, either alone or in various combinations 
These factors were- isoguvacine (Cambodge Research Biochemicals, Cambridge, UK), bicuculline 
(Sigma) and Picrotoxin (Sigma). The concentrations of the factors used, and their administration 
protocols, arc given in the Results 
Radioimmunoassay for a-MSH. The details of the assay have been reported earber (Van Zoest et 
al, 1989) Bound and free label were separated using the polyethylene glycol precipitation method. 
The assay shows equal affinity for desacctyl-ot-MSH and a-MSH and displays <0 01 % cross-
reactivity with adrenocorticotropic hormone. Sensitivity of the assay was 2 pg per sample of 50 μ] 
and each superfusion fraction was measured in duplicate. 
Radioimmunoassay for eyclic-AMP. Radioimmunoassay of cyclic-AMP was carried out according 
to the manufacturer's instructions (RPA 509, Amersham, Buckinghamshire, UK), with solutions of 
radioactive cychc-AMP and of first and second antibodies diluted 4-fold, without loss of sensitivity 
or selectivity of the assay. Detection limit was 1 fmole per sample of 100 μΐ The assay was 
performed using an Aspee automatic pipettor (Gilson, Vilhers le Bel, France). 
Calculations and statistics. In the figures data are graphically shown as means (n=4) and S.E.M. 
(vertical bars) of percent basal release. TTie 100% basal release was defined, for each lobe, as the 
mean a-MSH value in the three superfusion fractions immediately preceding the first treatment 
with isoguvacine In the case of the expenment with IBMX in the medium, 100% basal release of 
cyclic-AMP and a-MSH was defined, for each lobe, as the mean values in the three superfusion 
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fractions before each isoguvacine treatment. To calculate percentages of stimulation or inhibition of 
α-MSH release in the superfusion experiments, peak areas (before and during administration of 
ligands) were integrated and compared. The integrated areas were tested using Student's T-test. A 
Ρ value <0.05 was considered to indicate statistical significance. 
RESULTS 
The effect of Picrotoxin on isoguvacine-induced responses. Isoguvacine (IO-4 M) had a strong 
inhibitory action on α-MSH secretion which could be completely blocked by Picrotoxin (Fig. 
la). Picrotoxin itself had no clear effect on the secretion of α-MSH. However, a pulse of 
isoguvacine given after the Picrotoxin treatment resulted in a small but significant increase in 
α-MSH secretion (Fig. la). Stimulatory responses to isoguvacine were also seen following a 
short pulse of Picrotoxin (Fig. lb). The effect of Picrotoxin on isoguvacine responses was long 
lasting. The stimulatory response to isoguvacine was still evident two hours after Picrotoxin 
treatment (second post-picrotoxin isoguvacine pulse; Fig. lb) and, within the lime of the 
experiment, a full inhibitory response to isoguvacine never materialized following Picrotoxin 
treatment. 
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Fig. I. The effect of picrotoxin on isoguvacine induced inhibition of α-MSH secretion 
form superfused neurointermediate lobes of X. laevis. The vertical hatched areas 
indicate those fraction where isoguvacine (W4 M) was given. In (a) the isoguvacine 
was given during treatment with picrotoxin and in (b) the picrotoxin was given alone 
during 2 superfusion fractions. Picrotoxin concentration was 3.3*10"4 Μ. ¡η frame (a) 
Isoguvacine treatment subsequently caused 36.2 ± 5.6% (P<0.02) and 5.1 ± 4.4% 
(NS) inhibition and 18.4 ± 5.9% (P<0.05) stimulation. In frame (b) isoguvacine 
initially inhibited secretion by 33.7 ± 1.9% (P<0.001). After picrotoxin treatment 
isoguvacine subsequently stimulated secretion by 18.8 ± 3.4% (P<0.02), 3.4 ± 5.9% 
and 3.0 ± 9.3%. 
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The effect of bicucuUine on isoguvacine-induced responses. Isoguvacine (3.3 χ ΙΟ"5 M) 
induced a strong inhibitory response which could be completely antagonized by bicucuUine 
(Fig. 2). Because the stimulatory actions of isoguvacine following picrotoxin treatment were 
always small, we decided, in attempting to block the stimulation with bicucuUine, to 
simultaneously conduct control experiments with lobes not treated with bicucuUine. In this way 
direct comparisons could be made as to the degree of stimulation in the presence or absence of 
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Fig. 2. The effect of bicucuUine on isoguvacine induced inhibition of a-MSH secretion. 
Concentration of isoguvacine for each pulse was 3.3 χ 10'5 M and concentration of 
bicucuUine was W1 M. 
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Fig. 3. The effect of (a) picrotoxin and (b) picrotoxin followed by bicucuUine treatment 
on isoguvacine action on a-MSH secretion. The two experiments were conducted 
simultaneously. The concentration of isoguvacine was in each case 2 X Iff5 M, 
picrotoxin 10* M and bicucuUine IO4 M. In frame (a), the first post-picrotoxin pulse 
with isoguvacine caused a stimulation of 19.8 ± 6.7% (P<0.05). The second pulse had 
no significant effect on secretion (7.6 ± 6.0%). In frame (b), the post-picrotoxin pulses 
with isoguvacine had no effect on a-MSH secretion. 
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bicuculline. The control set of lobes gave an inhibitory response to the isoguvacine pulse given 
before picrotoxin treatment and stimulatory responses to each of the two isoguvacine pulses 
given after picrotoxin treatment (Fig. 3a). The first stimulatory response was significantly 
above basal level of secretion (P<0.05). These post-picrotoxin stimulatory responses were 
completely lacking in the bicuculline treated tissue (Fig. 3b). 
The effect of isoguvacine on the production of cyclic-AMP. Isoguvacine induced a clear 
increase in the efflux of cyclic-AMP to the superfusion medium (Fig. 4, upper profile). The 
isoguvacine treatment simultaneously induced an inhibition in the secretion of ot-MSH (Fig. 4, 
lower profile). Following picrotoxin treatment isoguvacine induced a slight but significant 
increase in cyclic-AMP efflux but had little or no effect on cx-MSH secretion (Fig. 4, upper 
and lower profiles, respectively). 
DISCUSSION 
It is generally known that activation of the GABAA receptor induces a chloride current across 
the plasma membrane. The current view is that the subunits of the GABAA receptor complex 
together form a CI-channel that opens upon receptor activation. In Xenopus melanotrope cells, 
GABAA receptor activation leads to an inhibition of a-MSH release (Verburg-van Kemenade 
et ai, 1987a), most likely through chloride ion influx and, subsequently, membrane hyper-
polarization. In accordance with this hypothesis, the chloride channel blocker picrotoxin 
antagonized the inhibition of a-MSH secretion induced by the GABAA receptor agonist 
isoguvacine. The stimulatory response induced by isoguvacine following picrotoxin treatment 
was our first indication that this receptor agonist has the potential to induce a stimulatory 
signalling event in Xenopus melanotrope cells. Apparently the effect of picrotoxin was long-
lasting because it took may hours following a single pulse of the toxin before there was any 
indication of a return of the inhibitory action of isoguvacine. It is unclear why stimulatory 
responses to isoguvacine appeared stronger in tissue pretrcated with the toxin rather than when 
the receptor agonist was given together with the toxin. 
The stimulatory action of isoguvacine on the secretory process of Xenopus melanotropes 
would appear to be a specific action on the GABAA receptor. This conclusion is based on the 
observation that the specific GABAA receptor antagonist bicuculline blocks the isoguvacine-
induced stimulatory responses. The observed stimulations do not appear to be equivalent to the 
very short, transient stimulations reported for GABAA receptor action on melanotropes of Rana 
(Adjeroud et al., 1986; Tonon et al., 1989). This latter stimulation is blocked by picrotoxin 
treatment and therefore it has been suggested that it could be the result of an efflux of СГ 
causing cell depolarization. In contrast, picrotoxin treatment was a prerequisite to obtain 
stimulatory responses from Xenopus melanotrope cells. We conclude that by blocking the 
strong inhibitory action of the GABAA receptor, through picrotoxin treatment, a stimulatory 
component of GABAA receptor action has come to the forefront. 
The stimulations induced by isoguvacine may very well be associated with production of 
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Fig. 4. The effect of Picrotoxin on the efflux of cyclic-AMP and secretion of a-MSH 
from superfused Xenopus neurointermediate lobes. The concentration of isoguvacine 
was 2*]0'5 M and Picrotoxin 3.3*10'' M. Cyclic-AMP production was stimulated by 
19.2 ± 7.6% (P<0.05) and 10.8 ± 3.6% (P<0.05). 
cyclic-AMP. This cyclic nucleotide is known to stimulate a-MSH secretion from melanotrope 
cells of X. laevis (Verburg-van Kemenade et ai, 1986). Moreover, as was previously reported 
(Verburg-van Kemenade et aL, 1987b), cyclic-AMP production, measured using a cyclic-AMP 
protein binding assay, is stimulated by isoguvacine in statically incubated Xenopus 
neurointenmediate lobes In the present study we measured the efflux of cyclic-AMP as an 
indication for the intracellular cyclic-AMP concentration. It is generally considered that this 
concentration is reflected by the amount of released cyclic-AMP (Barber and Butcher, 1983). 
Previous studies in our laboratory show that this is indeed the case for melanotrope cells of X. 
laevis (Jenks et al., 1991). Recently, we have conducted an extensive analysis of the 
appropriateness of efflux measurements to follow the dynamics of cyclic-AMP production 
(Chapter 6, this thesis). Using this approach we have now confirmed that isoguvacine 
treatment leads to an increase in the production of the cyclic nucleotide. The observation that 
isoguvacine still induced cyclic-AMP production after Picrotoxin treatment indicates that the 
stimulation of cyclic-AMP production is effectuated independently from isoguvacine action on 
the CI ion channel domain of the receptor. The fact that the increase in cyclic-AMP seen in 
these experiments was not accompanied by an increase in the secretion of a-MSH probably 
reflects the fact that these experiments were conducted in the presence of ШМХ, a 
phosphodiesterase inhibitor which is used to increase basal levels of cyclic-AMP thereby 
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permitting reliable measurements of the cyclic nucleotide. This treatment has previously been 
shown to render the Xenopus melanotropc cells insensitive to regulatory factors which 
stimulate secretion through activation of the adenylate cyclase system (Jenks et ai, 1991). This 
refractoriness is probably based on the fact that the intracellular cyclic-AMP levels in ШМХ-
treated cells is sufficiently high to fully support the secretory process. 
Our studies are the first to associate GABAA receptor activation with an increased 
production of cyclic-AMP. The exact mechanism coupling the Xenopus intermediate lobe 
GABAA receptor to cyclic-AMP production is unknown. It is clear that the action of the 
receptor on cyclic-AMP production is independent of its functioning as а СГ channel, and 
therefore we consider this action to reflect an independent signalling property of the receptor. 
GABAA receptors have no structural or functional similarity to receptors known to be directly 
involved in the regulation of adenylate cyclase, the so-called G-protein coupled receptors. 
Therefore, it would appear highly unlikely that the effect of the Xenopus intermediate lobe 
GABAA receptor on cyclic-AMP is through a direct coupling to the adenylate cyclase enzyme 
complex. A full explanation for this unique property of the Xenopus GABAA receptor awaits 
the structural characterization of the receptor. 
Concerning the potential physiological significance of the stimulatory component of the 
dual action of isoguvacine on a-MSH release, it is improbable that it would be directly 
involved in the control of a-MSH secretion. We observed this stimulation only when the 
inhibitory action of the receptor was blocked by a toxin. As no physiologically relevant 
mechanism to block CI" channel function is known, the stimulatory action on secretion would 
always be overshadowed by the more dominant inhibitory action of the receptor functioning as 
а СГ ion channel. Possibly, the cyclic-AMP generated through activation of the GABAA 
receptor has a function in the melanotrope cell that is not directly involved in regulating 
secretion, such as modulation of cellular functions related to long-term adaptational changes in 
biosynthetic or metabolic activity. 
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General discussion 
The studies desenbed in this thesis are concerned with the regulation of the activity of a 
neuroendoenne transducer cell, the melanotrope cell of the amphibian Xenopus laevis and with 
the mechanisms involved in this regulatory process Particular attention has been given to the 
charactenzation of the receptors involved in regulating the release of the main secretory 
product of the melanotrope, α-MSH, and of the second messenger systems that are controlled 
by these receptors 
Previous work (reviewed by Jenks et al, 1988) has identified a large number of receptors 
on Xenopus melanotrope cells Activation of these receptors causes an inhibition (dopamine Dj 
receptor, GABAA receptor, GABAB receptor and receptor for NPY) or a stimulation (receptors 
for CRH, sauvagine and TRH) of α-MSH secretion While the presence of these receptors in 
the pars intermedia was evident, there has been much debate as to the question of whether ot-
MSH receptors on the melanotrope cell exist (Kastm et al, 1971, Itumza, 1973, Huntington 
and Hadlcy, 1974) These receptors would be involved in autofeedback of α-MSH release In 
the expenments desenbed in Chapter 1, specific radioimmunoassays for α-MSH and ß-
endorphin (like α-MSH denved from POMC) as well as analysis of radiolabelled peptides 
have been earned out, to quantify the secretory response of melanotrope cells to α-MSH It is 
proven that a short-loop autofeedback system for α-MSH does not exist, though it remains 
possible that secretory products of melanotrope cells control their secretion through more 
complex feedback loops 
Most of the endogenous regulators of α-MSH secretion are known to act directly on the 
melanotrope cell (Verburg-van Kcmenade et al, 1986a, 1987a) Such action could not be 
demonstrated for NPY (Chapter 2) It was shown that NPY inhibits α-MSH release from 
cultured neurointcrmediate lobes, which do not contain presynaptic nerve terminals 
Apparently, NPY does not act m a presynaptic way on melanotrope cells The involvement of 
the folliculo-stellate cell of the pars intermedia in the indirect action of NPY on α-MSH 
secretion was therefore highly probable Indeed, receptors for NPY are present on Xenopus 
folliculo-stellate cells (De Rijk et al, 1991) The present study provided the first evidence that 
folliculo-stellate cells of the pars intermedia are involved in the regulation of an endocrine 
secretory process 
Chapter 3 addresses the question of the importance of the two GABA receptors m 
regulating α-MSH secretion For this purpose, a GABAB receptor antagonist, acting both m 
vivo and in viiro, was required Because no GABAB receptors of endoenne cells have been 
pharmacologically charactenzed, a survey way has been made of the effects of GABAB 
receptor antagonists used in non-endoenne systems, like the mammalian nervous system It 
appears that the pharmacological profile of the GABAB receptor of Xenopus melanotrope cells 
is rather similar to that of most GABAB receptors, though some differences are obvious From 
the use of the newly charactenzed antagonists, it is clear that, in vitro, the GABAB receptor is 
more sensitive to stimulation with GABA than the GABAA receptor Using the GABAB 
receptor antagonist in vivo, it appears that the GABAB receptor is either not involved or not 
essential in the tonic inhibition of α-MSH release in animals adapted to a white background 
Most likely, a mixture of inhibitory agents is involved in the in vivo process of melanotrope 
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cell-controlled background adaptation. 
The analysis of the signal transduction mechanisms controlled by the receptors that regulate 
ot-MSH secretion constitutes a large part of this thesis. In Chapters 4 and 5, the calcium/ІРз 
pathway was examined. It was found that the secretory process depends on the influx of 
extracellular calcium ions through voltage-operated calcium channels. From the observation 
that these channels are activated at high voltage (patch-clamp) and from their pharmacological 
profile (release studies) it is concluded that these channels are N-type voltage-operated calcium 
channels. In contrast to studies using frog and mouse melanotrope cells (Taraskcvich and 
Douglas, 1986; Lamacz et al., 1988), no evidence has been obtained for a role of the 
dihydropyridine-sensitive L-type calcium channel in the regulation of secretion. It is concluded 
that the exclusive involvement of N-type channels in the regulation of secretory activity of 
Xenopus melanotropes is a species specific phenomenon. Obviously, the Xenopus melanotrope 
may serve as a suitable model to study the significance of N-type channels for the control of 
endocrine secretory processes. 
The mobilization of Ca2* from intracellular stores does not seem to play an important role 
in the regulation of ot-MSH secretion, since thapsigargin, an agent known to mobilize calcium 
ions from intracellular stores, does not affect secretion. This notion is supported by the 
observation that established regulators of a-MSH secretion have no clear effect on IPj 
production. This second messenger is an endogenous mobilizcr of intracellular calcium (e.g. 
Bcrridge, 1987). The IPj/Ca2* mechanism in the melanotrope cell may be involved in long-
term changes in cellular activity occurring as a result of background adaptation (e.g. 
biosynthesis of secretory products). This is evident from the following data: (1) The IPj 
mechanism is much more active in black-adapted animals than in white-adapted animals. (2) 
After a shift in background colour, black animals retained the high level of inositol phosphates 
for several days, like white animals retained their low level of inositol phosphates. (3) The 
slow change in inositol metabolism coincides with the slow changes in biosynthesis of POMC 
mRNA (Ayoubi. 1991). 
Apart from calcium and IPj, the most important second messenger involved in the 
regulation of melanotrope cell activity is cyclic-AMP. Early studies had established that cyclic-
AMP production in Xenopus melanotropes is inhibited by dopamine and the GABAB receptor 
agonist baclofen and stimulated by sauvagine (Verburg-van Kemenade et al., 1987c; Jcnks et 
al., 1991). In these studies, static incubations were applied and, in part, a rather insensitive 
cyclic-AMP-binding assay. In Chapter 6, a new method for the simultaneous and dynamic 
recording of a-MSH release and cyclic-AMP production is described. The method is based on 
the assumption that efflux of cyclic-AMP from melanotrope cells is proportional to the 
intracellular concentration of the second messenger. This assumption is valid for cells in 
general (Barber and Butcher, 1981, 1983) and also for Xenopus melanotrope cells (Jenks et ai, 
1991). It is therefore possible to measure cyclic-AMP and a-MSH in the same superfusion 
fractions (using radioimmunoassays) and to study the dynamics of cyclic-AMP efflux in 
relation to a-MSH secretion. One of the most interesting findings is that an increase in cyclic-
AMP production is not necessarily coupled to an increase in a-MSH release. Probably, cyclic-
AMP plays an important role in secretion, but the stimulatory action of high cyclic-AMP 
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levels can be overruled by changes in the pla.sma membrane potential or the concentration of 
free cytosolic Ca2* Most likely, cychc-AMP controls other cellular processes besides the 
secretory activity In this way, cyclic-AMP may have a coordinating function with respect to 
different aspects of the complicated changes in cellular activity during background adaptation 
Dopamine and baclofen inhibit both ct-MSH release and cyclic-AMP efflux Both processes 
are inhibited with the same dynamics, suggesting a direct coupling between receptor and 
adenylate cyclase However, adenylate cyclase may not be the only effector coupled to 
dopamine or GABAB receptors of melanotrope cells In Chapter 7, it is shown that the 
inhibition of release induced by baclofen, but not by dopamine, can be reversed by agents that 
increase the intracellular concentration of cyclic-AMP This strongly suggests that the GABAB 
receptor is coupled to adenylate cyclase only, while the D2 receptor is coupled to at least one 
other mechanism capable of fiilly inhibiting oc-MSH release in a cychc-AMP-independent way 
Electrophysiological studies have shown that dopamine receptors of melanotrope cells may 
activate potassium channels and inactivate calcium channels in the plasma membrane 
(Williams et al, 1990b, Stack and Surprenant, 1991, Valentijn et al, 1991a,b, Keja et al, 
1992) However, the calcium lonophorc A23187 and blockers of potassium channels do not 
affect dopamine-induccd inhibition of a-MSH secretion It has to be concluded that the D, 
receptor directly controls multiple signal transduction mechanisms through a pertussis toxin-
sensitivc G-prolein Fach of these mechanisms is probably sufficient to completely inhibit a-
MSH secretion, but may have additional intracellular effects unrelated to secretion 
In Chapter 8, the signal transduction mechanisms of the GABAA receptor have been 
examined It is shown that the inhibitory action of this receptor is, as expected, mediated by an 
influx of chloride ions The inhibition of a-MSH release induced by the GABAA receptor 
agonist isoguvacine is completely antagonized by the chloride channel blocker Picrotoxin In 
fact, isoguvacine stimulated secretion after Picrotoxin, indicating the presence of a second 
signal transduction mechanism controlled by the GABAA receptor, which is independent of the 
chloride channel This second mechanism is somehow coupled to the cyclic-AMP pathway, as 
isoguvacine stimulates the efflux of cyclic-AMP from the cells, both before and after treatment 
with Picrotoxin This study is the first to associate GABAA receptor activation with a 
stimulation of cyclic-AMP production, but more study is required to establish by what 
mechanism the GABAA receptor interferes with the cyclic-AMP concentration 
It thus appears that all the inhibitory receptors have their own unique (set of) signalling 
mechanisms the NPY receptor acts on the folliculo-stellate cells to inhibit a-MSH secretion, 
the GABAB receptor inhibits adenylate cyclase, the dopamine receptor also inhbils cyclic-
AMP production, but has additional signalling mechanisms (probably couples to ion channels), 
and activation of the GABAA receptor induces a chloride influx and a stimulation of cyclic-
AMP production It is therefore probable that the physiological rationale of the multiple 
inhibitory receptors of Xenopus melanotrope cells is that each receptor has, besides its effects 
on secretion, diftercntial actions on additional cellular processes This possibility is currently 
under investigation in our department, and particular attention is being paid to differential 
etfects on processes related to background adaptation, like biosynthesis and processing of 
POMC, acetylation of POMC-dcnved peptides and the composition of the secretory signal A 
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model of the intracellular mechanisms controlled by the vanous receptors of Xenopus 
melanotrope cells is provided in figure 1 
Extracellular 
Fig. I. Overview of receptor-activated receptor mechanisms m melanotrope cells R = 
receptor, PKA = protein kinase A, PKC = protein kinase C. PLC = phospholipase C, 
AC = adenylate cyclase, DAG = diacy¡glycerol, IP3 = inositol 1,4,5-mphosphate, 
cAMP = adenosine 3',5'-cyclic monophosphate, ATP = adenosine 5'-tnsphosphate, D2 
= dopamine Dj receptor, В = GABAB receptor, А =САВАЛ receptor 
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De twee belangrijkste regelsystemen in dierlijke organismen worden gevormd door het 
zenuwstelsel en hel endocnene systeem Het zenuwstelsel verwerkt de zintuiglijke informatie 
en reageert daarop met signalen naar perifere organen, b ν spieren en spijsverteringsorganen 
Endocnene cellen produceren hormonen, die in het algemeen aan hel bloed worden afgegeven 
en op die manier naar doelwit-organen worden getransporteerd 
In alle dierlijke organismen is de samenwerking tussen het zenuwstelsel en het endocnene 
systeem van het grootste belang voor het optimaal functioneren van het organisme Door deze 
communicatie kan het dier met alleen zijn gedrag, maar ook lange-termijn processen, 
aanpassen aan veranderende omstandigheden Voorbeelden van zulke processen zijn groei en 
voortplanting 
Over de wijze waarop de interactie tussen zenuwstelsel en endocnen systeem verloopt 
bestaat nog veel onduideli)kheid Wel is duidelijk dal de communicatie in beide nchlingen 
verloopt het zenuwstelsel reguleert de activiteit van veel endocnene cellen en veel hormonen 
werken (mede) op het zenuwstelsel In sommige gevallen vindt een directe innervane van de 
endocnene klier plaats en wordt de secreloire activiteit van de endocnene cel bepaald door de 
hoeveelheid neurale boodschappers die door de zenuweinden worden afgegeven De neurale 
boodschappers, onder te verdelen in klassieke neurotransmitters en neuropeptiden, oefenen een 
stimulerende of juist een inactiverende invloed uit op de endocnene cel Dit proefschnft 
behandelt de vraag hoe de secretoire activiteit van een bepaalde endocnene cel, de 
melanotrope cel in de pars intermedia van de hypofyse van de amfibie Xenopus laevis, 
gereguleerd wordt door de neurale boodschappers 
De melanotrope cellen van Xenopus produceren het melanoforen-stimulerend hormoon (a-
MSH) Dit hormoon werkt op de pigment-bevattende cellen in de huid, de melanoforen, en zet 
aan tot dispersie van het zwarte pigment melanine Hierdoor knjgt de huid een zwart aanzien 
Voor het overleven van deze amfibie is het van belang dat zijn huidskleur wordt aangepast aan 
de kleur van de achtergrond Op een donkere achtergrond moet het dier dus een hoge 
concentratie a-MSH ш zijn bloed hebben, en op een lichte achtergrond een lage concentratie 
De kleur van de achtergrond wordt door het dier waargenomen en in het zenuwstelsel vertaald 
in activiteit van bepaalde neuronen in de hypothalamus Deze neuronen innerveren de 
hypofyse en geven daar hun boodschappers af die de activiteit van de melanotrope cellen 
bepalen Tot dusver zijn twee boodschappers geïdentificeerd die de afgifte van a-MSH 
stimuleren corticotropin-releasing factor (CRF) en thyrotropin-releasing hormone (TRH) Ten 
minste dne andere boodschappers inhiberen de hormoon afgifte γ-aminoboterzuur (GABA), 
dopamine en neuropeptide Y (NPY) De neurale boodschappers binden aan een voor die 
receptor specifieke receptor op het celoppervlak Het signaal dal de neurale boixlschapper 
vertegenwoordigt wordt door de receptor naar binnen doorgegeven door middel van een 
intracellulaire boodschapper ("second messenger") Activenng van de receptor zal dus leiden 
tot een toename of afname van de concentratie van intracellulaire boodschappers zoals calcium 
ionen, adenosine cyclisch S'.S'-monofosfaat (cychsch-AMP) of inositol 1,4,5-tnfosfaat (IP3) 
Dit proces wordt signaaltransductie genoemd 
Om meer inzicht te verknjgen in de manier waarop het zenuwstelsel de a-MSH afgifte 
reguleert, is in dit onderzoek aandacht geschonken aan de volgende vragen 1) Wordt de 
secretoire activiteit van melanotrope cellen uitsluitend bepaald door neurale boodschappers of 
is er ook een endocnene component betrokken bij de regulatie, mogelijk via een 
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terugkoppeling van het eigen secreticproduct op de afgifte ervan7 2) Werken de neurale 
boodschappers direct op de melanotrope cellen of zijn er andere hypofysecellcn die als 
intermediair optreden7 3) Welke receptoren worden door de verschillende boodschappers 
gebruikt en wat zijn de farmacologische eigenschappen van die receptoren7 4) Welke 
intracellulaire processen worden in werking gesteld door de binding van de neurale 
boodschappers aan hun receptoren7 
ad 1) Uit de expenmenten beschreven m hoofdstuk 1 blijkt dat a-MSH geen effect heeft op 
de afgifte van peptiden uit de melanotrope cellen Ook het volledige door melanolrope cellen 
afgegeven endocnene signaal (mengsel van peptiden) had geen invloed op het secretie proces 
Hieruit volgt dat de melanotrope cel niet gereguleerd wordt door middel van een direct 
tenigkoppelingsmcchanisme 
ad 2) De neurointermediaire lob bestaat uit een neuraal gedeelte (pars nervosa) en een 
endocnen gedeelte (pars intermedia) De pare intermedia wordt voor het overgrote deel 
gevormd door de melanotrope cellen, met daarnaast een kleine hoeveelheid glia-achtige 
stellaatcellcn Van de meeste van bovengenoemde neurale boodschappers is aangetoond dat 7e 
direct aangnjpen op de melanotrope cel Voor NPY kon dit niet worden aangetoond 
(hoofdstuk 2) NPY remde wel de a-MSH secretie door gekweekte ncuromicrmediaire lobben, 
die geen functionerende zenuweinden maar wel stellaatcellcn bevallen Kennelijk inhibecrt 
NPY de a-MSH secretie op indirecte wij/e, via de stellaatcel 
ad 3) Hoofdstuk 3 behandelt de receptoren voor een van de andere neurale boodschappers, 
GABA De melanotrope cel heeft twee verschillende receptoren voor deze neurotransmitter, de 
GABAA receptor en de GABAB receptor Activalie van de A of В receptor induceert een 
remming van de a-MSH secretie Om de bijdrage van elk type GABA receptor in de regulatie 
van de a-MSH secretie te onderzoeken was de farmacologische karaktensermg van beide 
receptoren noodzakelijk De farmacologie van de GABAA receptor is reeds eerder beschreven, 
maar voor GABAB receptoren van endocnene cellen was geen antagonist bekend Met behulp 
van de in dit hoofdstuk geïdentificeerde antagonisten werd vastgesteld dat de GABAB receptor 
gevoeliger is voor stimulatie met GABA dan de GABAA receptor Verder werd gevonden dat 
activatic van de GABAB receptor m vivo met essentieel is voor de inhibitie van α-MSH 
secretie in dieren die zijn geadapteerd aan een witte achtergrond Waarschijnlijk is een 
mengsel van meerdere inhibercnde neurale boodschappers verantwoordelijk voor de inhibitie 
van de secretie 
ad 4) De hoofdstukken 4-8 behandelen diverse aspecten van de intracellulaire processen van 
de melanolrope cel Aandacht wordt gegeven aan zowel de basale condities van de 
ongestimuleerde cel in vitro (hoofdstukken 4-6) als aan de effecten van activatie van specifieke 
receptoren op die intracellulaire processen (hoofdstukken 5-8) 
In hoofdstukken 4 en 5 wordt de rol van het Са27ІРз systeem van signaaltransductie 
behandeld Met behulp van clectrofysiologische technieken werd vastgesteld dat de 
melanotrope cellen van Xenopus spontane actiepotentidlen vuren en voltage-afhankelijke 
calciumkanalcn bezitten De rol van deze kanalen werd verder onderzocht met superfusie 
technieken Hel blijkt dal influx van Ca2* door met name N-type calciumkanalen essentieel is 
voor de α-MSH secretie Het vnj maken van calcium ionen uit intracellulaire opslag lijkt 
weinig bij te dragen aan de secretie Dit is in overeenstemming met de bevinding dal de 
concentratie van de intracellulaire boodschapper IP3, die Ca2+ vnj maakt uit iniracellulaire 
depots, niet of nauwelijks beïnvloed wordt door activatie van receptoren voor dopamine en 
GABA Mogeli|k is intracellulair opgeslagen calcium betrokken bij andere cellulaire processen 
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zoals biosynthese. Dit wordt gesuggereerd door de langzame veranderingen in IP, concentratie 
nadat dieren die geadapteerd zijn aan een zwarte achtergrond op een witte achtergrond 
geplaatst worden. 
Hoofdstukken 6-8 behandelen onder meer de rol van de intracellulaire boodschapper 
cyclisch-AMP in de regulatie van de a-MSH secretie. Er werd vastgesteld dat deze 
boodschapper een belangrijke rol speelt in de regulatie van de afgifte van a-MSH. Activering 
van de dopamine receptor of de GABAB receptor leidt tot een sterke daling in de produktie 
van cyclisch-AMP, die samenvalt met de remming van het secretieproces. Bovendien 
veroorzaken sauvagine en CRH (peptiden die de a-MSH afgifte stimuleren) een sterke stijging 
van de cyclisch-AMP produktie. De correlatie tussen intracellulaire cyclisch-AMP concentratie 
en secretie is echter niet absoluut, zoals blijkt uit experimenten met agentia die wel de 
cyclisch-AMP produktie verhogen, maar niet de a-MSH afgifte stimuleren. Ook het feit dat 
activatie van de GABAA receptor, hetgeen leidt tot remming van de secretie, een lichte stijging 
van de cyclisch-AMP produktie tot gevolg heeft, duidt er op dat de cyclisch-AMP concentratie 
en secretie-activiteit niet altijd direct gekoppeld zijn. Deze experimenten en het feit dat het 
effect van dopamine niet afhankelijk is van de intracellulaire cyclisch-AMP concentratie, 
bewijzen dat de cyclisch-AMP concentratie een belangrijke factor is bij het reguleren van de 
secretie, maar dat onder sommige omstandigheden bijvoorbeeld de potentiaal van de 
celmeinbraan of de calcium concentratie bepalend is. 
Het onderzoek heeft aangetoond dal de neurale boodschappers die de secretoire activiteit 
van de melanotrope cellen van Xenopus laevis bepalen, dit elk op een unieke wijze doen. 
Hierbij zijn de stcllaatcellen betrokken en een aantal verschillende signaaltransductie systemen. 
Vervolgonderzoek zal moeten aantonen of de verschillende boodschappers dus ook 
verschillende cellulaire processen reguleren, afgezien van het effect op a-MSH secretie. Dit zal 
dan een antwoord geven op de vraag waarom er zoveel boodschappers betrokken zijn bij de 
regulatie van de melanotrope cel en mogelijk leiden tot een groter inzicht in de fysiologische 
betekenis van de secretieproducten van de melanotrope cel. 
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